Comitato Scientifico

Dott. Stefano Ciaurelli, Msc

Scritto da Fabio Miliucci il 15 Aprile 2024. Pubblicato in Comitato Scientifico.

DIRETTORE AREA CLINICA CENTRI VITA365
E CMNS/VITA365

EDUCATION

Post-Graduate Research Assistant – University of Rome “La Sapienza”
Second level Master’s Degree in Genetics e PNEI – University of Rome “La Sapienza”
Graduate Research Assistant – Santa Lucia Foundation (FSL)
Master’s Degree – University Hospital “Bio-medical Campus” of Rome

REFERENCES

Resolutive Treatment of Actinic Keratosis through Peptides Extracted from Zebrafish Conveyed Across Laser-assisted Transcutaneous Delivery (Cryopass Therapy)
– Biava PM, Ciaurelli S, et al 2024
Speech to the European Parliament, Bruxelles 28/11/2023:
Prevenzione per la salute, nuovi approcci prospettive
Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryo during Organogenesis and their Role as Epigenetics Regulators able to Reverse Neurosensory Hearing Loss
– Biava PM, Ciaurelli S, et al 2022
Paradigm Shift: an overview of Nutrigenetics and Nutrigenomics
– Biava PM, Ciaurelli S, Gonzales MJ et al. 2021
From genetics determinants in the development of the general stress adjustment syndrome to the endophenotype of nutritional stress: characteristics and associated nutritional strategies
– Businaro R. & Ciaurelli S. 2017
Insulin receptor β subunit haploinsuffociency and long term depression: functional relationship between synaptic plasticity and auto-Nagy
– D’Amelio M, Ciaurelli S et al. 2015
Artoi 2021 international guidelines, along with SIO (Society Integrative Oncology)
Visiting Professor University of Rome “La Sapienza”
Reviewer of “Cancers”
Science communicator through television and web

Prof. Trevor Cornelius Stuart Archer, MD, PhD

Scritto da Fabio Miliucci il 15 Aprile 2024. Pubblicato in Comitato Scientifico.

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

Born: 25th October 1949
Nationality: British + Swedish citizenship.

Education and Appointments

1967 General Certificate of Education, ‘O’ levels – Wallington Grammar School, Surrey, England;
1969 Ordinary National Certificate, ONC, Applied Biology, Cambridgeshire College of Arts and Technology, Cambridge, England;
1971 Higher National Certificate/Diploma [BA], HNC/D, Applied Biology, Cambridgeshire College of Arts and Technology (now Cambridge Polytechnical College), Cambridge, England;
1974 Bachelor of Science, Single Honours ‘Psychology’, University of Newcastle-Upon- Tyne, Newcastle, England;
1979 Doctor of Philosophy, ‘Psychology’, Uppsala University, Uppsala, Sweden. 1981-Docent (Psychology), Uppsala University, Uppsala, Sweden.
1982. Docent (Psychiatric & Neurophysiologic Department), Ulleråkers Hospital, Uppsala.
1985. Professor (Psychology), Umeå University; Göteborg University (main affiliation); GuestProfessorships: Karlstad University; Örebro University; Madrid Complutense, Spain; Kalmar University, Sweden; Visiting Professor, University of Hawaii at Manoa, USA; Madrid University, Spain; La Sapienza University, Rome, Italy.
1978 Behavior Therapy Course (10-points). Course Supervisor. P-O Sjödén, Bengt Andersson.
1983, 1985, 1987 Leadership Techniques and Training with Negotiating Techniques. (Arranged by Astra Läkemedel AB). Stockholm, Södertälje & Åtvidaberg).

Positions

UK:

1967-1971 Assistant Scientific Officer, Institute of Animal Physiology, Babraham, Cambridge, England; Single Honours (’71-’74: University of Newcastle-upon-Tyne).

Sweden:

1974-1976 Laboratory Assistant, Neurophysiology Laboratory, Ulleråkers Hospital, Uppsala,
1976-1978 Mental Nurse (‘heltid’), Geriatric Ward, Ullersåkers Hospital, Uppsala, Sweden;
1978-1983 Research Scientist, Pharmacology Department, Astra Läkemedel AB, Södertälje, Sweden;
1983-1988 Head of Department for Psychoneuropharmacology, Astra Läkemedel AB, Södertälje, Sweden; Projektleader-Antidepressants-anxiolytics 1985-1988. 1985-1988 ‘Extraordinary’-professor (Adjunct), Umeå University, Umeå, Sweden.
1989[1stjan] – Professor, Department of Psychology, Göteborg University, Sweden. 1989-1996 Ordförande, Forskarutbildningsnämnden [Chairman, PhD-program Committee].
1989-present Founder and Member of PHD-program Committee [FUN and FUB].
1991-1993 Head (prefekt) of Department of Psychology, Göteborg University, Sweden.
1993-1995 Dean of Faculty of Social Sciences, Göteborg University, Sweden.[1993/4- both Head of Department and Dean-of-Faculty].
1995-1996 Committee for Assurance of Teaching Quality and Standards, University of Göteborg.
University/University-Hospital/Courses Affiliations:
1981-1989 Associate Professor, Psychology, Associate Professor, Ulleråker Psychiatry, Uppsala University, Sweden.
1988. ‘Extra’-ordinary Professor, Biological Psychology, Umeå University, Sweden.

Lab. Association Dept.Of Pharmacology.
1993-present Visiting Professor – Substance abuse, schizophrenia and PTSD clinical studies –
University Hospital of the 12th October, Madrid, Spain.

1994-jun-aug Visiting Professor, University of Hawaii at Manoa, Honolulu, Hawaii. Summer school – 2 postgraduate + 1 graduate courses [seven-week courses]. 1996-present Psychobiology [basic neurobiology, stress and health, drug abuse] course for socionom students, two terms/year, at the University of Orebro, Sweden. [Organiser].

1998 One-month course on Nootropic Drugs and Memory Models, for trainee psychiatrists, University of Madrid, Madrid, Spain.

2000-2004 Guest Professor at the University of Karlstad, Sweden.
2000-2001 Biopsychology (10 points) and Neuropsychology (5 points) postgraduate courses at the Universities of Örebro and Karlstad. [Organiser + Lecturer]

2000-2001
Neuropsychology postgraduate course (10 points) at University of Örebro.

[Organiser + Lecturer] 2002. Neurobiology of Cognition & Memory (5 points) postgraduate 2001-2002 ” ” Emotion, Stress & Personality (5 + 5 points)

2001-2005 Examiner [Examinator] – Degree of Master’s Examination – Karlstad University.
2005. Guest Professor at the University of Örebro, Examiner: C-kurs/D-kurs.
2003-8; 2010- Guest Professor at the University of Kalmar (Linne).Research Coordinator

[Psychology]; Examiner – sports and health.

8. Research Coordinator [Sports and Health]. Examiner: C-kurs/D-kurs. 2006-2009
Assessor [together with Professor emeritus Sven Carlsson], ranking the National Clinical Psychology Final Reports [Psykolog examensarbete].

Professional Invited Affiliations [Editorships] – International journals/societies:

– Founding Member of European Behavioural Pharmacology Society, 1984

Editor & Editorial Board

-(1) Editor, Scandinavian Journal of Psychology, 1988-96.
-(2) Editorial Board member of the Journal, Experimental Animal Behaviour, 1985- Treasurer and Executive Committee of the European Behavioral Pharmacology Society, 1986-92.
– Committee of European Brain & Behaviour Society, 1988-90.
-(3) Editorial Board member of the Journal, Behavioral Pharmacology, 1989-2010.
– Re-elected to EBPS full committee, 19th May, 1996-, Cagliari, Sardinia.
-(4) Editorial Board member of the Journal, Neurotoxicity Research, 1999

Founding Member of the Neurotoxicity Society, 1999.
-Council for the Neurotoxicity Society, 2001.
-(5) Editorial Committee of The European Journal of Psychiatry, 2004-
President, Neurotoxicity Society, 2005-2007.
-(6) Regional Editor, The Open Toxinology Journal, 2008-
-(7) Editorial Board member of the Journal, Acta Neurologica Scandinavica, 2008-(
8) Editorial Board member of the Journal, Advances in Integrative Omics and Applied Biotechnology, 2011-.
-(9) Editorial Board member, and Co-Editor, of the Journal, PSYCH JOURNAL, 2011-. -(10) Editorial Board member of the Journal, World Journal of Trauma and Critical Care.
-(11) Co-Editor andEditorial Board member of the Journal, Journal of Symptoms and Signs.
-(12) Editorial Board member, and Co-Editor, of the Journal, Dataset Papers in Cells Biology.
-(13) Editorial Board member of the Journal, Journal of Neurological Disorders.
-(14) Editorial Board member of the Journal, Intellectual Disability Diagnosis Journal. -(15)Editorial Board Member of the Journal, Journal of Neurology and Neurophysiology. -(16) Editorial Board Member of the Journal, International Journal of School and Cognitive Psychology.
-(17) Guest Editor of the Journal, Personality Science and Individual Differences: Character, Responsibility and Well-Being.
-(18) Editorial Board Member of the Journal, Autoimmune Disease and Theoretical Approaches.
-(19) Lead Guest Editor of the Journal, BioMed Research International Special Issue: Brain Toxicology and Disease States.
-(20) Editorial Board Member of the Journal, Pharmacologia
-(21) Editorial Board Member of the Journal, the Open Conference Proceedings Journal -(22) Editorial Board Member of the Journal, Journal of Health Science
-(23) Associate Editor of the Journal, Clinical Medicine, OMICS.
-(24) Editorial Board Member of the Journal, The Open Access Journal of Science and Technology.
-(25) Editorial Board Member of the Journal, Journal of Reward Deficiency Syndrome

(JRDS).
-(26) Editorial Board Member of the Journal, International Journal of Autoimmune Disorders and Therapy (IJADT).
-(27) Editorial Board Member of the Journal, SM Journal of Neurology and
Neuroscience.
-(28) Editorial Board Member of the Journal, Archives of Depression and Anxiety.
-(29) Editorial Board Member of the Journal, Psychiatry, open access.
-(30) Editorial Board Member of the Journal, Journal of Psychological Sciences.
– (31) Editor-in-Chief and Editorial Board Member of the Journal, Clinical and Experimental Psychology.
– (32) Editorial Board Member of the Journal, Clinical Depression.
– (33) Editorial Board Member of the Journal, Journal of Trauma & Acute Care.
– (34) Associate Editor, Cellular and Molecular Biology.
– (35) Editor-in-Chief and Editorial Board Member of the Journal, Journal of Psychiatry and Psychology Research: Well-being, Empowerment and Affective Profiles.
– (36) Editorial Board Member of the Journal, Bio Accent Open Access Journals Psychology.

Doctoral/Postgraduate Supervision:

-Abdul K. Mohammed – Umeå University – Examined October, 1986.
– Bruce G. Minor – Karolinska Institute – Examined March, 1987
– Johan Luthman1 – Karolinska Institute – Examined October, 1989. -Anders Fredriksson – Uppsala University – Examined September, 1994. -Torsten Norlander2 – Göteborgs Universitet – Examined May, 1997.

– Nadja Schröder3 – University of Porto Alegro, Brazil – Examined 9th September, 1999. Anki Nordmarker – Göteborgs Universitet – Psychology, examined for Master’s degree, October, 2010.
Henrik Bergman- Göteborgs Univ. – Psychology – Master’s(Lic), Examined 23rd october 2008

Anette Kjellgren- Göteborgs Universitet – PhD examined, 21 November, 2003. Överläkare Madeleine Zöller – Göteborgs University – Psychology, examined Masters 2009.
Erik Wästlund – Göteborgs University – Psychology, examined 23rd February, 2007. Ulla Karilampi- Göteborgs University – Psychology, examined Masters 2009,
Doctoral Dissertation examined 14th October, 2011.
Thomas Theorin – Örebro University – Psychology
Cristina Diaz Berciano – Madrid University [Complutense] – examined Masters, 2004. Eva Johansson – Göteborgs university – Psychology, examined 2002.
Per Kristiansson – Göteborgs university – PhD Examined 12th September, 2003.
Nina Svensson – Göteborgs university- Psychology, examined Masters, October, 2010.

Ann-Christine Andersson-Arntén – Göteborgs univ. – Masters’(Lic), Examined,9th may 2008
Caroline Wass6-Göteborgs university, Med.Fac Pharmacol, PhD,examined 14th December

2007
Lars Helldin4 – Uppsala university (Med.Fac.) – Psychiatry
Frank Stenman7 – Göteborgs university- Psychology
Erica Karlsson – Göteborgs university- Psychology – Masters (Lic), Examined, 9th may 2008; [Doctoral Dissertation examined 8th May (see below) ].
Erica Schütz, Göteborgs university- Psychology, Doctoral dissertation, 8th may, 2015. Per Hellström8 – Göteborgs university – Clinical Neuroscience, examined Doctoral Dissertation, May, 2011.
Anders Hedin – Örebro universitet – Idrottsvetenskap, Stage I (75%) examination 2008- 05-05;
doctorsexamination 2012-05-25.
Danilo Garcia9 – Göteborg university – Psychology, examined Doctoral Dissertation, 15th March 2012.
Kjell Svensson10 – Linnea university – Sports and Health Science.
Ali Al Nima – Göteborg university – Masters in Psychology.

1assistent-supervisor (Behav.Pharm.) to Doc. G. Jonsson (Astra Arcus AB) 2with Dr. R. Gustafsson as assisting supervisor (Örebro University)
3with Dr. I. Izquierdo as joint-supervisor (University of Porto Alegro, Brazil) 4assistent supervisor with Doc. L. Ekselius (Uppsala university)

5assistent supervisor with Doc. L. Svensson (Med. Fac., GU) 7with Doc. I. Thylefors (Psychology),
8with Carsten Wikkelsöö
9with Anwer Siddiqui

10with Marie Alaricsson

External Examiner (Fakultetsopponent vid doktorsdisputation):

-Tapani Korhonen – Jyväskylää Universitet, Finland, 1987.
-Per Kristian Ejde – Bergen Universitet, Faculty of Medicine, Norway, 1989.
-Arto Hiltunen – Uppsala Universitet, Sverige, 1990.
-Anders Lund – Bergen Universitet, Faculty of Medicine, Norway, 1992.
– Jonas Ahlbom – Uppsala Universitet, Faculty of Medicine, Uppsala, Sweden, 1995. -Riina Haidkind – University of Tartu, Tartu, Estonia, 2004.
-Patrik Millet – University of Luleå, Sweden, 2005.
-Pia Leppänen – University of Åbo, Åbo, Finland, 2009.

Assignments to Committees for Decisions concerning Academic Positions:

Assessed Professorships, Deans, Readers, Lecturers.[University-position- recommendation].

Bergen-Professor-Dr. Håkan Sundberg, 1989, later appointed Dean of Social Sciences, 1990

Cambridge university-Reader-Barry Everitt, 1989
Uppsala University-Professor-Dr. Bo Ekehammer, 1992,
Stockholm University-Professor-Dr. Lars-Göran Nilsson, 1993,
Umeå University-Professor-Dr. Claes von Hofstein, 1995,
Lund University-Professor-Dr. Kenneth Hugdahl [Proposed], 1994, Trondheim University-Professor-Dr. David Benton[Proposed], 1995, Trondheim University-Professor-Dr. S. Hansen[Proposed], 1995, Liverpool University-Professor-Dr. Steven Cooper [Proposed], 1994, Nottingham University-Professor-Dr. Steven Cooper[Proposed], 1993, Leeds University – Professor – Dr. Steven Cooper[Proposed], 1991,

Leeds-Professor-Dr. R. John Rodgers, 1997,
University of California at Irvine-Distinguished (Outstanding level & Academy of Science)-
Professor-Dr. James L. McGaugh, 1988,
Liverpool-Professor-Dr. Everard Thornton, 1992,
Åbo University- Professorship in the Humanities at the Swedish Language – Åbo Academy
University [Åbo Akademi, Humanistiska fakulteten], Matti Lainen, 2000,
Göteborg- Assoc. Professor-Ulf Berggren [Faculty of Dentistry], 1995,
Göteborg – Full Professor-Ulf Berggren [Faculty of Dentistry], 2003,
Uppsala – Full Professor-Mona Eliasson [Faculty of Social Sciences], 2003, Mittuniversitet, Östersund – Full Professor-Stig Vinberg [hälsovetenskap med inriktning mot arbetsliv]. 2011.
Karlstad Universitet, Institutionen för Sociala och Psykologiska studier, Professor i Psykologi – Anna Stigsdotter Neely, feb., 2015.
Hawaii-Fellow for Center of Advanced Studies in Behavioural Sciences-Professor Caroline Blanchard, 1995,
Tel Aviv,Isreal-Assistent Professor-Dr. Ina Weiner, 1991, 1993,
Institute of Neurology, University of London-Reader-Dr. J.L. Herberg, 1990, Liverpool-Reader-Dr. Everard Thornton, 1989,
Lancashire Polytechnic-Dean of Nursing Faculty-Dr. Everard Thornton, 1993, Newcastle, NSW, Australia-Associate Professor- Dr. H. Peter Pfister, 1990, again 1992, and again 1993.
Tel Aviv, Israel-Senior Lecturer+Fellow- Dr. Ina Weiner, 1990, again 1992.
Tuebingen, Germany – Prof. Werner Schimdt – Career assessment for MaxPlanck Institute, 2006.
Örebro-Lecturer-Dr. Pia Wennerholm, 2002,
Örebro-Lecturer-Dr. Annika Lantz, 2002,
University of the West Indies-Senior Lecturer- Dr. E. Thornton, 2002 London-Psychiatric Consultant-Dr. Madeleine Zöller, 2002,
East Anglia- Psychiatric Consultant-Dr. Madeleine Zöller, 2002,
Exeter- Psychiatric Consultant-Dr. Madeleine Zöller, 2002,
Thames region- Psychiatric Consultant-Dr. Madeleine Zöller, 2002,
University of West Indies, Trinidad-Senior Lecturer-Everard Thornton, 2003, Örebro-Lecturer-Dr. Anna Karen Andersson, 2003,
Örebro-Lecturer-2005
Örebro-Lecturer- Clinical Psychology-2006
Örebro-two lectureships-Psychology(developmental)-2008

Linné University lectureship-Clinical and Neuropsychology – Karin Grip – 2014. Karlstad University lectureship-Psychology-2015-Anna Neely-
Umeå University Lectureship-Sports Psychology-2015-6 –
Uppsala-Docent-Dr. Mona Eliasson, 1989, Professorship, 2007. Stockholm-Docent-Dr. Marie-Louise Wadenberg, 1998,

Luleå-Docent-Dr. Karl W. Sandberg, 1998,
Jyväskylä-Docent-Dr. Tapani Korhonen, 1990, Göteborg-Docent-Dr. Lena Nordholm, 1994,
Göteborg-Docent-Dr. Torsten Klint, 1993,
Göteborgs university, Social Sciences Faculty, Danilo Garcia, 2015.

Between 20-22 other senior lectureships/professorships (e.g. von Hofstein, Erneling, Lyxell, Hemlin, Öhlund, Molander, Lundquist, Persson, Gustafsson, etc,) lectureships, and ‘forskarassistent-ships’ (e.g. Nyberg, Gustafsson) not listed above have been carried out for Swedish and foreign universities.

Books/Edited Journal Issues:

1. Perspectives on Learning and Memory, coedited by L.G. Nilsson and T. Archer, LEA, New Jersey, 1985.
2. Aversion, avoidance and Anxiety: Perspectives on aversively motivated behavior, coedited by T. Archer and L.G. Nilsson, LEA, New Jersey, 1989.

3. Attention Deficit Disorder: Clinical and Basic Research, coedited by T. Sagvolden and T. Archer, LEA, New Jersey, 1989.
4. Behavioral Pharmacology of 5-HT, coedited by P. Bevan, A. Cools and T. Archer, LEA, New Jersey, 1989.

5. Behavioral Biology: Neuroendocrine Axis, coedited by Trevor Archer and Stefan Hansen, Lawrence Erlbaum Assoc. Publ., New Jersey, 1991.
6. Strategies for Studying Brain disorders: Affective Disorders and Drug Abuse, Vol. 1, coedited by Tomás Palomo and Trevor Archer, Farrand Press and Complutense, London and Madrid, 1994.
7. Strategies for Studying Brain disorders: Schizophrenia, Movement and age related cognitive disorders, Vol. 2, coedited by T. Palomo, T. Archer and R. J. Beninger, Farrand Press and Complutense, London and Madrid, 1994.
8. Dopamine Disease States.Edited by R.J. Beninger, T. Palomo and T. Archer, Madrid University Press, 1996.
9. Estados Patológicos De La Dopamina, Edited by R.J. Beninger, T. Palomo and T. Archer, Madrid University Press, 1997.
10. Interactive Monoaminergic Disorders. Edited by T. Palomo, R.J. Beninger and T. Archer, Madrid University Press-Editorial Sintesis, 1999.
11. Avances Neurocientificos y Realidad Clinica.I TRASTORNOS AFECTIVOS.[Advances in Neurosciences and Clinical Realities. I Affective Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 1999.
12. Avances Neurocientificos y Realidad Clinica. II TRASTORNOSESQUIZOPSICÓTICOS. [Advances in Neurosciences and Clinical Realities.II
Schizopsychotic Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2000.
13. Avances Neurocientificos y Realidad Clinica.III ALCOHOLISMO Y

TOXICOMANIAS. [Advances in Neurosciences and Clinical Realities.III Substance Abuse Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2001.
14. Catecholamines in Brain Disorders. Edited by T. Palomo, R.J. Beninger and T. Archer, Madrid University Press, 2001, in press.

15. Neurodegenerative Brain Disorders. Edited by T. Palomo, R.J. Beninger and T. Archer, Editorial Sintesis, Madrid, 2001.
16. Neurotoxicity Research: Neurotoxicological Aspects of Drug Abuse. Edited by R.M. Kostrzewa and T. Archer, Harwood Academic Publications, London, 2000.

17. Neurotoxicity Research: Neuroprotection and Restoration. Edited by R.M. Kostrzewa and T. Archer, Harwood Academic Publications, London, 2000, Volume 2.
18. Avances Neurocientificos y Realidad Clinica.IV TRASTORNOS COGNITIVOS. [Advances in Neurosciences and Clinical Realities.IV Cognitive Disorders], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2001. 19.Neurodevelopmental Liabilities Underlying Brain Disorders. Edited by T. Palomo,

R.J. Beninger, R.M. Kostrzewa and T. Archer, Graham Publishing, Graham Publishing, Mountain View, 2003.
20.Avances Neurocientificos y Realidad Clinica. V NEUROIMAGEN EN PSIQUIATRIA,[Advances in Neurosciences and Clinical Realities. v Neuroimaging

in psychiatry], Edited by T. Palomo, R.J. Beninger, M.A. Jiménez-Arriero and T. Archer, Editorial Sintesis, 2002.
21. Neurotoxicity Research: Neurodevelopmental liabilities in Drug Abuse. Edited by R.M. Kostrzewa, T. Palomo, R.J. Beninger, & T. Archer, Harwood Academic Publications, London, 2002.

22. Neurotoxicity Research: Neurodevelopmental liabilities in Schizophrenia and Affective Disorders. Edited by R.M. Kostrzewa, T. Palomo, R.J. Beninger, & T. Archer, Harwood Academic Publications, London, 2002.
23. Neurotoxicity Research: Neurodevelopmental liabilities in Movement disorders. Edited by T. Archer, Graham Academic Publications, London, 2003.

24. Gene-Environment interplay in Alcoholism and Substance Abuse Disorders. Edited by T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer, Graham Publishing, Mountain View, 2004.
25. Gene-Environment interplay in Affect and Dementia. Edited by T. Archer, Graham Academic Publications, Mountain view, 2004.
26. Gene-Environment interplay in Neurogenesis and Neurodegeneration, .Edited by T. Palomo, R.J. Beninger, R.M. Kostrzewa and T. Archer, Graham Publishing, Mountain View, 2004.
27. Gene-Environment interplay in Schizopsychotic Disorders, Edited by T. Palomo, T. Archer, R.M. Kostrzewa and R.J. Beninger, Graham Publishing, Mountain View, 2005.
28. Gene-Environment interplay in Neuropsychiatric Disorders, Edited by RJ Beninger, T Palomo, RM Kostrzewa and T Archer, Graham Publishing, Madrid and Mountain View, 2005.
29. Implications of Co-morbidity for Neuropsychiartic Disorders, Edited by T Palomo, RJ Beninger, RM Kostrzewa and T Archer, Graham Publishing, Madrid and Mountain View, 2007.
30. Neuronal Substrates of Co-morbidity, Edited by T. Archer, Volume 12, Graham Publishing, Madrid and Mountain View, 2007.
31. Beyond Neuropsychiatric Diagnostics: Symptoms not Disorders, Edited by T Palomo,

RJ Beninger, RM Kostrzewa and T Archer, Graham Publishing, Madrid and Mountain View, 2009.
32. Handbook of Neurotoxicity: Neurologic and Psychiatric Disease, Edited by T. Archer and U. Sailer, Springer, 2014.

33. Book Series: Frontiers in Personality Science and Individual Differences, with Danilo Garcia. Nature Publishing Group and Frontiers.
34. Neurotoxin Modelling of Brain Disorders – Life-long Outcomes in Behavioral

Teratology. RM Kostrzewa and T Archer, Springer, 2016.

TEXTBOOK OF PSYCHOLOGY: Psychology and Life

Gerrig, R.J., Zimbardo, P.G., Svartdal, F., Brennen, T., Donaldson, R., Archer, T. Psychology and Life, Pearson Publishing, 2012.

TEXTBOOK of PSYCHOLOGY:

Comer and Gould “Psychology Around US”. Chapter 5: Behavioural Neuroscience.Adaptation. Wiley: Chichester, 2013.

PhD Program Department of Psychology Course: Scientific Writing.

Grant Assessments

Fonds Wetenshappelijk Onderzoek – Research Foundation Flanders: “Levenslijn” HSFR – Sweden [3-year committee] Riksbanks Jubileum Fond – Sweden [7 + 1 major projects] MFR – Sweden

FRN – Sweden
National Science Foundation – USA
National Institute of Drug Abuse – USA
Natural Sciences & Engineering Research Council of Canada
Medical Research Council–Swindon, UK [3 occasions] Adlerbrecktskafond
Lundgrensfond
Wallenbergsfond
European Behavioural Pharmacology Society – Travel Grant awards.
Foundation for Polish Science (x 2)
Estonian Science Foundation (x 2)
Health Research Board of the Republic of Ireland (x 3).
Medical Research Council.
Programma Nazionale di Ricerche in Antartide (PNRA)Italian Scientific Committee for Antarctic
Research
Italian Medical Research Council.
Polish Science Foundation.

Successful Nominations for the Award of Honorary Doctorships – University of Göteborg

Professor Robert Hinde, Master of St. John’s College, University of Cambridge, UK.[Faculty of
Social Sciences], 1991.

Professor Gary Olson, University of Toronto, Department of Psychology, Canada.[Faculty of
Social Sciences], 1994.

Professor Lewis S. Seiden, Founder of the Seiden Laboratory of Physiological and Pharmacological Sciences and Psychiatry, University of Chicago, USA.[Faculty of Medicine], 1999.

Professor Steven Cooper, University of Liverpool, UK.[Örebro University], 2002.

Nomination Pending: Professor Thomas N Chase, NIH [Faculty of Medicine, Göteborg university].

Professor C. Robert Cloninger, University of St. Louis at Missouri, USA. 2012.

Conferences, Symposia and Meetings

1. 1984 Perspectives on Animal Learning and Human Memory, Umeå, Sweden, June 16-21, with L.G. Nilsson.
2. 1986 Inaugural Meeting of the European Behavioural Pharmacology Society, Antwerp, Belgium, June 29-July 5, with F.C Colpaert, T.W Robbins, M. Lyon and I. Stolerman.

3. 1987 Neurotoxins in Mental Disorders, Kuopio, Finland, May 28-29, with C. Fowler. 4. 1987 Perspectives on Aversively Motivated Behaviour, Umeå, Sweden, June 17-21, with L.G. Nilsson.
5. 1987 Attention Deficit Disorder: Basic and Clinical Issues, Oslo, Norway, with T. Sagvolden.

6. 1987 Behavioural Pharmacology of 5-HT, Amsterdam, Netherlands, October 27-31, with P. Bevan, C. Broekkamp and A.R. Cools.
7. 1988 First Polish-Swedish Meeting on Structure and Function in Neuroharmacology, Zoborow, Warsaw, Poland, May 4-8, with W. Kostowski.

8. 1988 The Neurobiology of Memory, Umeå, Sweden, June 5-7, with L-G Nilsson. Among the Invited Speakers: Eric Kandel, Endel Tulving, Larry Weiskrantz, Dick Thompson.

Eric Kandel was Nobel Prize Laureate 2000.
9. 1988 Second Meeting of the European Behavioural Pharmacology Society, Athens, Greece, September 2-5, with F.C. Colpaert, R. Dantzer, C. Spyraki, and I. Stolerman.
10. 1989 International Meeting in Honour of Knut Larsson: Neuroendocrine Axis in Behavioural Biology, Göteborg, Sweden, December 13-16, with S. Hansen.
11. 1990 Symposium in Memorium of Conrad Lorenz ”International Symposium on Evolutionary Aspects of Behavioural Sciences”, Göteborg, Sweden, May 21-24, with Percy
Löwenhardt (deceased).
12. 1990 Third Meeting of the European Behavioural Pharmacology Society, Noordwuitkahout, Netherlands, June 29-July 4, with F.C. Colpaert, A.R. Cools, M. Kruk, and I.
Stolerman.
13. 1991 Second Polish-Swedish Meeting on Structure and Function in Neuropharmacology, Zacopane, Poland, September 16-21, with Edmund Przegalinski. 14. 1992 International Meeting on Strategies for Studying CNS Active Compounds: Models, Screens and Clinical Syndromes, April 26-May 3, Madrid, Spain, with T. Palomo, and
L.S. Seiden.
15. 1992 Fourth Meeting of the European Behavioural Pharmacology Society, Cambridge, England, August 7-11, with F.C. Colpaert, A.R. Cools, T.W. Robbins, and I. Stolerman
16. 1992 Developmental Toxicology – Preclinical and clinical data in retrospect, August 27-28, Stockholm, Sweden.
17. 1993 3rd International Congress on Amino Acids and Analogues, August 23-27, Vienna, with W. Danysz.
18. 1995 International Symposium on Dopamine Disease States, October 18-21, Mojacar, Spain, with T. Palomo and R.J. Beninger.
19. 1996 World Congress of Psychiatry – Symposia organised by T. Palomo and T. Archer:
I. Some aspects of movement disorders
II. Dopamine dysfunction in psychiatric disorders
III. Schizophrenia: Dopamine – serotonin interactions
IV. Dopamine – serotonin interactions in disorders of affect

V. Sensitization in drug addiction
VI. Brain imaging in psychiatric disorders
Aspects of molecular biology in psychiatric disorders relating to memory and aging.

20. 1996 Symposium Organiser: “Neurodegenerative Bases of Movement Disorders” at the Fifth Meeting of the European Behavioural Pharmacology Society, Cagliari, Sardinia, 16th-21st May.
21. 1997 Estadios Patológicos de la Dopamina, Maj 29-30, Madrid, Spain, with J. Marechal and T. Palomo.

22. 1997 Interactive Monoaminergic Basis of Brain Disorders, October 8-12, Mojacar, Spain, with T. Palomo.
23. 1998 Catecholamines in Brain Disorders, November 20-21, Madrid, Spain, with T. Palomo.

24. 1999 Neurotoxicology, Degeneration and Protection in Brain Disease States, October

15-19, Mojacar, Spain, with T. Palomo and J. Borrell.
25. 2000 Advances in Neuroscience: Affective Disorders, January, 27-30, Madrid, Spain, with T. Palomo.
26. 2000 Advances in Clinical Neuroscience: Schizopsychotic Disorders, June, 7-10, Madrid, Spain, with T. Palomo.
27.
2001 Advances in Clinical Neuroscience: Substance Abuse Disorders, January, 25-28, Madrid, Spain, with T. Palomo.
28.
2001 Advances in Clinical Neuroscience: Cognitive Disorders and Dementia, June,
21-23 Madrid, Spain, with T. Palomo.
29. 2001 Joint Meeting of the Royal Medical Society (London) and Cerebro y Mente (Madrid) on Neurologic and Psychiatric Brain Disorders with T. Palomo and R. Guiloff, May
2-6, Madrid, Spain.
30. 2001 (Proposal) Third Polish-Swedish Meeting on Structure and Function in Neuropharmacology: Neurotoxicity and Neurodegeneration, With W. Danysz, R. Kostrzewa
& J. Vetulani, Zacopane, Poland.
31. 2001 NATO Conference on Etiologic Auto-toxic Cellular Processes in Neurodegenerative and Neuropsychiatric Disorders: Neuroprotective Strategies, to be held in Padua, Italy, in July, with Richard M. Kostrzewa, East Tennessee State University, Quillen
School of Medicine.

32. 2001 Neurodevelopmental Liabilities in Brain Disease States, October 18-22, Mojacar, Spain, with T. Palomo.
33.2001 Advances in Clinical Neuroscience: Movement and Neurodegenerative disorders, January, 21-23 Madrid, Spain, with T. Palomo.

34. 2002 Advances in Clinical Neuroscience: neuroimaging in psychiatry, January
24-26, Madrid, Spain, with T. Palomo.
35. 2003 Mechanisms for Neurodegenerative Disorders, April, 25-27, La Serena, Chile, with J. Segura-Aguilar and R. Kostrzewa.
36. 2003 Neurovulnerabilty for Brain Disease Due to Genetic-Environment Agents, October 15-19, Mojacar, Spain, with T. Palomo.
37. 2005 World Congress of Parkinsonism and Related Disorders, June 5-9, Berlin, with P. Riederer and M. Youdim.
38. 2005 Implications of Comorbidity for Etiology and Treatment of Neuropsychiatric Disorders, October 19-23, Mazagon, Spain, with T. Palomo.
39. 2005 Advances in Clinical Neuroscience: Dopaminergic systems in psychiatric disorders, May 12-15, Madrid, Spain, with T. Palomo.
40. [Under planning] 2008 Congress on the Brain in Health and Ill-health, October, North Point, Darjeeling, India, with the Rector, Headmaster and Principle of St. Joseph’s College and School.
41. 2007 World Congress of Parkinsonism and Related Disorders, 9-13 December, Amsterdam, with E. Wolters.
42. 2007 Progress in Alzheimer’s disease and Parkinson’s disease: Meeting in Honour

of Moussa Youdim’s 45 years in Science. 3-6th October, Haifa, Isreal.
43. 2007 III Neurotoxicity Society Meeting: Mechanisms of Neurodegenerative Disorders, 23-27 March, Pucon, Chile.
44. 2007 Beyond Neuropsychiatric Diagnostics: Symptoms not Disorders, October 17-21, Mazagon, Spain, with T. Palomo.
45. 2009 Staging in Neuropsychiatric Disorders: Etiopathogenesis and Treatment, October 14-19, Mojacar, Spain, with T. Palomo.
BIT’s 4th Annual World Congress of NeuroTalk-2013
Theme: Advances and Challenges in Neurosciences, Xi’an, China
Advisory Board Member.
46. Symposium Organiser: “ADHD: Diagnosis, Incidence and Intervention”; International Academy of Law and Mental Health, Vienna, 13-17 July, 2015.

Springer Book Series on “HANDBOOK OF NEUROTOXICITY” Series Editors: RM Kostrzewa and T Archer

Volumes number:

1. (Mal)adaptive Aspects of Developmental Stress. Eds: G Laviola & S Macri.
2. Isoquinolines and Beta-carbolines as Neurotoxins and Neuroprotectants. Eds. L Antkiewicz-Michaluk & H Rommelspacher.
3. Methylmercury and Neurotoxicity. Eds: S Ceccatelli & M Aschner.
4. Immunology and Psychiatry: from Basic to Clinic. Eds. N Müller & AM Myint. Award 2010

Lifetime Achievement Award from St. Joseph’s College, North Point.

Diploma (Phillip Khan-Panni, Chairman Alumnus Society) and NP Shield.

Award 2013

Honorary Member of the Polish Pharmacological Society 2013 To be Conferred may, 23-25, 2013.

Awards 2013

Honorary Professor and Honorary Professor in Pharmacology, Polish Science Academy and Pharmacological Society
23rd May, 2013.

Invitation 2014

Sansone Lecture on Well-being.University of Washington at St. Loius, Missouri.8thApril, 2014

Award 2014
The Sansone Award, University of Washington, St. Louis, Missouri, USA.

Judicial assignments

Expert Witness: Mål nr 27370-10, Socialnämnden I Gotlands kommun (Lagman Peter Freudenthal) Datum: 2010-09-02.

Expert Witness: Mål nr T 1058-11 27370-10, Socialnämnden I Gotlands kommun (Rådmannen Kristina Wirdemark)Datum: 2012-05-30.

Journals for which manuscripts have been reviewed 2000-2014

Abnormal & Behavioral Psychology Acta Neurologica Scandinavica (15+) Acta Psychiatrica Scandinavica Addiction Research & Therapy [OMICS] Aging Science

Alcoholism & Drug Dependence Alzheimer’s Disease & Parkinsonism American Journal of Psychiatry
Annual Research and Review in Biology Anxiety, Stress & Coping

Appetite
Archives of Physical Medicine and Rehabilitation (5)
Asian Journal of Social Psychology
Autism-Open access
Basic and Clinical Pharmacology and Toxicology Behavioural Brain Research
Behavioural Pharmacology (30+)
Behavioral & Neural Biology
Biological Psychiatry
BMC Neuroscience
BMC Psychiatry
Brain
Brain & Behavior
Brain, Behavior & Immunity
Brain Disorders & Therapy
Brain Research
Brain Research Bulletin
Brain Sciences
British Journal of Education, Society & Behavioural Science British Journal of Pharmacology
Cell & Molecular Biology x 5
Chemico-Biological Interactions
Clinical and Experimental Psychology
Clinical Depression
Clinical Epigenetics
Clinical Medical Journals
Cognitive, Affective and Behavioral Neuroscience
Current Neuropharmacology

Contemporary Clinical Trials
Degenerative Neurological and Neuromuscular Disease
Epigenetics in Creativity
Current Psychiatry Reviews
Early Child Development and Care
Environmental Toxicology & Pharmacology
European Child & Adolescent Psychiatry
European Journal of Oral Science
European Journal of Parapsychology
European Journal of Pharmacology
European Journal of Psychiatry
European Neuropsychopharmacology
Frontiers in Aging Neuroscience
Future Medicine: Clinical Practice
General Pharmacology
General Hospital Psychiatry
Global Journal of Allergy
Healthy Aging Research
Health and Quality of Life Outcomes
Intellectual Disability Diagnosis Journal
International Journal of Developmental Neuroscience
International Journal of Educational Policy Research and Review
International Journal of Emergency Mental Health and Human Resilience International Journal of Mental Health and Psychiatry
International Journal of Molecular Sciences: Neurological Injuries
International Journal of Molecular Sciences: Biochemistry, Molecular Biology and Biophysics

International Journal of Emergency Mental Health and Human Resilience International Journal of Neuropsychopharmacology
International Journal of Psychology
International Journal of School and Cognitive Psychology

Journal of Addiction Research & Therapy (5) Journal of AIDS and Clinical Research Journal of the American Aging Association Journal of Clinical Medicine and Research Journal of Cross-Cultural Psychology

Journal of Health Education Research & Development Journal of Health Science
Journal of Intellectual Disability-Diagnosis and Treatment Journal of Neural Transmission

Journal of Neurological Disorders
Journal of Neurology
Journal of Novel Physiotherapies
Journal of Positive Behavior Interventions Journal of Psychopharmacology

Journal of Physical Activity and Health Journal of Research and Development Journal of Signs and Symptoms Learning & Memory 16

Learning & Motivation
Molecular Psychiatry
Naunyn-Schmiedeberg’s Archives of Pharmacology
Neurodegenerative Disease Management
Neurology and Neurophysiology
Neuropsychiatric Disease and Treatment
Neurorehabilitation
Neuroscience
Neuroscience and Biobehavioral Reviews (5)
Neuroscience Letters
Neuropharmacology
NeuroReport
Nordic Journal of Psychiatry
Nordic Psychology
Nutritional Journal
OMICS PUBLISHING GROUP/ACR
OMICS General Medicine
Open Toxinology Journal
Neurotoxicity Research (30+)
Personality Science and Individual Differences: Character, Responsibility and Well-Being Pharmacology, Biochemistry & Behavior
Pharmacology & Toxicology
Physiology & Behaviour
PLOS ONE
Progress in Neuro-psychopharmacology & Biological Psychiatry Psychoneuroendocrinology
Psychopharmacology
PsychJournal
Psychological Reports: Perceptual & Motor Skills
Psychology and Psychotherapy
Psychology Research and Behavior Management
Scandinavian Journal of Psychology
Scandinavian Journal of Medical Science & Sports
Schizophrenia Bulletin
Schizophrenia Research
ScienceAsia
Scientific Research and Essays
Social Behavior and Personality
Stress & Health (10+) – Reviewer Runner-up Commendation Award 2012 –
Cary L Cooper, CBE, Editor-in-Chief, Stress and Health Journal, Wiley
Blackwell.
The World Journal of Biological Psychiatry
Trends in Cognitive Sciences
Series Volume Reviews: Neuropathology of Drug Addictions and Substance Misuse, Editor: V. Preedy, three volumes.

Prepublication textbook reviews:

Worth Publishers [Kolb & Wishaw: Biological Psychology; Gray: Psychology]. Harwood Academic Publications.
Sinauer Associates.
Lawrence Erlbaum Associates.

McGraw-Hill [Passer & Smith: Psychology] Thompson publications
Pearson Group
John Wiley & Sons

Elsevier: Proposal V. Preedy “Neuropathology of Drug Addictions and Substance Misuse.”

TREVOR ARCHER -LIST OF PUBLICATIONS

* 1. Sjödén, P.O. & Archer, T. Conditioned taste-aversion to saccharin induced by 2,4,5-Trichlorophenoxyacetic acid in rats. 5th Scandinavian Meeting on “Physiology and Behavior”, 1977, p. 40.

* 2. Sjödén, P.O. & Archer, T. Conditioned taste-aversion to saccharin induced by
2,4,5- Trichlorophenoxyacetic acid in albino rats. Physiology and Behavior, 1977, 19, 157-161.

* 3. Sjödén, P.O., Archer, T., Nilsson, L.G., & Carter, N. The role of environmental
context in taste-aversion conditioning as measured during extinction: Implications for a cognitive theory. 5th Scandinavian Meeting on “Physiology and Behavior”, 1977, p. 41.

* 4. Sjödén, P.O., Archer, T., & Söderberg, U. Effects of 2,4,5 Trichlorophenoxyacetic acid (2,4,5-T) on radioiodine distribution in rats. Bulletin of Environmental Contamination and Toxicology, 1977, 17, 670-678.

* 5. Doctoral Dissertation: Archer, T. Associative and non-associative processes in taste-aversion learning: Exteroceptive context and neophobic responses. Acta Universitatis Upsaliensis, 18, 1979.

6. Archer, T. & Sjödén, P.O. Positive correlation between pre- and post-conditioning saccharin intake in taste-aversion learning. Animal Learning and Behavior, 1979, 7, 144-148.

* 7. Archer, T. & Sjödén, P.O. Novel vs familiar exteroceptive contexts in tasteaversion conditioning and extinction. Report No. 246, Dept. of Psychology, Uppsala University, 1979.

8. Archer, T. & Sjödén, P.O. Neophobia in taste-aversion conditioning: Individual

differences and effects of contextual changes. Physiological Psychology, 1979, 7,

364-369.
9. Archer, T., Sjödén, P.O., & Carter, N. Control of taste-aversion extinction by

exteroceptive cues. Behavioral and Neural Biology, 1979, 25, 217-226. 10. Sjödén, P.O., Archer, T., & Carter, N. Conditioned taste-aversion induced by

2,4,5-Trichlorophenoxyacetic acid: Dose-response and pre-exposure effects.

Physiological Psychology, 1979, 7, 93-96.
11. Archer, T., Sjödén, P.O., Nilsson, L-G., & Carter, N. Role of exteroceptive background

context in taste-aversion conditioning and extinction. Animal Learning and Behavior, 1979, 7, 17-22.

1980

12. Archer, T. & Sjödén, P.O. Context-dependent taste-aversion learning with a familiar conditioning context. Physiological Psychology, 1980, 8, 40-46.

13. Archer, T., Sjödén, P.O., Nilsson, L-G., & Carter, N. Exteroceptive context in taste-aversion conditioning and extinction: Odour, cage and bottle stimuli. Quarterly Journal of Experimental Psychology, 1980, 32, 197-214.

14. Archer, T., Ögren, S.O., Fuxe, K., & Johansson, G. Studies on the functional role
of brain noradrenaline with the NA neurotoxin N-2-chloroethyl-N-ethyl-2- bromobenzyl amine hydrochloride (DSP4). Neuroscience Letters, 1980, Suppl. 5, p. 458.

15. Rönnberg, J., Archer, T., & Ohlsson, K. Temporal factors in audition and vision: A functional emphasis. Scandinavian Journal of Psychology, 1980, 21, 241-247.

16. Ögren, S.O., Archer, T., Holm, A-C., & Johansson, G.Acute and long-term effects of p-chloroamphetamine in one-way and two-way avoidance learning. Neuroscience Letters, 1980, Suppl. 5, p. 466.

17. Ögren, S.O., Archer, T., & Ross, S.B.Evidence for a role of the locus coeruleus noradrenaline system in learning. Neuroscience Letters, 1980, 20, 351-356.

18. Ögren, S.O., Fuxe, K., Archer, T., Hall, H., Holm, A-C., & Köhler, C. Studies on
the role of central 5-HT neurons in avoidance learning: A behavioral and biochemical analy sis. In: Serotonin: Current Aspects of Neurochemistry and Function, B. Haber and S. Gabay (Eds.), Plenum Press, 1980, pp. 681-705.

1981

19. Archer, T. & Sjödén, P.O. Environment-dependent taste-aversion extinc
tion: A question of stimulus novelty at conditioning. Physiological Psychology, 1981, 9, 102-108.

20. Archer, T., Ögren, S.O., Fuxe, K., Agnati, L., & Eneroth, P. On the interactive role
of central noradrenaline neurons and corticosterone in two-way active avoidance acquisition in the rat. Neuroscience Letters, 1981, 27, 341-346.

21. Archer, T., Ögren, S.O., & Johansson, C. The acute effect of p-chloroam
pheta-mine on the retention of fear conditioning in the rat: Evidence for a role of serotonin in memory consolidation. Neuroscience Letters, 1981, 25, 75-81.

22. Archer, T., Ögren, S.O., & Ross, S.B. N-2-chloroethyl-N-ethyl-2-bromoben zyl-amine hydrochloride (DSP4), a new selective noradrenaline neurotoxin, and taste neophobia in the rat. Physiological Psychology, 1981, 9, 197-202.

23. Archer, T., Ögren, S.O., Ross, S.B., & Johansson, G. DSP4, a selective noradrenaline neurotoxin, and avoidance learning in the rat. In: Quantification of Steady-State Operant Behavior, C.M. Bradshaw, E. Szabadi and C.F. Lowe (Eds.), Elsevier/North-Holland Biomedical Press, 1981, pp. 445-448.

24. Sjödén, P.O. & Archer T. Associative and non-associative effects of exter-oceptive context in taste-aversion conditioning with rats. Behavioral and Neural Biology, 1981, 33, 74-92.

* 25. Toneby, M., Archer, T., Hall, H., & Magnusson, O. Behavior teratological effects of prenatal haloperidol treatment on rat offspring. 2nd International Meeting of the Society for Developmental Neuroscience, 1981, p. 88.

26. Ögren, S.O., Archer, T., Fuxe, K., & Eneroth, P. Glucocorticoids, catechola-mines
and avoidance learning. In: Steroid Hormone Regulation of the Brain, K. Fuxe, J-Å. Gustafsson and L. Wetterberg (Eds.), Pergamon Press, 1981, pp. 355-377.

* 27. Ögren, S.O., Archer, T., Fuxe, K., Johansson, G., & Holm, A-C. Behavioral and biochemical studies on the effects of chronic administration of antidepressant drugs on central serotonergic receptor mechanisms. Symposium Abstract from New Vistas on Depression, 1981, Japan.

* 28. Ögren, S.O., Archer, T., Holm, A-C., & Johansson, G.5-HT depletion and avoidance acquisition as a function of shock intensity. 5th European Neuro science Congress, 1981, p. 523, Liege, Belgium.

29. Ögren, S.O., Archer, T., Holm, A-C., & Ross, S.B.Separating the associative
effects of serotonin depletors on active avoidance learning. In: Quantification of Steady-State Operant Behavior, C.M. Bradshaw, E. Szabadi and C.F. Lowe (Eds.), Elsevier/North-Holland Biomedical Press, 1981, pp. 449-452.

1982

30. Archer, T. DSP4-(N-2-chloroethyl-N-ethyl-2-bromobenzylamine), a new noradrenaline neurotoxin, and stimulus conditions affecting acquisition of two- way active avoidance. Journal of Comparative and Physiological Psychology, 1982, 96, 476-490.

31. Archer, T. Serotonin and fear retention in the rat. Journal of Comparative and Physiological Psychology, 1982, 96, 491-516.

32. Archer, T. The role of noradrenaline in learned behaviors: Studies using DSP4. Scandinavian Journal of Psychology, 1982, Suppl. 1, 61-71.

33. Archer, T., Cotic, T., Järbe, T.U.C. Attenuation of the context effect and lack of unconditioned stimulus-preexposure effect in taste-aversion learning following treatment with DSP4, the selective noradrenaline neurotoxin. Behavioral and Neural Biology, 1982, 35, 159-173.

* 34. Archer, T., Ross, S.B., Johansson, G., & Jonsson, G. Systemic DSP4, a selective noradrenaline neurotoxin, and two-way avoidance acquisition in the rat: Parametric relationships. 5th European Neuroscience Congress, 1982, p. 177, Liege, Belgium.

* 35. Archer, T., Ross, S.B., Ögren, S.O., Johansson, G., & Johansson, C.Serotonin and avoidance acquisition and retention. 6th European Neuroscience Congress, 1982, p. 283, Torremolinos, Spain.

36. Archer, T. & Sjödén, P.O. Higher-order conditioning and sensory preconditioning
of a taste-aversion with an exteroceptive CS1. Quarterly Journal of Experimental Psychology, 1982, 34, 1-17.

37. Archer, T., Ögren, S.O., Johansson, G., & Ross, S.B. DSP4-induced two-way
active avoidance impairment in rats: Involvement of central but not peripheral noradrenaline depletion. Psychopharmacology, 1982, 76, 303-309.

38. Archer, T., Ögren, S.O., & Ross, S.B. Serotonin involvement in aversive

conditioning: Reversal of the fear retention deficit by long-term p- chloroamphetamine but not pchlorophenylalanine. Neuroscience Letters, 1982, 34, 75-82.

* 39. Archer, T., Ögren, S.O., Ross, S.B., Johansson, G., & Johansson, C.Acute pchloroamphetamine and aversive conditioning in the rat. 1st International Congress of Brain and Behavior, 1982, p. 472, Lausanne.

* 40. Ögren, S.O., Archer, T., Johansson, C., & Johansson, G.Stress-induced analgesia and avoidance behavior – possible interactions with serotonergic neurotransmission. 13th C.I.N.P. Congress, 1982, p. 553, Israel.

41. Ögren, S.O., Fuxe, K., Archer, T., Johansson, G., & Holm, AC. Behavioral and biochemical studies on the effects of acute and chronic administration of anti- depressant drugs on central serotonergic receptor mechanisms. In: Advances in the Biosciences: Vol. 40, New Vistas in Depression, S.Z. Langer et al. (Ed.), Pergamon Press, 1982, pp. 11-19.

42. Ögren, S.O., Johansson, G., Johansson, C., & Archer, T. Serotonin neurons and aversive conditioning in the rat. Scandinavian Journal of Psychology, 1982, Suppl. 1, 7-15.

* 43. Ahlenius, S., Archer, T., Tandberg, B., & Hillegaart, V. Effects of (-)3- (3Hydroxyphenyl)-Nn-propylpiperidine (3-PPP), alone and in combination with haloperidol (HPD), on conditioned avoidance behavior, catalepsy and tread-mill performance in the rat. 5th Catecholamine Symposium, 1983, Göteborg, Sweden.

44. Archer, T. Signalled and unsignalled avoidance impairments following noradrenaline depletion with DSP4: An hypothesis incorporating an associative and non- associative factor. Scandinavian Journal of Psychology, 1983, 24, 75-87.

* 45. Archer, T. The use of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydro-chloride (DSP4) as a pharmacological tool for studying the role of noradre- naline in learned behaviors. In: Drugs as Tools, G. Lowe (Ed.), 1983, Abstract.

* 46. Archer, T., Jonsson, G., & Ross, S.B. Dose- and time-dependent effects of the nor adrenaline neurotoxin, DSP4, and comparison with other selective nor-adrenaline neurotoxins. 5th Catecholamine Symposium, 1983, Göteborg, Sweden.

47. Archer, T., Mohammed, A.K., Forsberg, B., & Siddiqui, A. Neophobia to novel taste and novel exteroceptive stimulus following DSP4 administration. Experimental Animal Behaviour, 1983, 2, 19-36.

48. Archer, T., Mohammed, A.K., & Järbe, T.U.C. Latent inhibition following
systemic DSP4: Effects due to presence and absence of contextual cues in taste- aversion learning. Behavioral and Neural Biology, 1983, 38, 287-306.

49. Archer, T., Mohammed, A.K., Ross, S.B., & Söderberg, U. T-maze learning, spontaneous activity and food intake recovery following systemic administ-ration of the noradre naline neurotoxin, DSP4. Pharmacology, Biochemistry & Behavior, 1983, 19, 121-130.

50. Archer, T., Ögren, S.O., Ross, S.B., & Magnusson, O. Retention deficits induced by acute p-chloroamphetamine following fear conditioning in the rat. Psychopharmacology, 1983, 82, 14-19.

* 51. Mohammed, A.K. & Archer, T.Behavioral effects of DSP4, a selective noradrenaline neurotoxin.First European Meeting on Experimental Analysis of Behavior, 1983, Liege, Belgium.

52. Mohammed, A.K., Everitt, B.J., Robbins, T.W., Dunn, L.T., Kilbourn, A., &
Archer, T. Noradrenaline and the latent inhibition effect in rats. 5th International Catechola mine Symposium, 1983, Göteborg, Sweden.

53. Sjödén, P.O. & Archer, T. Potentiation of a bottle aversion by taste in compound conditioning with rats. Experimental Animal Behaviour, 1983, 2, 1-18.

54. Söderberg, U., Fredriksson, A., Mohammed, A.K., Jonsson, G., Ross, S.B., & Archer, T. The role of olfactory bulbectomy and DSP4 treatment in avoidance learning in the rat. Neuroscience Letters, Suppl. 14, 1983.

* 55. Ögren, S.O., Archer, T., & Ross, S.B. Noradrenaline in learning and memory – the status of the cognitive deficit. 5th International Catecholamine Symposium, 1983, Göteborg, Sweden.

56. Ögren, S.O., Ross, S.B., Hall, H., & Archer, T. Biochemical and behavioral effects of antidepressant drugs. In: Drugs in Psychiatry: Volume I, Antidepressants, G.D. Burrows, T.R. Norman and B. Davis (Eds.), Elsevier/North-Holland Biomedical Press, 1983, pp. 13-34.

57. Ögren, S.O., Archer, T., & Johansson, C. Evidence for a selective brain nor-adrenergic involvement in the locomotor stimulant effects of amphetamine in the
rat. Neuroscience Letters, 1983 43, 327-331.

1984

58. Ahlenius, S., Archer, T., Tandberg, B., & Hillegart, V. Effects of (-)3-PPP on acquisition and retention of a conditioned avoidance response in the rat. Psychopharmacology, 1984, 84, 441-445.

59. Archer, T. Spontaneous recovery from damage to specific neurotransmitter systems. Trends in Pharmacological Sciences, 1984, 7, 263-264.

60. Archer, T., Jonsson, G., & Ross, S.B. A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat. British Journal of Pharmacology, 1984, 82, 249- 257.

61. Archer, T., Ross, S.B., & Minor, B.G. Attenuation of the post-decapitation convulsions after repeated treatment of rats with desipramine, imipramine and maprotiline. Acta Pharmacol. et Toxicol., 1984, 54, 372-378.

62. Archer, T., Sjödén, P.O., & Nilsson, L-G. The importance of contextual elements
in taste-aversion learning. Scandinavian Journal of Psychology, 1984, 25, 251- 257.

63. Archer, T., Söderberg, U., Mohammed, A.K., Fredriksson, A., & Ross, S.B. Active and passive avoidance performance following bilateral olfactory bulbectomy. Scandinavian Journal of Psychology, 1984, 25, 179-188.

64. Archer, T., Söderberg, U., Ross, S.B., & Jonsson, G. Role of olfactory
bulbectomy and DSP4 treatment in avoidance learning in the rat. Behavioral Neuroscience, 1984, 98, 496-505.

65. Archer, T. & Tandberg, B. Effects of acute administration of 5-Methoxy- N,Ndimethyltryptamine upon the latency and duration of post-decapitation convulsions. Acta Pharma col. et Toxicol., 1984, 55, 224-230.

66. Archer, T., Ögren, S.O., & Johansson, G. Stimulus conditions affecting rate of acquisition in a computer-operated version of the two-way active avoidance procedure. Scandinavian Journal of Psychology, 1984, 25, 89-95.

67. Archer, T., Ögren, S.O., & Ross, S.B. The effect of acute zimelidine and
alaproclate administration of two-way active avoidance: Comparison with other antidepressant agents, test of selectivity and sub-chronic studies. Psychopharmacology, 1984, 84, 188-195.

68. Fowler, C.J. & Archer, T. Brain injury and early catecholamine mobilization. Trends in Pharmacological Sciences, 1984, 5, 86-87.

69. Mohammed, A.K., Archer, T., & Järbe, T.U.C. Noradrenaline loss and the disruption of between-CS stimulus generalisation effects in aversion learning. Scandinavian Journal of Psychology, 1984, 25, 79-88.

* 70. Mohammed, A.K., Fredriksson, A., Archer, T., Söderberg, U., & Lewander, T.The effects of DSP4 and 6-hydroxydopamine on amphetamine-induced activity in rats. IUPHAR International Congress of Pharmacology, 1984, London, U.K.

71. Nilsson, L-G. & Archer, T. A cognitive theory to accommodate taste-aversion data. Umeå Psychological Reports, No. 180, 1984.

* 72. Söderberg, U., Mohammed, A.K., & Archer, T. Thermoregulation and water balance in rats after central noradrenaline depletion compared with effects of olfactory bulbectomy. First Symposium of the European Neuroendocrine Association, 1984.

73. Ögren, S.O., Archer, T., & Johansson, C. Stress-induced analgesia and avoidance behaviour: possible interactions with serotonergic neurotransmission. In: Stress Induced Anal gesia, M.D. Tricklebank and G. Curzon (Eds.), John Wiley & Sons, Ltd., 1984, pp. 165-183.

74. Ögren, S.O., Archer, T., & Ross, S.B. Norepinephrine in learning and memory –
The status of the cognitive deficit. In: Catecholamines: Neuropharmacology and Central Nervous System-Theoretical Aspects, A. Dahlström (Ed.), Alan R. Liss, Inc., New York, 1984, pp. 285-292.

1985

75. Ahlenius, S. & Archer, T. Normal and abnormal animal behaviour: Importance of catecholamine release by nerve impulses for the maintenance of normal behaviour. In: Neuro biology, R. Gilles and J. Balthazart (Eds.), Springer- Verlag Berlin Heidelberg, 1985, 329-343.

76. Archer, T., Arweström, E., Jonsson, G., Minor B.G., & Post, C. Complete
blockade and attenuation of 5-hydroxytryptamine induced analgesia following NA depletion in rats and mice. Acta Pharmacol.et Toxicol., 1985, 57, 255-261.

77. Archer, T. & Fowler, C.J. Towards an animal model for the cholinergic lesion in Alzheimer’s disease. Trends in Pharmacological Sciences, 1985, 61-62.

78. Archer, T., Fowler, C.J., Fredriksson, A., Lewander, T., Magnusson, O., Mohringe,

B., & Söderberg, U. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline. British Journal of Pharmacology, 1985, 85, 581-590.

79. Archer, T., Jonsson, G., & Ross, S.B. Active and passive avoidance following the administration of systemic DSP4, xylamine or p-chloroamphetamine. Behavioral and Neural Biology, 1985, 43, 238-249.

80. Archer, T., Järbe, T.U.C., Mohammed, A.K., & Priedite, G. The effect of stimulus preexposure upon the context effect in taste-aversion learning in noradrenaline- depleted rats. Scandinavian Journal of Psychology, 1985, 26, 158-169.

81. Archer, T., Minor, B.G., & Post, C. Blockade and reversal of 5-methoxy- N,Ndimethyltryptamine-induced analgesia following noradrenaline depletion. Brain Research, 1985, 333, 55-61.

82. Archer, T. & Sjödén, P.O. Effects of CS concentration in taste-aversion learning: Problems in assessing aversion strength. Scandinavian Journal of Psychology, 1985, 26, 42-52.

83. Archer, T., Sjödén, P.O., & Nilsson, L-G. Contextual control of taste-aversion conditioning and extinction. In: Context and Learning, P. Balsam and A. Tomie (Eds.), Lawrence Erlbaum Associates, New Jersey, 1985, pp. 225-271.

84. Archer, T., Tandberg, B., Renyi, L., & Ross, S.B. Antagonism of 5-methoxy-N,N- dimethyltryptamine-induced changes in postdecapitation convulsions in rats by repeated treatment with drugs enhancing 5-hydroxytryptamine neurotransmission. Journal of Pharmacological Pharmacology, 1985, 37, 648- 650.

85. Danysz, W., Fowler, C.J., & Archer T. Electrical intra-cranial self-stimulation: A potentially valid model for antidepressant action. Trends in Pharmacological Sciences, 1985, 6, 278-279.

86. Danysz, W., Jonsson, G., Mohammed, A.K., & Archer, T. The hindlimb extension
reflex is not a reliable marker of post-decapitation convulsions or spinal noradrenaline depletion in rats. European Journal of Pharmacology, 1985, 116, 331-333.

87. Minor, B.G., Post, C., & Archer, T. Blockade of intrathecal 5- hydroxytryptamineinduced antinociception in rats by noradrenaline depletion. Neuroscience Letters, 1985, 54, 39-44.

88. Nilsson, L-G. & Archer, T. Perspectives on animal learning and human memory.

In: Perspectives on Learning and Memory, L-G. Nilsson and T. Archer (Eds.),

Lawrence Erlbaum Assoc., New Jersey, 1985, pp. 3-14.
89. Nilsson, L-G. & Archer, T. Basic theoretical concepts. In: Perspectives on

Learning and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum

Assoc., New Jersey, 1985, pp. 15-18.
90. Nilsson, L-G. & Archer, T. Classification of concepts. In: Perspectives on

Learning and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum

Assoc., New Jersey, 1985, pp. 63-65.
91. Nilsson, L-G. & Archer, T. Connecting models. In: Perspectives on Learning and

Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum Assoc., New

Jersey, 1985, pp. 147-149.
92. Nilsson, L-G. & Archer, T. Experimental paradigms and ecology. In: Perspectives

on Learning and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence

Erlbaum Assoc., New Jersey, 1985, pp. 193-196.
93. Nilsson, L-G. & Archer, T. Short-term memory and attention. In: Perspectives on

Learning and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum

Assoc., New Jersey, 1985, pp. 115-117.
94. Nilsson, L-G. & Archer, T. General empirical laws. In: Perspectives on Learning

and Memory, L-G. Nilsson and T. Archer (Eds.), Lawrence Erlbaum Assoc.,

New Jersey, 1985, pp. 243-245.
95. Post, C., Arweström, E., Minor, B.G., Wikberg, J.E.S., Jonsson, G., & Archer, T.

Noradrenaline depletion increases noradrenaline-induced antinocicep-tion in

mice. Neuroscience Letters, 1985, 59, 105-109.
96. Robbins, T.W., Everitt, B.J., Cole, B.J., Archer, T., & Mohammed, A.K.

Functional hypotheses of the coeruleocortical noradrenergic projection: A review of recent experimentation and theory. Physiological Psychology, 1985, 13, 127- 150.

1986

97. Archer, T. Possible indications of noradrenergic involvement in behavioral

plasticity. International Union of Physiological Sciences. xxth International

Congress, 1986, p. 5.
98. Archer, T., Callenholm, N.E.B., Järbe, T.U.C., Minor, B., & Mohammed, A.K.

Taste/ tactile cue discrimination in taste-aversion learning following depletion of

noradrenaline. Scandinavian Journal of Psychology, 1986, 27, 39-51.
99. Archer, T., Cotic, T., & Järbe, T.U.C. Noradrenaline and sensory preconditioning

in the rat. Behavioral Neuroscience, 1986, 100, 704-711.
100. Archer, T., Danysz, W., Jonsson, G., Minor, B.G., & Post, C. 5-methoxy-

N,Ndimethyltryptamine-induced analgesia is blocked by a-adrenoceptor

antagonists in rats. British Journal of Pharmacology, 1986, 89, 293-298. 101. Archer, T., Fredriksson, A., Jonsson, G., Lewander, T., Mohammed, A.K., Ross, S. B., & Söderberg, U. Central noradrenaline depletion antagonizes aspects of d-

amphetamine-induced hyperactivity in the rat. Psychopharmacology, 1986, 88,

141-146.

102. Archer, T., Jonsson, G., Minor, B.G., & Post, C. Noradrenergic-serotonergic interactions and nociception in the rat. European Journal of Pharmacology, 1986, 120, 295-307.

103. Archer, T., Mohammed, A.K., Danysz, W., Järbe, T.U.C., & Jonsson, G. Attenuation of sensory preconditioning by noradrenaline depletion in the rat. Behavioural Brain Research, 1986, 20, 47-56.

104. Archer, T., Mohammed, A.K., & Järbe, T.U.C. Context-dependent latent
inhibition in taste-aversion learning. Scandinavian Journal of Psychology, 1986, 27, 277-284.

105. Danysz, W., Jonsson, G., Minor, B.G., Post, C., & Archer, T. Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N- dimethyltrypta mine. Behavioral and Neural Biology, 1986, 46, 71-86.

106. Danysz, W., Minor, B.G., Jonsson, G., Post, C., & Archer, T. Spinal noradrenergic neurotransmission and the analgesia induced by brief footshock. Brain Research, 1986, 365, 169-173.

107. Danysz, W., Minor, B.G., Post, C., & Archer, T. Chronic treatment with antidepressant drugs and the analgesia induced by 5-methoxy-N,N-dimethyl-tryptamine: Attenuation by desipramine. Acta Pharmacol.et Toxicol., 1986, 59, 103-112.

108. Fernandez-Guasti, A., Hansen, S., Archer, T., & Jonsson, G. Noradrenalineserotonin

interactions in the control of sexual behavior in the male rat: DSP4-induced noradrenaline depletion antagonizes the facilitatory effect of sero-tonin receptor agonists, 5MeODMT and lisuride. Brain Research, 1986, 377, 112-118.

109. Fowler, C.J., Danysz, W., Archer, T. Noradrenaline-stimulated inositol
phosphoipid breakdown as a measure of Alpha1-adrenoceptor function in rat hip- pocampal miniprisms after repeated antidepressant treatment. Journal of Neural Transmission, 1986, 66, 197-208.

110. Fowler, C.J., Magnusson, O., Mohammed, A.K., Danysz, W., & Archer, T. The
effect of selective noradrenergic lesions upon the stimulation by noradrenaline of inositol phos pholipid breakdown in rat hippocampal miniprisms. European Journal of Pharmacology, 1986, 123, 401-407.

111. Järbe, T.U.C., Callenholm, N.E.B., Mohammed, A.K., & Archer, T. Noradrenaline and the context-dependent extinction effect. Physiology & Behavior, 1986, 38, 495-501.

112. Minor, B.G., Archer, T., Post, C., Jonsson, G., & Mohammed, A.K. 5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats. Journal of Neural Transmission, 1986, 66, 243-259.

113. Mohammed, A.K., Callenholm, N.E.B., Järbe, T.U.C., Swedberg, M.D.B., Danysz, W., Robbins, T.W., & Archer, T. Role of central noradrenaline neurons in the contextual control of latent inhibition in taste aversion learning. Behavioural Brain Research, 1986, 21, 109-118.

114. Mohammed, A.K., Danysz, W., Ögren, S.O., & Archer, T. Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior. Neuroscience Letters, 1986, 64, 139-144.

115. Mohammed, A.K., Jonsson, G., & Archer, T. Selective lesioning of forebrain noradrenaline neurons at birth abolishes the improved maze learning perfor- mance induced by rearing in complex environment. Brain Research, 1986, 398, 6-10.

116. Mohammed, A.K., Jonsson, G., Sundström, E., Minor, B.G., Söderberg, U., &
Archer, T. Selective attention and place navigation in rats treated prenatally with methyl azoxymethanol. Developmental Brain Research, 1986, 30, 145-155.

117. Mohammed, A.K., Jonsson, G., Söderberg, V., & Archer, T. Impaired selective

attention in methylazoxymethanol-induced microencephalic rats. Pharmacology,

Biochemistry & Behavior, 1986, 24, 975-981.
118. Post, C., Minor, B.G., Davies, M., & Archer, T. Analgesia induced by 5-

hydroxytryptamine receptor agonists is blocked or reversed by noradrenaline-

depletion in rats. Brain Research, 1986, 363, 18-27.
119. Renyi, L., Archer, T., Minor, B.G., Tandberg, B., Fredriksson, A., & Ross, S.B.

The inhibition of the cage-leaving response – A model for studies of the serotonergic neuro transmission in the rat. Journal of Neural Transmission, 1986, 65, 193-210.

120. Archer, T. 5-Hydroxytryptamine antagonists and the 5-methoxy- N,Ndimethyltryptamine-induced changes of postdecapitation convulsions. Pharmacology & Toxicology, 1987, 60, 37-42.

121. Archer, T. Towards animal models of mental retardation. Trends in Pharmacological Sciences, 1987, 8, 165-166.

122. Archer, T., Arweström, E., Minor, B.G., Persson, M-L., Post, C., Sundström, E., & Jonsson, G. (+)-8-OH-DAPT and 5-MeODMT induced analgesia is antagonised by nor adrenaline depletion. Physiology and Behavior, 1987, 39, 95-102.

123. Archer, T., Fredriksson, A., Lewander, T., & Söderberg, U. Marble burying and spontaneous motor activity in mice: Interactions over days and effect of diazepam. Scandinavian Journal of Psychology, 1987, 28, 242-249.

124. Danysz, W., Fowler, C.J., Ahlenius, S., & Archer, T. ‘Selective’ lesions of brain neurotransmitters can be misleading. Trends in Pharmacological Sciences, 1987, 8, 45-46.

125. Danysz, W., Fowler, C.J., & Archer, T. Experimental methods employed in antidepressant research – critical review. New Trends in Experimental and Clinical Psychiatry, 1987, 3, 59-88.

126. Danysz, W., Minor, B.G., Mohammed, A.K., Pucilowski, O., Plaznik, A.,
Kostowski, W., Post, C., & Archer, T. Chronic treatment with antidepressant drugs and ECT differentially modifies the hypothermic action of clonidine and guanfacine. Pharmacology & Toxicology, 1987, 60, 305-311.

127. Mohammed, A.K., Wahlström, G., Tiger, G., Björklund, P-E., Stenström, A.,

Magnusson, O., Archer, T., Fowler, C.J., & Nordberg, A. Impaired performance of rats in the Morris swim-maze test late in abstinence following long-term sodium barbital treatment. Drug and Alcohol Dependence, 1987, 20, 203-212.

128. Post, C., Archer, T., & Gordh Jr., T. Spinal a-adrenergic mechanisms for analgesia. Schmertz – Pain – Doleur, 1987, 3, 107-114.

129. Post, C., Gordh Jr., T., Minor, B.G., Archer, T., & Freedman, J.Antinociceptive effects and spinal cord tissue concentrations after intrathecal injections of guanfacine or clonidine to rats. Anesthesia and Analgesia, 1987, 66, 317-324.

130. Post, C., Persson, M.L., Archer, T., Minor, B.G., Danysz, W., & Sundström, E. In creased antinociception by Alpha-adrenoceptor drug after spinal cord nor- adrenaline denervation. European Journal of Pharmacology, 1987, 137, 107- 116.

131. Teiling, A.K.Y., Mohammed, A.K., Minor, B.G., Järbe, T.U.C., Hiltunen, A.J., & Archer, T. Lack of effects of prenatal exposure to lidocaine upon development of behavior in rats. Anesthesia and Analgesia, 1987, 66, 533-541.

1988

132. Archer, T. Possible indications of noradrenergic involvement in behavioral plasticity. In: Cellular Mechanisms of Conditioning and Behavioral Plasticity, C. Woody, D.L. Alkon, and J. McGaugh (Eds.), 1988, Plenum Publ. Corp., pp. 445-455.

133. Archer, T. Ethopharmacological approaches to aggressive behavior. Nordic Journal of Psychiatry, 1988, 42, 471-477.

134. Archer, T., Danysz, W., Fredriksson, A., Jonsson, G., Luthman, J., Sundström. E.,
& Teiling, A. Neonatal 6-hydroxydopamine induced dopamine depletions: Motor activity and performance in maze learning. Pharmacology, Biochemistry & Behavior, 1988, 31, 357-364.

135. Archer, T., Fredriksson, A., Sundström, E., Luthman, J., Lewander, T., Söderberg, U., & Jonsson, G. Prenatal methylazoxymethanol treatment potentiates d- amphetamine- and methylphenidate-induced motor activity in male and female rats. Pharmacology and Toxicology, 1988, 63, 233-239.

136. Archer, T., Hiltunen, A.J., Järbe, T.U.C., Kamkar, M.R., Luthman, J., Sundström,

E., & Teiling, A. Hyperactivity and instrumental learning deficits in methylazoxymethanoltreated rat offspring. Neurotoxicology and Teratology, 1988, 10, 341-347.

137. Danysz, W., Kostowski, W., & Archer, T. Some aspects of stress and
depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 1988, 12, 405-419.

138. Danysz, W., Plaznik, A., Kostowski, W., Malatynska, E., Järbe, T.U.C., Hiltunen, A., & Archer, T. Comparison of desipramine, amitriptyline, zimel-dine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacology and Toxicology, 1988, 62, 42-50.

139. Fowler, C.J., Thorell, G., Sundström. E., & Archer, T. Norepinephrine-stimulated inositol phospholipid breakdown in the rat cortex following serotoninergic lesion. Journal of Neural Tranmission, 1988, 73, 205-215.

140. Järbe, T.U.C., Falk, U., Mohammed, A.K., & Archer, T. Acquisition and reversal
of taste/tactile discrimination after forebrain noradrenaline depletion. Behavioral Neuroscience, 1988, 102, 925-933.

141. Minor, B.G., Danysz, W., Post, C., Jonsson, G., Sundström, E., & Archer, T. Nor adrenergic and serotonergic involvement in brief shock-induced analgesia in rats. Behavioral Neuroscience, 1988, 102, 915-924.

142. Minor, B.G., Persson, M.L., Post, C., Jonsson, G., & Archer, T. Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced anti- nociception abolished by intrathecal 6-hydroxydopamine. Journal of Neural Transmission, 1988, 72, 107-120.

143. Post, C., Archer, T., & Minor, B.G. Evidence for crosstolerance to the analgesic effects between morphine and selective a2-adrenoceptor agonists. Journal of Neural Transmission, 1988, 72, 1-9.

144. Sjödén, P.O. & Archer, T. Exteroceptive cues in taste-aversion learning, no artifact: Reply to holder. Animal Learning & Behavior, 1988, 16, 235-239.

145. Sjödén, P.O. & Archer, T. Contextual cues in taste-aversion. Animal Learning & Behavior, 1988, 16, 242-243.

146. Sundström, E., Archer, T., Melander, T., & Hökfelt, T. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neuroscience Letters, 1988, 88, 331-335.

1989

147. Archer, T. Neurotoxin-induced cognitive and motor activity modification: A catecholamine connection. In: Attention Deficit Disorder: Clinical and Basic Research, T. Sagvolden and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 287-322.

148. Archer, T. Perspectives on the determinants of hedonic value. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 41-44.

149. Archer, T. 5-HT, pain and anxiety. In: Behavioral Pharmacology of 5-HT, P. Bevan, A. Cools and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 299-300.

150. Archer, T., Beninger, R.J., Järbe, T.U.C., & Seiden, L.S. Latent learning in a radial arm maze following neonatal dopamine depletion. Behavioral Pharmacology, 1989-90, 1, 191-199.

151. Archer, T. & Järbe, T.U.C. Neurobiological perspectives on aversively motivated behavior. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 223-229.

152. Archer, T. & Mohammed, A.K. Neurochemistry and behavior: Differential postweaning housing and catecholamines. In: The Ethoexperimental Analysis of Behavior, R.J. Blanchard and P. Brain (Eds.), Martinus Nijhoff Press, 1989, pp. 525-537.

153. Archer, T. & Nilsson, L-G. Clinical perspectives on aversively motivated behavior. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 139-144.

154. Archer, T., & Nilsson, L.G. Catecholamine substrates of learned and spontaneous behaviors: Relationships between attention and learning in cognition and behavioral plasticity. In: Background Papers for the Workshop on Neural

Mechanisms of Learning and Memory, J. Delacour (Ed.). European Science

Foundation, 1989.

155. Archer, T. & Sagvolden, T. Basic mechanisms of drug action: Catecholaminergic issues. In: Attention Deficit Disorder: Clinical and Basic Research, T. Sagvolden, and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 191-197.

156. Archer, T. & Sagvolden, T. Model experiments of attention deficit disorder and hyperkinetic syndrome. In: Attention Deficit Disorder: Clinical and Basic Research, T. Sagvolden and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 255-259.

157. Beninger, R.J. & Archer, T. Neuroethological perspectives on aversively motivated behavior. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989 pp. 335-342.

158. Berge, O.G., Post, C., & Archer, T. The behavioral pharmacology of serotonin in
pain processes. In: Behavioral Pharmacology of 5-HT, P. Bevan, A. Cools and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp.301-319.

159. Bevan, P., Lorens, S., & Archer, T. Behavioural pharmacology of 5-HT: Possible progress in the laterality of concepts. In: Behavioral Pharmacology of 5-HT, P. Bevan, A. Cools and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 459-474.

160. Ferreira, A., Hansen, S., Nielsen, M., Archer, T., & Minor, B.G. Behavior of
§mother rats in conflict tests sensitive to antianxiety agents. Behavioral Neuroscience,

1989, 103, 193-201.
* 161. Fowler, C.J., Cowburn, R., Archer, T., Mohammed, A.K., & Cross, A.J.
§Alzheimer’s disease is a multitransmitter disorder: Implications of “cholinergic” animal

models. Alzheimer Actualities, 7, 8.
162. Gärling, T. & Archer, T. Methodological and conceptual perspectives on aversive §conditioning. In: Aversion, Avoidance & Anxiety: Perspectives on aversively

motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum

Assoc., New Jersey, 1989, pp. 371-379.
163. Hiltunen, A.J., Järbe, T.U.C., Kamkar, M.R., & Archer, T. Behaviour in rats

maintained by low differential reinforcement rate: Efffects of ?1- tetrahydro- cannabinol, cannabinol and cannabidiol, alone and in combination. Neuropharmacology, 1989, 28, 183-189.

164. Järbe, T.U.C. & Archer, T. 5-HT, drug discrimination and aversion. In: Behavioral Pharmacology of 5-HT, P. Bevan, A. Cools and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 397-406.

165. Kostowski, W., Plaznik, A., & Archer, T. Possible implications of 5-HT function
for the etiology and treatment of depression. New Trends in Experimental and Clinical Psychiatry, 1989, 5, 91-116.

166. Luthman, J., Fredriksson, A., Lewander, T., Jonsson, G., & Archer, T. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6- hydroxydopamine treatment. Psychopharmacology, 1989, 99, 550-557.

167. Luthman, J., Fredriksson, A., Sundström, E., Jonsson, G., & Archer, T. Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behavioral Brain Reseach, 1989, 33, 267-277.

168. Minor, B.G., Danysz, W., Jonsson, G., Mohammed, A.K., Post, C., & Archer, T.
Adaptive changes in a-2 adrenoceptor mediated responses: Analgesia, hypothermia and hypoactivity. Pharmacology & Toxicology, 1989, 65, 143-151.

169. Nilsson, L-G. & Archer, T. Aversively motivated behavior: Which are the perspectives? In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 437-465.

170. Overmier, J.B. & Archer, T. Historical perspectives on the study of aversively motivated behavior: History and new look. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer and L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 3-39.

171. Plaznik, A., Kostowski, W., & Archer, T. Serotonin and depression: Old problems and new data. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1989, 13, 623-633.

172. Sagvolden, T. & Archer, T. Attention deficit disorder: Clinical issues. In: Attention Deficit Disorder: Clinical and Basic Research, T. Sagvolden and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 25-29.

173. Sagvolden, T. & Archer, T. Future perspectives on ADD research. An irresistible challenge. In: Attention Deficit Disorder: Clinical and Basic Research, T. Sagvolden and T. Archer (Eds.), Lawrence Erlbaum Assoc., New Jersey, 1989, pp. 369-389.

174. Sjödén, P.O. & Archer, T. Taste-aversion conditioning: The role of contextual stimuli. In: Aversion, Avoidance & Anxiety: Perspectives on aversively motivated behavior, T. Archer & L-G. Nilsson (Eds.), Lawrence Erlbaum Assoc., 1989, pp. 87-120.

1990

175. Eriksson, P., Archer, T., & Fredriksson, A. Altered behavior in adult mice exposed to a single low dose of DDT and its fatty acid conjugate as neonates. Brain Research, 1990, 23, 514(1), 141-2.

176. Fredriksson, A., Plaznik, A., Sundström, E., Jonsson, G., & Archer, T. MPTPinduced hypoactivity in mice: Reversal by L-Dopa. Pharmacology & Toxicology, 1990, 67, 295-301.

177. Gillberg, P.G., Hartvig, P. Gordh, T., Sottile, A., Jansson, I., Archer, T., & Post, C. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat. Psychopharmacology, 1990, 100, 464-469.

178. Mohammed, A.K., Wahlström, G., Archer, T., & Nordberg, A. Learning deficits in aged rats pretreated chronically with barbital and tested late in abstinence: Alleviation by tetrahydroaminoacridine. Journal of Neural Transmission, 1990, 2, 285-294.

179. Post, C., & Archer, T. Interactions between 5-HT and noradrenaline in analgesia.

In: Serotonin and Pain, J-M. Besson (Ed.), Elsevier Science Publishers B.V.

(Biomedical Division), 1990, pp. 153-173.
180. Sundström, E., Fredriksson, A., & Archer, T. Chronic neurochemical and

behavioral changes in MPTP-lesioned C57 BL/6 mice: A model for Parkinson’s

disease. Brain Research, 1990, 528, 181-188.
181. Archer, T. Animal models and drug screens in depression: Pragmaticism and the

validity requirement. In: “Animal models in psychopharmacology”, B. Olivier, J. Mos & J. Slangen (Eds.), Birkhaüser, Verlag AG, Basel, 1991, pp. 243-250.

182. Archer, T. Learning techniques to study memory processes in opiate and/ or adrenergic systems. In: Peripheral Signaling of the Brain: Role in Neuronal- Immune Interactions, Learning and Memory, R.C.A. Frederickson, J.L. McGaugh, and D.L. Felten (Eds.). Hogrefe and Huber Publishers, Toronto, 1991, pp. 315-332.

183. Archer, T. & Nilsson, L.-G. Unitary concepts in behavioral biology. In:
Behavioral Biology: Neuroendocrine Axis, T. Archer and S. Hansen, (Eds.), L. Erlbaum, Hillsdale, N.J., 1991, pp. 255-266.

184. Archer, T., Hård, E., & Hansen, S. Animal models of mental retardation. In: Neuromethods Vol. 19 : Animal Models in Psychiatry, II, A. Boulton, G. Baker, and M. Martin-Iverson (Ed.). The Humana Press., Clifton, N.J., 1991, pp. 273- 314.

185. Danysz, W., Archer, T., & Fowler, C.J. Screening for new antidepressant compounds. In: Behavioral Models in Psychopharmacology, P. Willner (Ed.), Cambridge University Press, 1991 pp. 126-156.

186. Luthman, J., Fredriksson, A., Plaznik, A., & Archer, T. Ketanserin and mianserin treatment reverses hyperactivity in neonatally dopamine-lesioned rats. Journal of Psychopharmacology, 1991, 5, 418-425.

187. Teiling-Gårdlund, A., Archer, T., Danielsson, M., Danielsson, B., Fredriksson, A., Lindquist, N.G., Lindström, H., & Luthman, J. Effects of prenatal exposure to tribu tyltin and trihexyltin on behaviour in rats. Neurotoxicology and Teratology, 1991, 13, 99-105.

1992

188. Archer, Trevor Functional and neuroendocrine correlates of memory in normal and disease states: I. Putative neurotransmitters in animal models of depression and dementia. Rapport HSFR , 1992.

189. Archer, T. & Fredriksson, A. Functional changes implicating dopaminergic systems following perinatal treatments. Developmental Pharmacology and Therapy, 1992, 18, 201-222.

* 190. Archer, T. & Nilsson, L.G. Symposium i biologisk psykologi: minnets psykologi och neurobiologi. Rapport 1992.

191. Fredriksson, A., Dahlgren, L., Danielsson, B., Eriksson, P., Dencker, L., & Archer,
T. Behavioural effects of neonatal metallic mercury exposure in rats. Toxicology, 1992, 74, 151-160.

192. Kostowski, W., Dyr, W. Krzascik, P., Järbe, T.U.C., & Archer, T. 5Hydroxytryptamine 1A receptor agonists in animal models of depression and
anxiety. Pharmacology & Toxicology, 1992, 71,24-30.

*193. Nilsson, L-G. & Archer, T. Neurobiologi av minne. Rapport 1992.
194. Nilsson, L.-G., & Archer, T. Biological aspects of memory and emotion: Affect

and cognition. In: “The Handbook of Emotion and Memory”, S.-Å.

Christiansson (ed.), Lawrence Erlbaum Associates, 1992, 99.289-305. 195. Rönnberg, J. & Archer, T. Purposive Behaviour in cognition and perception:

Considerations of awareness in memory. Scandinavian Journal of Psychology,

1992, 33, 86-91.
196. Wahlström, G., Archer, T. & Lärkfors, L. Nerve growth factor (NGF) in rat brain

following long-term barbital treatment: relation to convulsions and cognitive function. Neuroscience Letters, 1992, 137, 65-68.

1993

197. Archer, T. The antinociceptive efficacy of typical and atypical antidepressant compounds: Further evidence for serotonergic function in analgesia. Nordic Journal of Psychiatry, 1993, 47, 347-349.

198. Archer, T. Behavioural retardation in the neuropathology of mental
retardation. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 1993, 101, 35-56.

199. Archer, T. & Fredriksson, A. Neuroleptics – Preclinical and mechanistic studies.

In: Developmental toxicology – Preclinical and clinical data in retrospect.. A. Sundwall, B. R. Danielsson, O. Hagberg, E. Lindgren, P. Sjöberg & A. Victor (Eds). Stockholm, 1993, pp. 123-136.

200. Archer, T. Use of antidepressants in pain: Chronic and acute studies in the laboratory. Nordic Journal of Psychiatry, 1993, 47, 7-8.

201. Danielsson, B., Fredriksson, A., Dahlgren, L., Teiling-Gårdlund, L., Olsson. L.,

Dencker, L., & Archer, T. Behavioural effects of prenatal metallic mercury inhalation exposure in rats. Neurotoxicology and Teratology, 1993, 15, 391- 396.

202. Fredriksson, A., Teiling-Gårdlund, A., Bergman, K., Oskarsson, A., Ohlin, B., Danielsson, B., & Archer, T. Effects of maternal dietary supplementation with selenite on the postnatal development of rat offspring exposed to methyl mercury in utero. Pharmacology and Toxicology, 1993, 72, 377-382.

1994

203. Archer, T. The role of conditioning in the use of placebo. Nordic Journal of Psychiatry, 1994, 49, 43-53.

204. Archer, T. & Fredriksson, A. Functional effects of MPTP in mice: Studies on parkinsonian validity. Polish Journal Pharmacology, 1994, 46, 197-198.

205. Archer, T. & Nilsson, L.-G. Context effects in learning and memory: Human and animal perspectives. In: The Memory System of the Brain. J. Delacour (ed.), Vol. 4,.1994, pp. 153-181. London: World Scientific Press.

206. Archer, T. & Palomo, T. Introduction: Depressive, anxiety and drug abuse disorders. In: Strategies for Studying Brain Disorders. Vol. I. Depressive, anxiety and drug abuse disorders. (Eds. T. Palomo & T. Archer), Madrid, Farrand Press, 1994, pp. 1-8.

207. Beninger, R. J., Palomo, T. & Archer, T. Introduction: Schizophrenia, movement disorders and age related cognitive disorders. In. Strategies for Studying Brain Disorders (Eds. T. Palomo, T. Archer & R. J. Beninger), Madrid, Vol. 2, Farrand Press, 1994, p. 1-14.

208. Danysz, W. & Archer, T. Glutamate, learning and dementia – selection of evidence. Journal of Amino Acids, 1994, 7, 147-163.

209. Erlandsson, S. I. & Archer, T. Tinnitus, pain and affective disorders. In: Strategies for Studying Brain Disorders: Vol. I. Depressive anxiety and drug abuse disorders. (Eds. T. Palomo & T. Archer), Madrid, Farrand Press, 1994, pp. 123-142.

210. Fredriksson, A. & Archer, T. MPTP-induced behavioural deficits in mice: validity

and utility of a model of parkinsonism. In: Strategies for Studying Brain Disorders. Vol. II. Schizophrenia, movement disorders and age related cognitive disorders. (Eds. T. Palomo, T. Archer & R. J. Beninger), Madrid, Farrand Press, 1994, 201-231.

211. Fredriksson, A. & Archer, T. MPTP-induced behavioural and biochemical
deficits: A parametric analysis. Journal of Neural Transmission, 1994, 7, 123- 132.

212. Fredriksson, A., Gentsch, C. & Archer, T. Effect of the competitive NMDA antagonist, CGP 40116, and low dose of L-Dopa on the motor activity deficit of MPTP-treated mice. Behavioural Pharmacology, 1994, 5, 599-606.

213. Fredriksson, A., Gentsch, C. & Archer, T. Synergistic interactions between NMDA antagonists and L-dopa on activity in MPTP-treated mice. Journal of Neural Transmission, 1994, 97, 197-209.

214. Fredriksson, A., Platznik, A., Sundström, E. & Archer, T. Effects of D1 and D2 agonists on spontaneous motor activity in MPTP treated mice. Pharmacology and Toxicology, 1994, 75, 36-41.

215. Parker, Adrian & Archer, T. Conflict behavior: Approach-approach, approachavoidance and avoidance-avoidance. Encyclopedia of Human Behavior, Academic Press, 1994, Vol. 1:665-673.

216. Rydenhag, B., Sjöström, A., Archer, T. & Conradi, N.G. A new operant discrimination test procedure for resident rats. Physiology and Behavior, 1994, 55, 47-51.

217. Ögren, S. O. & Archer, T. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile. Psychopharmacology, 1994, 114, 383-391.

1995

218. Archer, T., Dahlgren, L. & Järbe, T. U.C. Effects of dopamine depletion and social housing upon spatial navigation and learning. MS to be revised.

219. Archer, T. & Fredriksson, A. MPTP treatment of mice: functional changes and their modulation. Behavioural Pharmacology, 1995, Suppl.7, 25-26.

220. Archer, T., Minor, B.G., & Post, C. Antagonism of 5-MeODMT analgesia by

DSP4: Effect of clonidine. Submitted, 1993.
221. Danysz, W., & Archer, T. Glycine and NMDA receptors: emerging problems of

physiological significance. Elsevier Trends Journals, 1993, 5, 34-37. 222. Danysz, W., Post, C., Minor, B. G., Behbebani, M. B., Schultzberg, M. & Archer.

T. Supraspinal mediation of 5-methoxy-N, N-dimethyltryptamine-induced

analgesia. Pharmacology & Toxicology, submitted
223. Järbe, T. U.C. & Archer, T. 5-Hydroxytryptamine 1A Agonists and DRL 72-sec.

schedule performance. To be submitted.
*224. Mohammed, A.K., Luthman, J., Magnusson, D., Jonsson, G., Archer, T., &

Winblad, B. Behavioral deficits induced by neonatal dopamine depletion are

modified by enriched environment. Manuscript submitted
225. Danysz, W., Minor, B.G., Post, C., Behbehani, M., & Archer, T. 5-Methoxy-

N,Ndimethyltryptamine induced analgesia: Effects of route of administration and

cell recording. Submitted. 1993.
226. Archer, T. Antinociception and 5-HT 1A receptor sensitivity after

treatment with desipramine, zimelidine and mianserin in rats. Nordic Journal of

Psychiatry, 1993, 48, 33-44.
227. Wultz, B., Sagvolden, T., Moser, M-B., Moser, E.I. & Archer, T. The

spontaneously hypertensive rats as an animal model of attention-deficit hyperactivity disorder: Effects of reduced central noradrenaline levels in hyperac tivity and on reactivity to methylphenidate. Behavioural Pharmacology, 1991, 00, 00-00.

228. Ögren, S. O. & Archer, T. & Johansson, C. Serotonin and active avoidance learning. Behavioural Neuroscience, 1993, 00, 0-00.

229. Ögren, S. O., Archer, T. & Johansson, C. Effects of 5-HT depletion on 1-way and 2-way acquisition. Psychopharmacology, 1994, 00, 00-00.

230. Archer, T., Bassen, M., Fredriksson, A. & Luthman, J. Effects of dopamine agonists upon motor activity in MPTP-treated mice and 6-OHDA-treated rats. Spanish Journal of Neurology, 89, 12-16.

231. Fredriksson, A. & Archer, T. Synergistic interactions between COMT- /MAOinhibitors and L-Dopa in MPTP-treated mice. Journal of Neural Transmission, 1995, 102, 19-34.

1977-1995 = 147.

1996

232. Palomo, T., Archer, T. and Beninger, R.J. Dopamine disease states: From Parkinson’s disease to Schizophrenia. In: Dopamine Disease States, R.J. Beninger, T. Palomo & T. Archer (Eds.)., Madrid University Press, 1996, pp.1-6.

233. Archer, T., Bassen, M., Peters, D., Luthman, J. and Fredriksson, A. Dopaminergic-glutamatergic balance in the forebrain: functional studies of movement disorders in rats and mice. In: Dopamine disease states, T. Palomo, T. Archer & R.J. Beninger (Eds)., Madrid Univ. Press, 1996, pp. 117-154.

234. Fredriksson, A., Bassen, M. & Archer, T. MPTP-induced deficits in learning and motor activity: Possible neuroprotective effects in parkinsonism. In: Dopamine disease states, T. Palomo, T. Archer & R.J. Beninger (Eds)., Madrid Univ. Press, 1996, pp. 83-116.

235. Klint, T., Bassen, M., Vlastos, H., Dahlgren, L. & Archer, T. Antipsychotic or potential antipsychotic compounds alter MK-801 effects upon motor activity and maze learning in male rats: Comparison with 5-HT antagonists. In: Dopamine disease states, T. Palomo, T. Archer & R.J. Beninger (Eds)., Madrid Univ. Press, 1996, pp. 155-180.

236. Fredriksson, A., Bassen, M., Cervini, M. A., Post, C., Archer, T. & McArthur, R.
Effects of dopamine agonists upon locomotor function in denervated mice and rats: Comparison with cabergoline. In: Dopamine disease states, T. Palomo, T. Archer & R.J. Beninger (Eds), Madrid Univ. Press, 1996, pp. 181-210.

237. Luthman, J., Radesäter, A-C., Bassen, M. and Archer, T. Functional and neurochemical responses to interventions in the developing dopamine system. In: Dopamine Disease States, R.J. Beninger, T. Palomo and T. Archer (Eds), Madrid Univ. Press, 1996, pp. 337-358.

238. Palomo, T., Beninger, R.J. and Archer, T. Neurotoxicity and functional concomitants in neurodegenerative brain disorders. In: Dopamine Disease States, R.J. Beninger, T. Palomo and T. Archer (Eds), Madrid Univ. Press, 1996, pp. 569- 605.

239. Fredriksson, A. & Archer, T. Alpha-phenyl-tert-butyl-nitrone (PBN) reverses age- related maze learning preformance and motor activity deficits in mice. Behavioural Pharmacology, 1996, 7, 1-9.

240. Fredriksson, A., Archer, T. & Eriksson, P. Modulation of diazepam-induced changes in motor activity and marble-burying by neonatal treatment with diazepam. Submitted to Environmental Toxicology & Pharmacology.

241. Klint, T., Bassen, M., Vlastos, H., Dahlgren, L. & Archer, T. Effects of
antipsychotic or putative antipsychotic compounds on alterations induced by MK- 801 upon motor activity and maze learning performance in male rats. Submitted to Behavioural Pharmacology.

242. Luthman, J., Bassen, M., Fredriksson, A. & Archer, T. Functional changes induced by neonatal 6-hydroxydopamine lesions: Effects of dose levels on behavioural parameters. Behavioural Brain Research, 1997, 82, 213-221.

243. Fredriksson, A., Gentsch, C. & Archer, T. COMT-inhibitor – L-DOPA interactions and motor activity in MPTP-treated mice. To be submitted to Journal of Neural Transmission.

244. Fredriksson, A., Ericsson, P. & Archer, T. Alpha-phenyl-tert-butyl-nitrone (PBN) reverses age-related learning performance and motor activity deficits in C57/BL6 mice. Journal of Neural Transmission, 1997, 104, 579-592.

245. Fredriksson, A., Danielsson, B. R. G., Dencker, L. & Archer, T. Prenatal
coexposure to metallic mercury vapour and methylmercury produce additive behavioural changes in adult rats. Neurotoxicology & Teratology, 1996, 7, 129- 134.

246. Teiling-Gårdlund, A., Fredriksson, A., Dahlgren, I.L., Danielsson, B., Lewander,
T., & Archer, T. Effects of prenatal exposure to a novel antipsychotic compounds, remoxipride, on behaviour in rat. To be submitted.

247. Westergren, S., Rydenhag, B., Archer, T. & Conradi, N. G. Effects of prenatal
alcohol exposure on activity and learning in Sprague-Dawley rats. Pharmacology, Biochemistry & Behaviour, 1996, 55, 515-520.

248. Archer, T., Peters, D. and Lindholm, K-J. Psychopathy: Concepts, etiology, epidemiology and treatment. Nordic Journal of Psychiatry, 36, 24245-24249.

249. Archer, T. and Fredriksson, A. Effects of acute/chronic, subthreshold/threshold doses of L-Dopa in MPTP-treated mice: I Influence of competitive and

noncompetitive NMDA antagonists. In: Interactive monoaminergic Disorders, T. Palomo, R.J. Beninger and T. Archer (Eds), Madrid Univ. Press, 1999. pp. 573- 606.

250. Fredriksson, A. and Archer, T. Effects of acute/chronic, subthreshold/threshold doses of L-Dopa in MPTP-treated mice: II Effects of MAO/COMT inhibitors. In: Interactive monoaminergic Disorders, T. Palomo, R.J. Beninger and T. Archer (Eds), Madrid Univ. Press, 1999. pp. 607-654.

251. Norlander, T., Bergman, H. and Archer, T. Effects of flotation REST on creative problem solving and originality. Journal of Environmental Psychology, 1998, 18, 399-408.

252. Palomo, T., Beninger, R.J., & Archer, T. Interactive Monoaminergic Basis of
Anxiety and Depression. In: Interactive Monoaminergic Disorders, T. Palomo, R.J. Beninger & T. Archer (Eds), Madrid University Press. 1999. pp. 35-46.

253. Palomo, T., Archer, T., & Beninger, R.J. Interactive Monoaminergic Basis of Schizopsychotic Disorder. In: Interactive Monoaminergic Disorders, T. Palomo, R.J. Beninger & T. Archer (Eds), Madrid University Press. 1999. pp. 333-342.

254. Archer, T., Beninger, R.J., & Palomo, T. Interactive Monoaminergic systems in Movement Disorders. In: Interactive Monoaminergic Disorders, T. Palomo, R.J. Beninger & T. Archer (Eds), Madrid University Press. 1999. pp. 547-554.

255. Beninger, R.J., Palomo, T., & Archer, T. Interactive Monoaminergic systems in Substance abuse disorders. In: Interactive Monoaminergic Disorders, T. Palomo, R.J. Beninger & T. Archer (Eds), Madrid University Press, 1999, pp. 199-212.

256. Fredriksson, A., Palomo, T., Chase, T.N. & Archer, T. Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: Effects of glutamate antagonists. Journal of Neural Transmission, 1999, 106, 283-300.

257. Norlander, T., Nordmarker A., & Archer, T. Effects of alcohol and frustration on experimentally induced Graffiti. Scandinavian Journal of Psychology, 1998, 39, 201-207.

258. Fredriksson, A., Palomo, T., & Archer, T. Effects of MAO inhibitors upon MPTP mice chronically-treated with suprathreshold doses of L-Dopa. Behavioural Pharmacology, 2000, 11, 571-581.

259. Fredriksson, A., Palomo, T., & Archer, T. Effects of co-administration of

anticonvulsant agents and subthreshold/suprathreshold doses of L-Dopa upon motor behaviour of MPTP-treated mice. Journal of Neural Transmission, 106, 889-909.

260. Norlander, T., Bergman, H., & Archer, T. Primary Process in Competitive Archery Performance: Effects of Flotation REST. Journal of Applied Sports Psychology, 1999, 11, 194-209.

261. Norlander, T., Dahlin A., & Archer, T. Health in Women: effects of life events, social support and personality. Psychological Reports, 2000, 96, 76-78.

262. Nordmarker A., Norlander, T., & Archer, T. The effects of alcohol intake and induced frustration upon experimental graffiti. Social Behaviour and Personality, 2000, 28, 15-28. in press.

263. Jiménez-Arriero, M.A., Ponce, G., Huidobro, J., Rubio, G., Archer, T., & Palomo, T. Clinical evidence of naltrexone efficacy in the treatment of alcohol dependence. In: Interactive Monoaminergic Disorders, edited by T. Palomo, R.J. Beninger & T. Archer. Madrid University Press, 1999, pp. 275-290.

264. Schröder, N., Archer, T., Eriksson, P., Izquierdo, I & Fredriksson, A. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. XIII Reuniao Anual da Federacao de Sociedades de Biologia Experimental, Caxambu, MG, Brazil, pp.16-18, 1998.

265. Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicology and Applied Pharmacology, 1999, 159, 25-30.

266. Fredriksson, A., Palomo, T., & Archer, T. Clonidine mobilization of L-Dopa-tolerant MPTP mice. In: Catecholamine Disease States, edited by T. Palomo, R.J. Beninger & T. Archer. Madrid University Press, 1999, pp. 29-41.

267. Norlander, T., Erixon, A., & Archer, T. Psychological Androgyny and Creativity: Dynamics of Gender-role and Personality trait. Journal of Social Behaviour and Personality, 2000, 28, 423-435.

268. Fredriksson, A., Eriksson, P., Ankarberg, E., Palomo, T., & Archer, T. Neonatal Nicotine administration influences ethanol-induced behaviours. Alcohol, 2000, 21, 1-9.

269. Wästlund, E., Norlander, T., & Archer, T. Exploring cross-cultural differences in selfconcept: A meta-analysis of SDQ1. Cross Cultural Research, 2001, 35, 280- 302.

270. Svensson, N., Norlander, T., & Archer, T. Group versus Individual Performance of Creative Tasks. The Korean Journal of Thinking and Problem Solving, 2002, 12, 15-34.

271. Norlander, T., Gård, L., Lindholm, L., & Archer, T. New Age: Exploration of outlook- on-life frameworks from a phenomenological perspective. Mental Health, Religion and Culture, 6, 1-20.

272. Archer, T., & Fredriksson, A. Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice I: Dose-, Time- and Parameter- dependency. Neurotoxicity Research, 2000, 1, 235-247.

273. Fredriksson, A., & Archer, T. Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice II: Interactions with apomorphine. Neurotoxicity Research, 2000, 1, 249-259.

274. Palomo, T., Archer, T., & Beninger, RJ. Catecholamines in Brain Disease States. In Catecholamine Disease States, edited by T. Palomo, RJ Beninger & T. Archer, Madrid University Press, Madrid, pp. xx-xx, 2000.

275. Norlander, T., Kjellgren, A., & Archer, T. The Experience of Flotation-REST as a Function of Setting and Previous Experience of Altered State of Consciousness. Imagination, Cognition and Personality, 2001, 20, 41-57.

276. Archer, T., Palomo, T., & Fredriksson, A. Functional expressions of noradrenergic receptor changes following denervation with DSP4: Interactive and parametric effects of clonidine. In Neurodegenerative Disorders, edited by T. Palomo, RJ Beninger & T. Archer, Editorial Sintesis, Madrid, pp.181-212, 2001.

277. Archer, T., & Fredriksson, A. Restoration and putative protection in Parkinsonism.

In Neurodegenerative Disorders, edited by T. Palomo, RJ. Beninger & T.

Archer, Editorial Sintesis, Madrid, pp.609-665, 2001.
278. Archer, T., & Fredriksson, A. The role of a2-adrenoceptor agonists upon MPTP-

induced deficits. Catecholamine Disorders, 2002, xx, 000-000.
279. Fredriksson, A., Schröder, N., & Archer, T. Neurofunctional deficits in mice induced

by postnatal iron exposure: dose, time and MPTP interactions. In Neurodegenerative Disorders, edited by T. Palomo, RJ. Beninger & T. Archer, Editorial Sintesis, Madrid, pp. 449-480, 2001.

280. Palomo, T., Jhamandas, K., Beninger, R.J., & Archer,T. Neurotoxicity and neurodegeneration: implications for neuropsychiatric disorders. In Neurodegenerative Disorders, edited by T. Palomo, RJ. Beninger & T. Archer, Editorial Sintesis, Madrid, pp. 23-30, 2001.

281. Fredriksson, A., Danysz, W., Quack, G., & Archer, T. Effects of co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa upon the motor behaviour of MPTP-treated mice. Journal of Neural Transmission, 2001, 108, 167-187.

282. Archer, T., & Fredriksson, A. Restoration and putative protection of MPTPinduced functional deficits. Neurotoxicity Research, 2000, 2, 251-292.

283. Jiménez-Arriero, M.A., Ponce, G., Huidobro, J., Rubio, G., Archer, T., &
Palomo, T. Clinic evidence of naltrexone on long-term alcohol dependent treatment.Alcoholism: Clinical and Experimental Research, 2000, 17, 51-64.

284. Kjellgren, A., Sundequist, U., Norlander, T., & Archer, T. Effects of flotation-REST on muscle tension pain. Pain Research & Management, 6, 181-189.

285. Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. Maze
learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Developmental Brain Research, 2000, 119, 65-74.

286. Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I., & Archer, T. Postnatal iron and adult MPTP induced neurodegeneration and functional deficits in mice. Parkinsonism & Related Disorders, 2001, 7, 97-105.

287. Norlander, T., & Archer, T. Predicting performance outcome in ski and swim § championship: Discriminant effectiveness of mood, perceived exertion and dispositional optimism. Perceptual and Motor Skills, 94, 153-164.

288. Schröder, N., Fredriksson, A., Izquierdo, I., & Archer, T. Memory deficits in adult rats following postnatal iron administration. Behavioural Brain Research, 124, 77-85.

289. Beal, M.F., Palomo, T., Kostrzewa, R.M., & Archer, T. Neuroprotective and neurorestorative strategies for neuronal injury. Neurotoxicity Research, 2000, 2, 251-292.

290. Archer, T., & Fredriksson, F. Effects of a-adrenoceptor agonists in chronic morphine administered DSP4-treated rats: Evidence for functional cross-sensitization. Neurotoxicity Research, 3, 411-432.

291. Archer, T., Palomo, T., & Kostrzewa, R.M. Neurotoxicity and substance abuse: further fuel for regulatory dilemma. Neurotoxicity Research, 2001, 3, 1-6.

292. Pramling, N., Norlander, T., & Archer, T. Moral expression in six-to-seven yearold children’s stories in Sweden, Hungary and China: a phenomenological study. Childhood, 2001, 8, 361-382.

293. Norlander, T., Kjellgren, A., & Archer, T. Effects of Flotation- versus Chamberrestricted environmental stimulation technique (REST) on creativity and realism under Stress and Non-stress conditions. Journal of Environmental Psychology, accepted for publication.

294. Palomo, T., Beninger, R.J., & Archer, T. Substance dependence disorders:
interactive and neurotoxic potential. In Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders, edited by T. Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T. Archer, pp. 25-48. Editorial Sintesis, 2001.

295. Palomo, T., Beninger, R.J., Jhemandas, K.H., & Archer, T. Neurodegenerative diseases of the brain: genetic and environmental factors. In Neurodegenerative Disorders, edited by T. Palomo, R.J. Beninger and T. Archer, pp. 213-224, Editorial Sintesis, 2001.

296. Palomo, T., Beninger, R.J., Jhemandas, K.H., Kostrzewa, R.M., Beal, M.F., &
Archer, T. Protective and restorative strategies in the neurodegenerative disorders. In Neurodegenerative Disorders, edited by T. Palomo, R.J. Beninger and T. Archer, pp. 481-500, Editorial Sintesis, 2001.

297. Pramling, N., Norlander, T., & Archer, T. Conceptualization of the Unknown by 6-, 9- and 14-year-old children: Search for a ‘heffalump’. Childhood, 2001, 10, 379-392.

298. Löfqvist, A.H., & Archer, T. A theoretical framework for the understanding of psychosomatic reactions. Manuscript submitted for publication.

299. Rubio, G., Jiménez-Arriero, M.A., Ponce, G., Archer, T., & Palomo, T.
Neurobiological basis of primimg: its importance in alcoholism. In Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders, edited by T. Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T. Archer, pp. Xx-xx. Editorial Sintesis, 2001.

300. Wästlund, E., Norlander, T., & Archer, T. Internet blues revisited: A replication and extension of Kraut et al. (1998) Internet Paradox study. CyberPsychology and Behaviour, 2001, 4, 385-391.

301. Löfqvist, A.H., & Archer, T. Functional somatic syndromes – a matter of stress

response patterns.Journal of Chronic Fatigue Syndromes, in press.
302. Fredriksson, A., Palomo, T., McArthur, R., & Archer, T. Effects of acute

administration of DA agonists on locomotor activity: MPTP versus neonatal

intracerebroventricular 6-OHDA treatment. Neurotoxicity Research, in press. 303. Palomo, T., Gorriti, M.A., Ponce, G., Archer T., & Jimenez Arriero, M.A. From

basic research on the tetrahydrocannabinoids to the study of alterations associated with consumption. In Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders, edited by T. Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T. Archer, pp. 197-223. Editorial Sintesis, 2001.

304. Norlander, T., Blom, A., Archer, T. Role of High School Teachers in Swedish Psychology Education: Phenomenological Circumstances. The Qualitative Report, 2001 7, 1-15.

305. Dal-Pizzol, F., Klamt, F., Frota, M.L.C., Andrades, M.E., Caregnato, F.F., Schröder, N., Quevedo, J., Izquierdo, I., Archer, T., & Moreira, J.C.F. Neonatal iron exposure induces oxidative stress in adult Wistar rats. Molecular Brain Research, 2001, 130, 109-114.

306. Mohammed, A.H., & Archer, T. Effects of housing conditions on functional development in rats.Pharmacology, Biochemistry & Behavior, manuscript invited for publication.

307. Folkesson, P., Nyberg, C., Archer, T., & Norlander, T. Football referees’ experience of threat and violence: Effects of age, experience and life orientation on outcome of coping strategy. Aggressive Behaviour, 2002, 28, 317-327.

308. Norlander T., Bood, S-Å., & Archer, T. Performance during stress by different occupational groups: Affective personality, Age and regularity of physical exercise. Social Behaviour and Personality, 2002, 30, 495-508.

309. Archer, T., Palomo, T., & Fredriksson, A.F. Restorative effects of glutamate antagonists in experimental parkinsonism. Amino Acids, 2002, 23, 71-85.

310. Fredriksson, A., & Archer, T. Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptic drugs and postnatal administration. Amino Acids, 2002, 23, 111-132.

311. Archer, T., Palomo, T. & Fredriksson, A. Neonatal 6-hydroxydopamine-induced hyperactivity: Blockade by dopamine reuptake inhibitors and effect of acute damphetamine. Neurotoxicity Research, 2002, 4, 247-266.

312. Archer, T., Palomo, T., & Fredriksson, A. Functional deficits following neonatal dopamine depletion and isolation housing: circular water maze acquisition under pre-exposure conditions and motor activity. Neurotoxicity Research, 2002, 4, 503-522.

313. Archer, T., Palomo, T., & Beninger, R.J. Structural and functional neuroimaging as
an avenue towards the understanding of brain abnormalities in health and disease. In Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders, edited by T. Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T. Archer, pp. 197-223. Editorial Sintesis, 2002.

314. Palomo, T., Beninger, R.J., & Archer,T. Neuroimaging in psychiatry. Advances in Neurosciences and Clinical Realities:neuropsychiatry, edited by T. Palomo, R.J. Beninger, M.A. Jimenez-Arriero and T. Archer, pp. 197-223. Editorial Sintesis, 2002.

315. Fredriksson, A., Schröder, N., & Archer, T. Neurobehavioural deficits following Postnatal iron overload: I Spontaneous motor activity. Neurotoxicity Research, 2003, 5, 53-76.

316. Fredriksson, A., Schröder, N., & Archer, T. Neurobehavioural deficits following Postnatal iron overload: II Instrumental learning performance. Neurotoxicity Research, 2003, 5, 77-94.

317. Palomo, T., Archer, T., Beninger, R.J., & Kostrzewa, R.M. Neurodevelopmental liabilities of substance abuse. Neurotoxicity Research, 2002, 4, 267-279.

318. Palomo, T., Kostrzewa, R.M., Archer, T., & Beninger, R.J. Neurodevelopmental liabilities in Schizophrenia and Affective disorders. Neurotoxicity Research, 2002, 4, 397-408.

319. Fredriksson, A., & Archer, T. Effect of postnatal iron administration on MPTPinduced behavioural deficits and neurotoxicity: behavioural enhancement by LDopa-MK-801. Behavioural Brain Research, 2003, 139, 31-46.

320. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Sites of movement disorder: Genetic and environmental agents in developmental perturbations. Neurotoxicity Research, 2003, 5, 1-27.

321. Archer, T., Palomo, T., McArthur, R., & Fredriksson, A. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal 6hydroxydopamine. Neurotoxicity Research, 2003, 5, 95-110.

322. Norlander, T., Bergman, H., & Archer, T. Relative constancy of personality characteristics and efficacy of a 12-month training program in facilitating coping strategies. Social Behaviour and Personality, 2002, 30, 773-784.

323. Archer, T., & Fredriksson, A. Antihypokinesic effect of a2-adrenoceptor agonists upon MPTP-induced behavioural deficits. Journal of Neural Transmission, 2002, 110, 183-200.

324. Archer, T. Environmental agents and vulnerability in cognitive deficits. In Advances in Neurosciences and Clinical Realities: Genetic-environmental neurovulnerability in psychiatry, edited by T. Palomo, R.J.Beninger, Jimenez- Arriero and E. Huertas. Pp. 151-179 .Editorial Sintesis, 2003.

325. Fredriksson, A., Archer, T., Alm, H., Gordh, T., & Eriksson, P. Neurofunctional deficits and potentiated apoptosis by postnatal NMDA antagonist administration. Behavioural Brain Research, 2004, 153, 367-376.

326. Fredriksson, A., Archer, T., Alm, H., Gordh, T., & Eriksson, P. Neurofunctional deficits and potentiated apoptosis by neonatal administration of ethanol. Submitted.

327. Fredriksson, A., Eriksson, P., Alm, H., & Archer, T. Neurofunctional deficits and potentiated apoptosis by postnatal MK-801 treatment. Submitted

328. Kristensson, P., Gustafsson, A., & Archer, T. Harnessing the creative potential among users. Journal of Product Innovation Management, 2004, 21, 4-14.

329. Bood, S.Å., Archer, T., & Norlander, T. Affective personality as determinant of factors influencing stress experience. Individual Differences Research, 2004, 2, 26-37.

330. Janson, L., Archer, T., & Norlander, T. Timing in sports performance: psychophysiological analysis of technique in male and female athletes. Athletic Insight, 2003, 10, 1-10.

331. Janson, L., Archer, T., & Norlander, T. Case studies of muscle activity in running. Submitted.

332. Kjellgren, A., Norlander, T., Sundequist, U., & Archer, T. Altered consciousness in Chamber-REST and Flotation-REST: Experience of Experimental Pain and Subjective Stress. Social Behaviour and Personality, 2004, 32, 103-116.

333. Norlander, T., Moås, T., & Archer, T. Noise and stress in primary and secondary

school children: stress reduction and increased concentration ability through a short but regular exercise and relaxation program. School Effectiveness and School Improvement, 2005, 16, 91-99.

334. Perrin-Wallqvist, R., Archer. T., & Norlander, T. Adolescent’s fire-setting awareness under boredom: relation to personality variables. Psychological Reports, 2004, 94, 863-871.

335. Wästlund, E., Reinikka, H., Norlander, T. & Archer, T. Effects of VDT and paper presentation on consumption and production of information: Psychological and physiological factors. Computers in Human Behavior, 2005, 21, 377-394.

336. Archer, T., and Fredriksson, A. Neonatal Iron and Adult MPTP administration induced motor behaviour deficits and brain iron concentrations in mice. submitted

337. Fredriksson, A., & Archer, T. Hyperactivity Following Postnatal NMDA Antagonist Treatment: reversal by D-amphetamine-induced. Neurotoxicity Research, 2003, 5, 401-416.

338. Norlander, T., von Schedvin, H., & Archer, T. Thriving as a function of Affective Personality and Occupation: Relation to Personality Factors, Coping Strategies and Stress. Anxiety, Stress, and Coping, 2005, 18, 105-116.

339. Esbjörnsson, H., Lithell, P., Wästlund, E., Jansson, B., & Archer, T. Perfectionism, Subjective Stress, Anxiety/Depression, and Optimism as determinants of Affective Personality type. Submitted.

340. Fredriksson, A., Eriksson, P., & Archer, T. Environmental agents inducing functional deficits after postnatal treatment: Effects of acute Psychostimulant administration. Acta Paediatrica, revised manuscript under preparation.

341. Fredriksson, A., & Archer, T. Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotoxicity Research, 2004, 6, 435-456.

342. Svensson, J., Diez, M., Engel, J., Wass, C., Tivesten, Å., Jansson, J-O., Isaksson, O., Archer, T., Hökfelt, H., & Ohlsson, C. Endocrine, liver-derived insulin-like growth factor-I (IGF-I) is of importance for spatial memory learning in mice. Journal of Endocrinology, 2006, 189, 617-627.

343. Fredriksson, A., Eriksson, P., & Archer, T. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice. Journal of Neural Transmission, 2006, 113, 137-150.

344. Pålsson, E., Klamer, D., Wass, C., Archer, T., Engel, J., & Svensson, L. The effects
of phencyclidine on latent inhibition in taste-aversion conditioning: Differential effects of preexposure and conditioning. Behavioural Brain Research, 2004, 157, 139-146.

345. Klamer, D., Pålsson, E., Wass, C., Archer, T., Engel, J., & Svensson, L. Antagonism
of nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning. Behavioural Brain Research, 2005, 161, 60-68.

346. Janson, L., Archer, T., & Norlander, T. Achievement of timing at the highest competitive level: the necessity of a ‘driving conviction’. Athletic Insight, 2005, 7, 37-49.

347. Palomo, T., Archer, T., Beninger, R.J., & Kostrzewa, R.M. Neurodevelopmental aspects of substance abuse. In Neurodevelopmental Liabilities in Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 3- 22. Fundacion Cerebro y Mente, Madrid, 2003.

348. Palomo, T., Kostrzewa, R.M., Archer, T., & Beninger, R.J. Neurodevelopmental liabilities in schizophrenia and affective disorders. In Neurodevelopmental Liabilities in Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 235-254. Fundacion Cerebro y Mente, Madrid, 2003.

349. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations. In Neurodevelopmental Liabilities in Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 557-596. Fundacion Cerebro y Mente, Madrid, 2003.

350. Archer, T., Palomo, T., & Fredriksson, A. Neonatal 6-hydroxydopamine-induced hypo/hyperactivity: blockade by dopamine reuptake inhibitors and effect of acute Damphetamine. In Neurodevelopmental Liabilities in Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 207-234. Fundacion

Cerebro y Mente, Madrid, 2003.

351. Archer, T., Palomo, T., & Fredriksson, A. Functional deficits following neonatal dopamine depletion and isolation housing: circular water maze acquisition under

pre-exposure conditions and motor activity. In Neurodevelopmental Liabilities in Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 399-428. Fundacion Cerebro y Mente, Madrid, 2003.

352. Archer, T., Palomo, T., McArthur R., & Fredriksson, A. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment. In Neurodevelopmental Liabilities in Brain Disease States, edited by R.J. Beninger, T. Palomo, R.M. Kostrzewa & T. Archer, pp. 623-644. Fundacion Cerebro y Mente, Madrid, 2003.

353. Fredriksson, A., & Archer, T. Postnatal iron treatment followed by subchronic haloperidol alters motor behaviour in mice. Neurotoxicity Research, 2006, 10, 123-129.

354. Palomo, T., Archer, T., Kostrzewa, R.M., & Beninger, R.J. Gene-environment interplay in schizopsychotic disorders. Neurotoxicity Research, 2004, 6, 1-10.

355. Palomo, T., Beninger, RJ., Kostrzewa, RM., & Archer, T. Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes. Neurotoxicity Research, 2004, 6, 159-173.

356. Palomo, T., Beninger, RJ., Kostrzewa, RM., & Archer, T. Gene-environment
interplay in Alcoholism and other substance disorders: expressions of heritability and factors influencing vulnerability. Neurotoxicity Research, 2004, 6, 343-361.

357. Palomo T., Archer, T., Beninger, RJ.,& Kostrzewa, RM. Gene-environment interplay in neurodegeneration and neurogenesis. Neurotoxicity Research, 2004, 6, 415- 434.

358. Karlsson, E., & Archer, T. Relationship between personality characteristics and affect: Gender and affective personality. Individual Differences Research, 2007, 5, 44-58.

359. Agerström, J., Möller, K., & Archer, T. Influence of affective personality and level of perfectionism on moral reasoning: Effect of gender. Journal of Personality and Social Psychology, 2006, 34, 1259-1276.

360. Helldin, L., Karilampi, U., Norlander, T., & Archer, T. Functional determinants of cognitive performance and symptom profile in a cohort of schizophrenic patients. Psychiatry Research, 2006, 40, 738-745.

361. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. Remission in

prognosis of functional outcome: a new dimension in the treatment of patients

with psychotic disorders. Schizophrenia Research. 2007 Jul; 93(1-3):160-8. 362. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. Remission and

cognitive ability in a cohort of patients with schizophrenia. Journal of Psychiatric

Research, 2006 Dec;40(8):738-45.

363. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. The influence of cognitive ability for the attainment of remission by a cohort of patients with schizophrenia spectrum disorder. Under review.

363. Karilampi, U., Helldin, L., Hjärthag, F., Norlander, T., & Archer, T. Cognitive functioning in male and female schizophrenic outpatients and healthy volunteers: Influence of learning performance level. Archives of Clinical Neuropsychology, 2007, 22, 161-174.

365. Karilampi, U., Helldin, L., Norlander, T., & Archer, T. Cognitive and daily functioning in a cohort of schizophrenic outpatients: Gender and level of performance. Under review.

366. Archer, T., & Palomo, T. In memory or Ken ‘Kakeu’ Hodson: a man for all seasons.

In: Gene-environment Interplay in Neuropsychiatric Disorders, (Eds. T. Palomo, RJ. Beninger, RM. Kostrzewa & T. Archer), Cerebro y Mente Publications, Madrid, pp. xxiii-xxv.

367. Helldin, L., Kane, J., Karilampi, U., Norlander, T., & Archer, T. Experience of quality of life and attitude to care and treatment in patients with chronic schizophrenia spectrum disorder: role of remission. Under review.

368. Archer, T., & Fredriksson A. Influence of noradrenaline denervation upon MPTP- induced deficits in mice. Journal of Neural Transmission, 2006, 113, 1119- 1129.

369. Svensson, N., Archer, T., & Norlander, T. Validation of the Swedish version of the Regressive Imagery Dictionary: Effects of alcohol and emotional-enhancement on primarysecondary process relations. Creativity Research Journal, in press.

370. Andersson-Arntén, A-C., Jansson, B., & Archer, T. Influence of affective personality type upon coping behaviour, mood and self-reported stress. Individual Differences Research, in press.

371. Pagels, P., Lidman, U., & Archer, T. Influence of brisk, daily exercise upon blood lipid and affective health profiles in Swedish adults. Under review.

372. Svensson, L., Zhang, J., Pålsson, E., Klamer, D., Wass, C., Archer, T., & Engel, JA. Neuronal development following early exposure to iron. Submitted

373. Pålsson, E., Klamer, D., Wass, C., Fejgin, K., Archer, T., & Engel, JA. Acute behavioural effects of PCP: Lack of influence by aripiprazole. Submitted.

374. Archer, T., & Fredriksson, A. Iron influence upon dopaminergic and noradrenergic contributions to movement disorder and psychotic behaviour. In Comorbidity in Neuropsychiatric Disorders, edited by T. Palomo, R.J. Beninger, R.M. Kostrzewa & T. Archer. Cerebro y Mente Publications, Madrid, 2007, pp. Xx- xx, in press.

375. Fredriksson, A., and Archer, T. Postnatal iron overload destroys NA-DA functional interactions. Journal of Neural Transmission, 2007, 114, 137-150.

376. Archer, T. Comorbidity influences in neuropsychiatry: symptom plasticity constraints on etiology and treatment. European Journal of Psychiatry, 2005, 19, 197-207.

377. Hellström P, Edsbagge M, Archer T, Tisell M, Tullberg M, Wikkelsø C. The neuropsychology of patients with clinically diagnosed idiopathic normal pressure

378. Kjellgren, A., André, H., Johansson, I., & Archer, T. Acute smoking and nociception: effect of gender. Under review.

379. Wass, C., Archer, T., Pålsson, E., Fejgin, K., Klamer, D., Engel, J., & Svensson, L. Effect of phencyclidine and nitric oxide dependent mechanisms on spatial learning and memory in rats. Behavioural Brain Research, 2006, 171, 147-153.

380. Archer, T., & Beniniger RJ. Movement disorder neurodevelopment and neurobehavioural expression. Journal of Neural Transmission, 2006, 5-12.

381. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Comorbidity implications in brain disease: neuronal substrates of symptom profiles. Neurotoxicity Research, 2006, 10, 1-13.

382. Karlsson, E., & Archer T. Affective state, stress and Type A-personality as a function of gender and affective personality. Social Behavior and Personality, 2008, 36, xx-xx.

383. Wass, C., Archer, T., Pålsson, E., Fejgin, K., Klamer, D., Axelsson, Å., Engel, J., & Svensson, L. Phencyclidine affects memory in a Nitric oxide-dependent manner: working and reference memory. Behavioural Brain Research, 2006, 174, 49-55.

hydrocephalus.

Neurosurgery. 2007, 61(6):1219-26; discussion 1227-8.

384. Archer, T., & Karlsson, E. Cognition-mediated emotional processing as a consequence of type of affective personality: the notion of empowerment reinforcement. Invited book chapter.

385. Archer, T., & Fredriksson, A. Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor. Neurochemical Research, 2007, 32, 1625-1639.

386. Archer, T. The enigmatic department of psychology. In: Ett Ämne blir till Psychologi I Göteborg – en kort historia med ett långt förflutet, 1956-2006 [The origins of
Psychology in Göteborg – a short story with a long history, 1956-2006], (Eds. C. Falkhe, E. Hjelmquist, I. Lundberg, I. Nilsson, T. Tjus), 2006, Department of Psychology, Göteborg, pp. 88-92.

387. Wästlund, E., Norlander, T., & Archer, T. The effect of page layout on mental workload: a dual task experiment. Computers in Human Behavior, 24, 1229-1245.

388. Wästlund, E., & Archer, T. Short-term and long-term working memory loads derived from computer-based primary and secondary tasks. Submitted.

389. Archer, T., Adriansson, L., Plancak, A., & Karlsson, E. Influence of affective personality on cognition-mediated emotional processing: Need for empowerment. European Journal of Psychiatry, 2007, 21, 248-262.

390. Archer, T., & Fredriksson A. Behavioural supersensitivity following neonatal 6- hydroxydopamine: attenuation by MK-801. Neurotoxicity Research, 2007, 12, 113-124.

391. Hill, F., Landberg, S., Walter, S., & Archer, T. An astonishing proximity to reality: a phenomenological study of employment-seekers’ experience of the OPQ32i questionnaire. Submitted.

392. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders. Neurotoxicity Research, 2007, Vol 12, 43-60.

393. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotoxicity Research, 2007 Vol. 12, 29-42.

394. Archer, T. Symptom-profiles underlying maladaptive emotional-cognitive risk behaviours: contributions of stress, negative affect, low self-image, impulsiveness, external locus of control and temperament. Submitted

395. Palomo, T., Archer, T., Kostrzewa, R.M., & Beninger, R.J. Comorbidity of substance abuse with other psychiatric disorders. Neurotoxicity Research, 2007, Vol. 12, 17-27.

396. Zöller, M., Karlsson, E., & Archer, T. Self-rated affect among adults presenting psychiatric diagnosis. Individual Differences Research, 2009, 7, 14-28.

397. Karilampi, U., Helldin, L., & Archer, T. Global assessment of functioning (GAF) in a cohort of schizopsychotic patients: relation to measures of cognitive performance. Submitted

398. Andersson-Arntén, A-C., Jansson, B., & Archer, T. Partnership relations and work stress as predictors of health and illhealth. Submitted

399. Wass, C., Archer, T., Engel, J., Pålsson, E., Fejgin K., Svensson, L., & Klamer, D. Effects of phencyclidine on cognitive flexibility: targeting the nitric oxide system. Submitted.

400. Raustorp, A., Archer, T., Svensson, K., Perlinger T & Alfredsson M. Physical self- esteem – a five year follow-up study of Swedish adolescents. International Journal of Adolescent Medical Health, 2009, 21, 497-507.

401. Archer, T., Adolfsson, B., & Karlsson, E. Affective personality as cognitive-emotional presymptom profiles regulatory for self-reported health predispositions. Neurotoxicity Research, 2008, 14, 1-25.

402. Archer, T., & Beninger, R.J. Werner J. Schmidt (1950-2007) pushing the envelope of neuroscience: a true academician and complete gentleman. Neurotoxicity Research, 2007, 12, 1-4.

403. Wass, C., Fejgin K., Pålsson, E., Engel, J., Archer, T., Svensson L., & Klamer, D. Phencyclidine-impaired social behaviour is improved by inhibition of nitric oxide production. Submitted.

404. Hellström, P., Archer, T., Tullberg, M., & Wikkelsö, C. Neuropsychological effects of shunt surgery in patients with clinically diagnosed idiopathic normal pressure hydroencephalus (INPH). Neurosurgery, 2008, 63, 527-535.

405. Archer, T. Identifying Symptoms in Diagnostic Labyrinths: Adaptive Beacons from

Biomarkers and Genetic Polymorphisms. European Journal of psychiatry, 2008,

22, 9-16.

406. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Focussing on symptoms in neuropsychiatry: conscious and unconscious expression in brain dysfunction. Neurotoxicity Research, 2008, 14, 1-20.

407. Palomo, T., Kostrzewa, R.M., Beninger, R.J., & Archer, T. Schizopsychotic symptomprofiles and biomarkers: beacons in diagnostic labyrinths. Neurotoxicity Research, 2008, 14, 79-96.

408. Edvardsson, A., Hedelin, L., & Archer, T. Self-directed talk by athletes: an avenue for success in sport. Submitted.

409. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise. Neurotoxicity Research, 2008, 14,151-168.

410. Andersson-Arntén, A., Rosén, S., Jansson, B., & Archer, T. Partnership relations mediate work stress effects on health: effects on gender. Submitted.

411. Zöller, M., & Archer, T. Predicting stress in male and female psychiatric patients and healthy volunteers. Social Behavior and Personality, 2009, 37, 1081-1094. 412. Karlsson, E., & Archer, T. Personal profiles determining quality of sleep in non-

clinical populations: role of gender. To be submitted.
413. Archer, T., Kostrzewa, R.M., Beninger, R.J., & Palomo, T. Cognitive symptoms

facilitatory for diagnoses in neuropsychiatric disorders: executive functions and

locus of control. Neurotoxicity Research, 2008, 14, 205-225.
414. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Symptom Veracity and

Diagnostic Veniality in Brain Dysfunction: Conscious and Nonconscious Expression in Impulsiveness and Decision-making. In: “Beyond Neuropsychiatric Diagnosis: Symptoms Not Disorders”, (T. Palomo, R.J. Beninger, R.M. Kostrzewa & T. Archer, Eds.), 2009, pp. 3-37. F.P. Graham Publishing: Mountain Home, TN.

415. Palomo, T., Beninger, R.J., Kostrzewa, R.M., & Archer, T. Beyond neuropsychiatric diagnosis: symptoms not disorders. In: “Beyond Neuropsychiatric Diagnotics: Symptoms not Disorders” (T Palomo, RJ Beninger, RM Kostrzewa and T Archer, Eds.), 2009, pp. vii-xii, F.P. Graham Publishing: Mountain Home, USA.

416. Andersson-Arntén, A., & Archer, T. Sexual Satisfaction as a Function of Partnership

Attributes and Health Characteristics: Effect of Gender. In: Psychological Wellbeing (IE Wells, Ed.), 2010, Nova Science Publishers Inc.: NY, Chapter 3, pp. Xx-xx.

417. Archer, T., Johansson, B., & Fredriksson, A. Exercise alleviates Parkinsonism: Clinical and Laboratory Evidence. Acta Neurologica Scandinavica, 2011. DOI: 10.1111/j.1600-0404.2010.01360.x, 2011.

418. Archer, T. Neurodegeneration in Schizophrenia. Expert Reviews in Neurotherapeutics, 2010, Jul;10(7):1131-41.

419. Archer, T., & Fredriksson, A. Physical exercise restores MPTP-induced deficits in mice: standard long-term and progressive-incremental neurotoxin administration. Neurotoxicity Research, 2010, 18, 313-27, 2010.

420. Archer, T. Effects of Physical exercise on Brain Disorder Conditions: Clinical and Laboratory Studies. Manuscript invited, Neurotherapeutics.

421. Archer, T. Stages in the pathophysiology and eventual treatment of brain disorders. European Journal of Psychiatry, 24, 5-8, 2010.

422. Archer, T., & Kostrzewa, R.M. Staging neurological disorders: expressions of cognitive and motor disorder. Neurotoxicity Research, 18(2):107-11,2010. 423. Archer, T. Effects of exogenous agents on brain development: stress, abuse and

therapeutic compounds. CNS Neuroscience & Therapeutics, 2011, 17, 470-489.

DOI: 10.1111/j. 1755-5949-2010.0017.x.

424. Archer, T., Kostrzewa, R.M., Beninger, R.J., & Palomo, T. Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression. Neurotoxicity Research, 2010, 18, 287-305.

425. Archer, T., Kostrzewa, R.M., Palomo, T., & Beninger, R.J.Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment. Neurotoxicity Research, 2010,18(3-4):211-28.

426. Archer, T., Beninger, R.J., Palomo, T., & Kostrzewa, R.M. Epigenetics and biomarkers in the staging of neuropsychiatric disorders. Neurotoxicity Research, 2010, 18, 347-66.

427. Archer, T., Kostrzewa, R.M., Beninger, R.J., & Palomo, T. Staging neurodegenerative disorders: structural, regional, biomarkers and functional progressions. Neurotoxicity Research, 2011, Apr 15.DOI 10.1007/s12640-010-9190-2, 19, 211-234.

428. Adrianson, L., Ancok, D., Ramdhani, N., & Archer, T. Cultures influences on health, affect, self-esteem and impulsiveness: an Indonesian-Swedish comparison. International Journal of Research Studies in Psychology, DOI: 10.5861/ijrsp.2013.228.

429. Andersson-Arntén, A-C., Johansson C., & Archer, T. Influence of self-esteem and impulsiveness upon motivation and affect in adolescents and young adults. Submitted for publication.

430. Archer, T. Physical exercise alleviates debilities of normal aging and Alzheimer’s disease. Acta Neurologica Scandinavica, DOI: 10.1111 / j.1600- 0404.2010.01412.x., 2011.

431. Braverman, E.R., Chen, T.J.H., Waite, R.L., Bowirrat A., Allen, C., Yelandi, S., Damle, U., Madigan, M., Giordan, J., Downs, B.W., DiNubile, N., Palomo, T., Archer, T., & Blum, K. Neuroquantum theories of psychiatric genetics: can weak forces induce epigenetic influence on future genomes? Journal of Neuroquantology, in press.

432. Karilampi, U., Helldin, L., Hjärthag, F., & Archer, T. Vigilance profiles and remission in schizophrenia. Submitted for publication.

433. Archer, T., Fredriksson, A., Schulz, E., Kostrzewa, R.M. Influence of physical exercise on neuroimmunological functioning and health: aging and stress. Neurotoxicity Research, 2011, 20, 69-83, DOI: 10.1007/s12640-010-9224-9.

434. Fredriksson, A., Stigsdotter, I.M., Hurtig, A., Ewalds-Kvist, B., & Archer, T. Running wheel activity restores MPTP-induced functional deficits. Journal of Neural Transmission, 2011, 118, 407-420. DOI: 10.1007/s00702-010-0474-8.

435. Archer, T., & Fredriksson, A. Delayed exercise-induced functional and neurochemical partial restoration following MPTP. Neurotoxicity Research, in press, DOI: 10.1007/ s12640-011-9261-z.

436. Blum, K., Giordano, J., Morse, S., Madigan, M., Downs, BW., Waite R., Kerner, M., Damle, U., Braverman, E.R., Femino, J., Bailey, J., DiNubile, N., Miller, D., Archer, T., Simpatico, T. Understanding the high mind: humans are still evolving genetically. The HOAB Journal, accepted for publication.

437. Archer, T., Moradi, S., Welin, A., Hakiminejad, N., & Andersson-Arntén, A.C. Physical exercise, stress and affect. Submitted.

438. Archer, T., & Blum, K. Epigenetics in Neuropsychiatry. In OMICS: Biomedical 62

Perspectives and Applications, Chapter 25, D Barh,K Blumand MA Madigan (Eds.),
2011, CRC, San Diego.

439. Archer, T., & Bright, P. Functional and structural MRI studies on impulsiveness: AttentionDeficit/Hyperactive Disorder and Borderline Personality Disorders. In “Neuroimaging – Cognitive and Clinical Neuroscience” volume, Chapter 10, Editor: P. Bright, 2012, pp. 205-228; InTech: Rijeka, Croatia. DOI: 10.5772/1815.

440. Archer, T., Oscar-Berman, M., & Blum K. Epigenetics in Developmental Disorder: ADHD and Endophenotypes. Journal of Genetic Syndromes & Gene Therapy, 2, 1-10. DOI: 10.4172/2157-7412.1000104.

441. Archer, T., & Kostrzewa, R.M. Physical exercise alleviates ADHD symptoms: regional deficits and developmental trajectory. Neurotoxicity Research, 2012, 21(2):195- 209., DOI: 10.1007/s12640-011-9260-0.

442. Pagels, P., Raustorp, A., Archer, T., Lidman, U., & Alricsson, M. Influence of moderate, daily physical activity upon body composition and blood lipid profile in Swedish adults. Journal of Physical Activity & Health, 2012, 9(6):867-74.

443. Archer, T., Svensson, K., & Alricsson M. Physical exercise ameliorates deficits induced by traumatic brain injury. Acta Neurologica Scandinavica, accepted for publication.

444: Archer, T. Influence of physical exercise on traumatic brain injury deficits: scaffolding effect. Neurotoxicity Research, accepted for publication. DOI: 10.1007/s12640-011-9297-0.

445. Karilampi, U., Helldin, L., & Archer, T. Cognition and global assessment of functioning in male and female outpatients with schizophrenia spectrum disorders. Journal of Nervous and Mental Disease, 2011, 199, 445-448.

446. Garcia, D., & Archer, T. Adolescent life satisfaction and well-being. Journal of Alternative Medical Research, 2012, 4, 271-279.

447. Garcia, D., Kerekes, N., Andersson Arntén, A-C., & Archer, T. Temperament, character, and adolescent’s depressive symptoms: focussing on affect. Depression Research and Research, 2012.DOI: 10.1155/2019/925372..

448. Rylander, P., Heden, A., Garcia, D., & Archer, T. Will the Peer leader please stand up? The Personality of the athletic Peer leader in elite and non-elite sport teams.

Journal of Research Studies in Psychology, 2013, 65–74. DOI:

10.5861/ijrsp.2013.451.
449. Archer, T., & Fredriksson A. The restorative effects of physical exercise and Milmed

on MPTP-induced deficits. Submitted.
450. Garcia, D., Kerekes, N.,& Archer, T. A will (Persistence) and a proper way leading to

happiness: self-directedness mediates the effect of persistence on Positive Affectivity. Personality and Individual Differences, 2012,DOI: 10.1016/j.paid.2012.07.025..

451. Scharin, M., Archer, T., & Hellström, P. Affective Spectrum Disorders (AfSD) in an urban Swedish adult psychiatric unit: a descriptive study. Depression Research and Treatment, accepted for publication, 2012.

452. Scharin, M., Hulterström, I., & Archer, T. Family work in psychiatric outpatient care: a brief introduction to methodology and theory. Submitted.

453. Scharin, M., Starmark, A., Archer, T., Voionmaa, K., Malmgren, H., & Hellström, P. MADRS-S, an important tool in psychiatry: hierarchical versus dimensional approach. Submitted.

454. Scharin, M., Nordlund, A., Archer, T., & Hellström, P. Mini WAIS, a method to assess general intellectual function in psychiatric patients. Submitted.

455. Scharin, M., Archer, T., Nordlund, A., & Hellström, P. Global assessment of functioning, a validity study of the self-report version. Submitted.

456. Heden, A., Andersson Arntén, A-C., & Archer, T. Exercise and affective status: opponent process effect.

457. Garcia, D., Archer, T., Moradi, S., & Ghiabi, B. Waiting in vain: managing time and customer satisfaction at call centers. PSYCHOLOGY, 2012, 3, 213-216. DOI: 10.4236/psych. 2012.32030.

458. Archer, T., Oscar-Berman, M., Blum, K., & Gold, M. Neurogenetics and epigenetics in impulsive behavior: impact on reward circuitry impairments. Journal of Genetic Syndromes & Gene Therapy, in press, DOI: org/10.4172/2157- 7412.1000115.

459. Garcia, D., Ghiabi, B., Moradi, S., Siddiqui, A., Archer, T. The happy personality: a tale of two philosophies. In: Psychology of Personality, (Ed. EF Morris and F-A Jackson), 2012. Pp. 41-59,New York: Nova Science Publishers Inc.

460. Blum K, Bagchi D, Barh D, Giordano J, Morse S, Downs BW, Waite RL, Downs JM,

Madigan M , Ross-Coker C, Archer T, Braverman ER. Sugar craving a world epidemic: Is there a nutrigenomic solution? Journal of Functional Foods (in process).

461. Garcia, D., Archer, T., Moradi, S., Andersson Arntén, A. Exercise frequency, high activation positive affect, and psychological well-being: beyond, age gender and occupation. Psychology, 2012, 3, 328-336. DOI: 10.4236/psych.2012.*****.

462. Archer, T., Ricci, S., Garcia, D., & Rapp-Ricciardi, M. Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders. Accepted Neurotoxicity Research, doi: 10.1007/s12640-014-9473-0.

463. Archer, T., & Fredriksson, A. Physical exercise as intervention in Parkinsonism. In Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa), Springer.

464. Garcia, D., Archer, T., Sailer, U. The happy time perspective: the Zimbardo time perspective inventory in relation to subjective and psychological well-being. Submitted.

465. Garcia, D., Sailer, U., & Archer, T. Past, present, and future life satisfaction among young adults. Submitted.

466. Archer, T., Karilampi, U., Ricci, S., & Rapp-Ricciardi, M. Neurotoxic vulnerability underlying schizophrenia spectrum disorders. In Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa), Springer.DOI 10.1007/978-1-4614-5836-4_119, Springer Science+Business Media, New York, pp. 2181-2205.

467. Archer, T., Ricci, S., & Rapp-Ricciardi M. Drug Abuse Neurotoxicity: Nicotine and Alcohol as Developmental Stressors. In Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa), Springer, DOI 10.1007/978-1-4614-5836-4_119, Springer Science+Business Media, New York, pp. 2003-2023.

468. Sandberg, K.W., Pan, Y., & Archer, T. Recall and recognition of user codes: PIP versus PIN personal identification code. Submitted.

469. Lindahl, M., & Archer, T. Depressive expression and antidepressive protection: positive affect, motivation and self-efficacy. Pychology (PSYCH) Journal, 2013, 4, 495-505. DOI: 10.4236/psych.2013.46070.

470. Ricci, S., Businaro, R., Ippoliti, F., Lo Vasco, V.R., Massoni, F., Onofri, E., Troili, G.M., Pontecorvi, V., Morelli, M., Rapp Ricciardi, M., Archer, T. Altered cytokine and BDNF levels in Autism Spectrum Disorders: expression of immunoexcitotoxicity.

Neurotoxicity Research, accepted for publication, DOI: 10.1007/s12640-013-

9393-4.
471. Archer, T., & Kostrzewa, R.M. The neurotoxic agency of stress: from perinatal to

adolescent induction. In: (Mal)adaptive Aspects of Developmental Stress, (Eds. G Laviola and S Macri), Springer,DOI: 10.1007/978-1-4614-5605-6, Springer, New York, pp. 1-20.

472. Josefsson, T., Lindwall, M., & Archer, T. Physical exercise intervention in depressive disorders: meta-analysis and systematic review. Scandinavian Journal of Medicine and Science in Sports, doi: 10.1111/sms.12050.

473. Archer, T., Ricci, S., Rapp-Ricciardi, M., Kostrzewa, R.M. Polluting agents in Parkinsonism: I Transition metals. In Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa), Springer.

474. Al Nima, A., Archer, T., & Garcia, D. Adolescents’ happiness-increasing strategies, temperament, and character: Mediation models on subjective well-being. Health, 2012, Health, 4, 802-810. DOI: 10.4236/health.2012.410124.

475. Archer, T., Rapp-Ricciardi, M., Ricci, S., Kostrzewa, R.M. Polluting agents in Parkinsonism: I Organic Agents. In Handbook of Neurotoxicity, (Ed. R.M. Kostrzewa), Springer.

476. Archer, T., Fredriksson, A. Pharmacogenomics and personalized medicine in Parkinson’s disease. In: “Omics for Personalized Medicine”, (ed. D Barh et al), Springer.DOI 10.1007/978-81-322-1184-6_14, pp. 265-287.

477. Archer, T., Ricci, S., & Rapp Ricciardi M. Pharmacogenomics and personalized medicine in Mood disorders. In: “Omics for Personalized Medicine”, (ed. D Barh et al), Springer.DOI 10.1007/978-81-322-1184-6_15, pp.237-264.

478. Archer, T., & Johansson, B. Pharmacogenomics and personalized medicine in Alzheimer’s disease. In: “Omics for Personalized Medicine”, (ed. D Barh), Springer.DOI 10.1007/978-81-322-1184-6_16, pp. 289-308.

479. Archer, T., Oscar-Berman, M., Blum, K., & Gold, M. Epigenetic modulation of mood disorders. Journal of Genetic Syndromes & Gene Therapy, Accepted for Publication.

480. Al Nima, A., Rosenberg, P., Archer, T., Garcia, D. Anxiety, affect, self-esteem, stress: mediation and moderation effects on depression. PLOS ONE, 8(9): e73265. doi:10.1371/journal.pone.0073265.

481. Schütz, E., Archer, T., & Garcia, D. Character profiles and adolescents’ self-reported experiences. Personality and Individual Differences, 54 (2013) 841–844.

482. Al Nima, A., Archer, T., & Garcia, D. The happiness-seeking strategies scales and well-being in a sample of Swedish adolescents. International Journal of Happiness and Development, 1, 196-211.

483. Garcia D., & Archer, T. When reaching our potential predicts low values: a longitudinal study about performance and organizational values at call centres. Journal of Service Science and Management, 5, 313-317.

484. Archer, T., & Fredriksson, A. Fusion models and fusioning in Parkinsonism: protection and restoration by wheel-running and Milmed. In R.M. Kostrzewa (ed), Handbook of Neurotoxicity, DOI 10.1007/978-1-4614-5836-4_95, Springer Science+Business Media, New York, 2013, pp. 2047-2063.

485. Archer, T., Andersson-Arntén A.C., Garcia, D.,& Rapp Ricciardi M. Factors governing personal health and development: stress (distress) and empowerment. PanMinerva Med, 2014, 56(Suppl. 1 to No. 1):101-111.

486. Kjell, O.N.E., Nima, A.A., Sikström, S., Archer, T & Garcia D. The Relationships between Iranian and Swedish Adolescents’ Personality Traits, Subjective Well- Being and Psychological Well-Being. PeerJournal, accepted for publication.

487. Sailer, U., Nima, A.A., Archer, T., Garcia, D. Time perspective and well-being. Submitted.

488. Garcia, D., Archer, T., & Nima, A.A. Temperament and Character’s relationship to subjective well-being in Salvadorian adolescents and young Adults. Journal of Adolescence, accepted for publication.

489. Garcia, D., Ghiabi, B., Nima, A.A., & Archer, T. The end of happiness: temporal distance and judgements of life satisfaction in Sweden, Iran, Spain and El Salvador. International Journal of Happiness and Development, in press.

490. Nima, A., A., Archer, T., & Garcia, D. (2013). Predicting Performance at Call-centres: Work Climate, Exercise Frequency & Virtues. International Society for the Study of Individual Differences Meeting. Barcelona, Spain. Submitted.

491. Ödman, T., Ödman, N., Rabotchi, E., Archer, T.. Design experiments of a wireless performance measuring system for difference sizes of mammals.International Journal on Communications, Antenna and Propagation, Submitted.

492. Archer, T., & Fredriksson, A. The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice. Neurotoxicity Research, accepted for publication. Doi: 10.1007/s12640-013-9405-4.

493. Ödman, T., Ödman, N., Rabitchi, E., Fredriksson, A., Linden, M.,& Archer, T. Wireless measuring systems for rodent exercise and motor performance.

494. Schütz, E., Garcia, D., Archer, T. Personal profiles determining quality of sleep in nonclinical populations: effect of gender. Submitted.

495. Archer, T., & Fredriksson, A. Amelioration of MPTP-toxicity by running exercise: co- administration with Milmed yeast. Submitted.

495. Garcia, D., Rapp Ricciardi, M., & Archer, T. The productive and happy agent: performance and positive emotions at call centres. International Journal of Happiness and Development, 2014, X, 000-000.

497. Scharin, M., & Archer, T. The Gothenburg Model of Family Work in Psychiatry A Brief Introduction to Methodology and Theory. Family Medicine & Medical Science Research, 2:1, doi: 4172/2327-4972.1000103.

498. Onofri, E., Mercuri, M., Salesi, M., Rapp Ricciardi, M., Archer, T., Ricci, S. Cognitive performance deficits and dysgraphia in Alzheimer’s disease patients.Neurology and Neurophysiology, 2014, 5:4. DOI: 10.4172/2155-9562.1000223.

499. Schütz, E., Sailer, U., Al Nima, A., Rosenberg, P., Andersson-Arntén, A-C., Archer, T., & Garcia, D. The affective profiles in the USA: Happiness, depression, life satisfaction and happiness-enhancing strategies.PeerJ, 1:e156; DOI 10.7717/peerj.156.

500. Schütz, E., Archer, T., & Garcia, D. Affective state, stress and Type A personality as a function of gender and affective profiles. International Journal of Research Studies in Psychology, accepted for publication.DOI: 10.5861/ijrsp.2013.450.

501. Onofri, E., Mercuri, M., Salesi, M., Ferrara, S., Troili, G., Massoni, F., Simeoni, C., Rapp Ricciardi, M., Ricci, S., Archer, T. Dysgraphia in relation to cognitive performance in patients with Alzheimer’s disease.Accepted for publication, Journal of Intellectual Disability – Diagnosis and Treatment, 2013, 1, 000-000.

502. Andersson Arntén, A-C., Al Nima, A., Schütz, E., Abd Algafoor, N., Moradi, S., Archer, T., Garcia, D. Police Personnel Affective Profiles: Differences in perceptions of the work climate and motivation. Journal of Police and Criminal Psychology, accepted for publication.

503. Garcia, D., Anckarsäter, H., Kjell, O.N.E., Rosenberg, P., Cloninger, C.R., Archer, T., & Sikström, S. Personality and Adolescents’ narratives: Agentic and communal values are predicted by the semantic representation of written narratives of positive and negative life events. Accepted for publication.

504. Garcia, D., Nima, A.A., & Archer, T. International note: Temperament and character’s relationship to subjective well-being in Salvadorian adolescents and young adults. Journal of Adolescence 2013, 36, 1115-1119. DOI: 10.1016/j.adolescence.2013.08.018.

505. Moradi, S., Andersson Arnten, A-C., Archer, T., Garcia, D. Motivation as a mediator: Internal and external factors fostering engagement.

506. Archer, T. Physical exercise intervention in Autoimmune disease. Autoimmune Diseases and Therapeutic Approaches, accepted for publication.

507. Cipollone, D., Businaro, R., Ricci, P., Onofri, E., Massoni, F., Rapp-Ricciardi, M., Archer, T., & Ricci, S. Biological Therapeutics and Pharmacovigilance in Italy. International Journal of Autoimmune disorders & Therapy, 2015, DOI: 10.15344/ijadt/2015/102.

508. Jimmefors, A., Garcia, D., Rosenberg, P., Mousavi, F., Adrianson, L.,& Archer, T. Locomotion (empowering) and assessment (disempowering) self-regulatory dimensions as a function of affective profiles in high school students. International Journal of School and Cognitive Psychology, Accepted for publication. 1: 103. DOI:

509. Archer, T., & Garcia, D. Physical exercise influences academic performance and well- being in children and adolescents. International Journal of School and Cognitive Psychology: 2014: DOI: 10.4172/1234-3425.1000e102.

510. Archer, T. Health benefits of physical exercise for children and adolescents. OMICS Medical Journals: Novel Physiotherapies, 4: 203-207.DOI: 10.4172/2165- 7025.1000203.

511. Moradi, S., Nima, A.A., Rapp Ricciardi, M., Archer, T., & Garcia, D. Exercise, character strengths, well-being and learning climate in the prediction of performance over a six-month period at a call center. Frontiers in Psychology, in press, 2014, 5, DOI: 10.3389/fpsyg. 2014.00497.

512. Garcia, D., Ghiabi, B., Rosenberg, P., Nima, A.A., & Archer, T. Differences in affective

profiles in Temperament and Character in Salvadorians: the self-fulfilling experience as a function of agentic (self-directedness) and communal (cooperativeness) values. Accepted for Publication, International Journal of Happiness and Development, 2014.

513. Archer, T., & Garcia, D. Physical exercise improves cognition in brain disorders: Alzheimer’s disease. In: Diet and Exercise in Cognitive Function and Neurological Diseases. Tahira Farooqui and Akhlaq A. Farooqui (Eds.), pp. 175-181. © 2015 John Wiley & Sons, Inc.

514. Garcia, D., Nima, A.A., Rappe, C., Rapp-Ricciardi, M.,& Archer, T. The relationship between the JobMatchTalent and the NEO PI-R: Construct validation of an instrument designed for recruitment of personnel. Accepted for Publication, PLOS ONE.

515. Mousavi, F., Archer, T., Anckarsäter, H., & Garcia, D. Agency, communion, and intelligence in the child and adolescent twin study in Sweden: Persistence, not self- directedness or cooperativeness, is related to twins’ cognitive abilities. Frontiers in Personality Science and Individual Differences, accepted.

516. Sailer, U., Rosenberg, P., Nima, A.A., Gamble, A., Gärling, T., Archer, T., & Garcia, D. A happier and less sinister past, a more hedonistic and less fatalistic present and a more structured future: Time perspective and well-being. PeerJ, Accepted for publication.

517. Garcia, D., Jimmefors, A., Adrianson, L., Rosenberg, P., & Archer, T. High school pupils’ achievement, self-regulation (locomotion and assessment), and psychological well-being. PeerJ 3:e847. DOI: 10.7717/peerj.847.

518. Mousavi, F., Garcia, D., Archer, T., & Ewalds-Kvist, B. Swedish High-school Pupils’ attitudes to drugs in relation to drug usage, impulsiveness and other risk factors. PeerJ, accepted for publication.DOI: 10.7717/peerj.410.

519. Archer, T., & Garcia, D. Physical exercise improves cognition and health in ADHD. Submitted.

520. Archer, T., Garcia, D., & Cloninger, C.R. Personal attributes that endower empowerment mediated by positive affect: resilience, intrinsic motivation, self- regulation, and character. Submitted.

521. Garcia, D., Lindskär, E.,& Archer, T. Thinking outside the box about indicators of wellbeing: agency, communion, and the positivity. International Journal of Happiness and Development, accepted for publication.

522. Onofri, E., Mercuri, M., Donato, G., Rapp Ricciardi, M., Ricci, S., & Archer, T. Dysgraphia and cognitive deficits in Alzheimer’s disease and Lewy Body Dementia.

523. Archer, T., Garcia, D., Kostrzewa, R.M. Exercise and dietary restriction for promotion of neurohealth benefits.

524. Garcia, D., Lindskär, E., Archer, T. To schedule or not to schedule: Agentic and cooperative teams at call centers. Frontiers in Psychology: Personality and Social Psychology, 2014,DOI: 10.3389/fpsyg.2014.00999.

525. Rapp Ricciardi, M., Garcia, D..Åkerman, J., Archer, T., Andersson-Arntén, A-C., Ambjörnsson, A. Professional Group Development trainers’ personal characteristics and

affective profiles. Frontiers in Psychology: Personality and Social Psychology,

accepted for publication.
526. Lundblad, S., Hansson, B., & Archer, T. Affect-group intervention for alexithymia in

eating disorders. Journal of Emergency Mental Health: Mental Health and

Human Resilience, 2015, 17, 219-223. DOI: 10.4172/1522-4821.1000144. 527. Onofri, E., Ricci, S., Rapp Ricciardi, M., & Archer, T. Writing in Alzheimer’s disease

patients: personal, spatial and temporal orientation deficits. Submitted.
528. Garcia, D., MacDonald, S., & Archer, T. Two different approaches to the affective

profiles model: median splits (variable-oriented) and cluster analyses (person-

oriented). PeerJ, 2015, DOI: 10.7717/peerj.1380.
529. Garcia, D., Adrianson, L., & Archer, T. The dark side of The Affective Profiles:

differences in psychopathy, Machiavellianism, and narcissism. Sage Open, 2015,

1-14. DOI: 10.1177/2158244015615167.
530. Lange, E., Mannerkorpi, K., Cider, Å., Archer, T.,& Wentz, K. Heart rate response

during and after exercise in women presenting fibromyalgia: comparison with

healthy controls. Submitted.
531. Archer, T., Josefsson, T., & Lindvall, M. Effects of physical exercise on depressive

symptoms and biomarkers in depression. CNS Neurological Disorders and Drug

Targets, 2014, Nov 30, 13, xxx-xxx. PMID: 25470398.

532. Garcia, D., & Archer, T. Positive affect and age as predictors of exercise compliance. PeerJ, 2014, 2:e694. DOI: 10.7717/peerJ.694.

533. Archer, T., & Garcia, D. Exercise and dietary restriction for promotion of neurohealth benefits. Health, 2015, DOI: 10.4236/***.2015.*****.

534. Rapp Ricciardi, M., Hoff, E., Schaller, J., Garcia, D., & Archer, T. Personal attributes linked to empowerment that influence receptivity to coaching leadership. Submitted.

535. Archer, T., & Kostrzewa, RM. Physical exercise alleviates health defects, symptoms and biomarkers in schizophrenia spectrum disorders. Neurotoxicity Research, 2015. DOI: 10.1007/s12640-015-9543-y.

536. Onofri, E., Mercuri, M., Salesi, M.L., Rapp Ricciardi M., & Archer, T. Cognitive performance deficits and dysgraphia in Alzheimer’s disease patients. The Open Conference Journal, accepted for publication.

537. Archer, T., & Garcia, D., & Fredriksson, A. Restoration of MPTP-induced deficits Exercise + Milmed® Co-treatment. PeerJ 2014, 2:e531.DOI 10.7717/peerj.531.

538. Blum, K., Braverman, E.R., Archer, T., Thanos, P.K., Badgaiyan, R., Febo, M., Dushaj, K., Li, M., & Gold, M.S. Neuroquantum theories of psychiatric genetics: can physical forces induce epigenetic influence on future genomes? NeuroQuantology, 2015. DOI: 10.14704/nq.2015.13.1.799.

539. Winge, H., Archer, T., & Garcia, D. Job Match: an instrument for workforce recruitment and development. Personality and Individual Differences, 2014, 60, S34-S36. DOI: 10.1016/j.paid.2013.07.074.

540. Rapp Ricciardi, M., Schaller, J., Garcia, D., & Archer, T. Coaching leadership training in high-tech settings. International Journal of Mentoring and Coaching, 2015, Vol. 13(3), xx-xx.

541. Nordmarker, A., Hjärthag, F., Perrin-Wallqvist, R., Archer, T. Graffiti – expressionism and vandalism: gender, affective status, and impulsiveness among adolescents. Submitted.

542. Archer, T., Businaro, R., Rapp Ricciardi, M. Physical exercise benefits that delay the advance of aging. Submitted.

543. Nordmarker, A., Perrin-Wallqvist, R., Archer, T. Graffiti, for Joy (elation) and Confirmation. An interview study with graffitists in Adolescence. Submitted.

544. Onofri, E., Mercuri, M., Archer, T., Rapp Ricciardi, M., Massoni, F., & Ricci, S. Effect of cognitive fluctuations on handwriting in Alzheimer patient: a case study. Accepted for publication in Journal Acta Medica.

545. Massoni, F., Ricci, P., Rapp Ricciardi, M., Luzi, E., Archer, T, Ricci, S. Quality of life during chemotherapy: implications for social and legal medicine. European Journal of Oncology, 2015, 20, 73-80.

546. Lundblad, S., Garcia, D., Hansson, B., Archer, T. Emotional well-being in Anorexia nervosa: Negative affect, sleeping problems, use of mood-enhancing drugs and exercise frequency. Archives of Depression and Anxiety, 1, 2015, 1-5.

547. Archer, T. Exercise as therapy: Health and Well-being. Journal of Intellectual Disability-Diagnosis and Treatment, 2015, 3, 76-81, DOI: 10.6000/2292- 2598.2015.03.02.5.

548. Archer, T. Epigenetic changes induced by exercise. Reward Deficiency Syndromes Journal, 2015, DOI: 10.17756/jrds.2015-011.

549. Archer, T. Exercise alleviates Autism Spectrum Disorder Deficits. Autism Open Access, 2015, doi.org/10.4172/2165-7890.1000150.

550. Garcia, D., Andersson-Arntén, A.A., & Archer, T. Character, responsibility and well- being: influences on mental health and constructive behavior patterns. Frontiers in Psychology, 2015, doi: 10.3389/fpsyg.2015.01079.

551. Fahlgren, E., Nima, A.A., Archer, T., & Garcia, D. Person-centered osteopathic practice: Personality, Ill-being and Well-being among osteopathic patients in Sweden PeerJ 2015, 3:e1349. DOI: 10.7717/peerj.1349.

552. Mousavi, F., Rozsa, S., Nilsson, T., Archer, T., Anckarsäter, H., Garcia, D. Personality and intelligence: persistence not self-directedness, cooperativeness or self- transcendence, is related to twins’ cognitive abilities. PeerJ, 2015, 3:e1195. DOI: 107717/peerj.1195.

553. Garcia, D., Lundblad, S., & Archer, T. Time perspective, personality, and temporal life satisfaction among anorexia nervosa patients. Submitted.

554.Lindskär,E.,Ryberg,F.,Mousavi,F.,Rosenberg,P.,Archer,T.,&Garcia,D. Affective profiles motivation to exercise, basic psychological needs in exercise, and propensity to exercise during a six-month period. Submitted.

555. Garcia, D., Schütz, E., & Archer, T. Differences in happiness-increasing strategies between and within affective profiles. Frontiers, submitted.

556. Archer, T., & Kostrzewa RM. Exercise and nutritional benefits in PD: Rodent Models and Clinical Settings. In: RM Kostrzewa and T Archer (Eds.) Neurotoxin

Modelling of Brain Disorders – Life-long Outcomes in Behavioral Teratology.

Springer.
557. Archer, T. Noradrenergic-dopaminergic interactions due to DSP4 – MPTP

neurotoxin treatments: iron connection. In: RM Kostrzewa and T Archer (Eds.) Neurotoxin Modelling of Brain Disorders – Life-long Outcomes in Behavioral Teratology. Springer.

558. Lundblad, S., Magnusson, J., Hansson, B., & Archer, T. Cognitive-affective status in anorexia nervosa: self-image and absence of positive emotions. Clinical and Experimental Psychology, accepted for publication.

559. Archer, T. Physical exercise as an epigenetic factor determining behavioral outcomes. Clinical and Experimental Psychology, 2015, 1: e101. doi:10.4172/cep.1000e101.

560. Archer, T. Exercise influences in depressive disorders: symptoms, biomarkers and telomeres. Clinical Depression, 2015, 1: e101. DOI: 10.4172/cdp.1000e101.

561. Archer, T., & Garcia, D. Exercise intervention in traumatic brain injury. Trauma & Acute Care, 2015, 1, 1-3.

562. Garcia, D., Ghiabi, B., Nima, A.A., & Archer, T. The end of happiness: temporal distance and judgements of life satisfaction in Sweden, Iran, El Salvador and Spain. International Journal of Happiness Development, in press.

563. Archer, T., Jansson, B., & Olsen, K. Effects of age upon leadership attributes from recruitment instrument: a selective developmental trajectory. Clinical and Experimental Psychology, 2015. DOI: 10.4172/cep.1000006.

564. Haddad, B., Ångman, M., Garcia, D., & Archer, T. Dark Triad, sociosexual orientation and religiousness: an association and moderation study. Submitted.

565. Onofri, E., Mercuri, M., Archer, T., Rapp Ricciardi, M., & Ricci, S. Six months follow-up of AD patients’ Dysgraphia and Cognitive Dysfunction: legal medical consideration. Clinical Interventions in Aging, Accepted for publication.

566. Archer, T., & Garcia, D. Attention-deficit/hyperactive disorder: Focus upon aberrant N-methyl-D-aspartate receptor systems. In: RM Kostrzewa and T Archer (Eds.) Neurotoxin Modelling of Brain Disorders – Life-long Outcomes in Behavioral Teratology. Springer.

567. Zöller, M.E.T., & Archer, T. Emotional disturbances expressed by deaf patients: Affective deaf syndrome. Accepted for publication, Clinical and Experimental Psychology.

568. Blum, K., Febo, M., Fahlke, C., Archer, T., Berggren, K., Demetrovics, Z., Dushaj, K., & Badgaiyan, R. Hypothesizing balance endorphinergic and glutaminergic systems to treat and prevent relapse to reward deficiency behaviors: coupling D- phenylalanine and N-acetyl-L-cysteine (NAC) as a novel therapeutic modality. Clinical Medical Reviews and Case Reports, 2015, 2:8. ISSN: 2378-3656.

569. Sailer, U., Archer, T., Al Nima, A., & Garcia, D. A question of time and affect: the affective profiles model, psychological well-being, and Zimbardo’s notion of time perspective. Submitted.

570. Jimmefors, A., Garcia, D., Al Nima, A., & Archer, T. Affective profiles and self- regulatory mode: Locomotion (empowering), assessment (disempowering), and well-being: the benefits of time and locomotion. In preparation.

571. Archer, T., & Kostrzewa, R.M. Neuroteratology and animal modeling of brain disorders. In: RM Kostrzewa and T Archer (Eds.) Neurotoxin Modelling of Brain Disorders – Life-long Outcomes in Behavioral Teratology. Springer.

572. Archer, T., & Garcia, D. Affective profiling to determine propensity for empowerment or disempowerment: protective attributes or afflictive proclivities in depressive states. Clinical and Experimental Psychology: doi: 10.4172/cep.1000e102.

573. Garcia, D., Sailer, U., Al Nima, A., & Archer, T. Questions of time and affect: a person’s affectivity profile, time perspective, and well-being. Submitted.

574. Archer, T. Physical exercise and its impact on psychology. Clinical and Experimental Psychology, 2015, 1:1, DOI: 10.4172/cep.S1-e001.

575. Archer, T. The influence of physical exercise on well-being and health. Submitted. 576. Archer, T., Ricci, S., Massoni, F., & Rapp-Ricciardi, M. Cognitive benefits of exercise

intervention. Current Psychiatry Reviews, accepted for publication.
577. Zöller, M.E.T., Schütz, E., & Archer, T. Motor impulsivity in affective deaf syndrome.

Submitted.

trevor.archer@psy.gu.se

International Peer Review Journal articles: 357 published/in press Number of different journals: 130 International Scientific Peer-review Journals

International Peer-review Journals that TA has published

1. Physiology and Behavior
2. Bulletin of Environmental Contamination and Toxicology
3. Animal Learning and Behavior
4. Physiological Psychology
5. Behavioral and Neural Biology
6. Quarterly Journal of Experimental Psychology
7. Neuroscience Letters
8. Scandinavian Journal of Psychology
9. Journal of Comparative and Physiological Psychology
10. Psychopharmacology
11. Experimental Animal Behaviour
12. Pharmacology, Biochemistry & Behavior
13. Trends in Pharmacological Sciences
14. British Journal of Pharmacology
15. Acta Pharmacol. et Toxicol.
16. Behavioral Neuroscience
17. Brain Research
18. European Journal of Pharmacology
19. Behavioural Brain Research
20. Journal of Neural Transmission
21. Developmental Brain Research
22. Pharmacology & Toxicology
23. New Trends in Experimental and Clinical Psychiatry
24. Drug and Alcohol Dependence
25. ümertz – Pain – Doleur
26. Anesthesia and Analgesia
27. Nordic Journal of Psychiatry
28. Neurotoxicology and Teratology
29. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30. Behavioral Pharmacology
31. Alzheimer Actualities
32. Neuropharmacology
33. Journal of Psychopharmacology

34. Developmental Pharmacology and Therapy
35. Acta Pathologica, Microbiologica et Immunologica Scandinavica
36. Polish Journal Pharmacology
37. Journal of Amino Acids
38. Encyclopedia of Human Behavior
39. Spanish Journal of Neurology
40. Journal of Environmental Psychology
41. Journal of Applied Sports Psychology
42. Psychological Reports
43. Social Behaviour and Personality
44. Toxicology and Applied Pharmacology
45. Journal of Social Behaviour and Personality
46. Alcohol
47. Cross Cultural Research
48. The Korean Journal of Thinking and Problem Solving
49. Mental Health, Religion and Culture
50. Neurotoxicity Research
51. Imagination, Cognition and Personality
52. Alcoholism: Clinical and Experimental Research
53. Pain Research & Management
54. Parkinsonism & Related Disorders
55. Perceptual and Motor Skills
56. Childhood
57. Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders 58. CyberPsychology and Behaviour
59. Journal of Chronic Fatigue Syndromes
60. The Qualitative Report
61. Molecular Brain Research
62. Aggressive Behaviour
63. Journal of Product Innovation Management
64. Individual Differences Research
65. Athletic Insight
66. School Effectiveness and School Improvement
67. Computers in Human Behavior
68. Anxiety, Stress, and Coping
69. Journal of Endocrinology
70. Psychiatry Research
71. Schizophr Research
72. Journal of Psychiatric Research
73. Archives of Clinical Neuropsychology
74. Creativity Research Journal
75. Neurosurgery and Neurology
76. Neurochemical Research
77. International Journal of Adolescent Medical Health
78. Neurosurgery
79. Acta Neurologica Scandinavica
80. Expert Reviews in Neurotherapeutics
81. CNS Neuroscience & Therapeutics
82. International Journal of Research Studies in Psychology

83. Journal of Neuroquantology

84. The HOAB Journal

85. Biomedical Perspectives and Applications
86. Journal of Genetic Syndromes & Gene Therapy
87. Journal of Physical Activity & Health
88. Journal of Nervous and Mental Disease
89. Journal of Alternative Medical Research
90. Depression Research and Research
91. Journal of Research Studies in Psychology
92. Personality and Individual Differences
93. PSYCHOLOGY
94. Journal of Functional Foods
95. Pychology (PSYCH) Journal
96. Scandinavian Journal of Medicine and Science in Sports
97. Health
98. PLOS ONE
99. International Journal of Happiness and Development
100. Journal of Service Science and Management
101. PeerJournal
102. Journal of Adolescence
103. Family Medicine & Medical Science Research
104. Autoimmune Diseases and Therapeutic Approaches
105. Journal of Intellectual Disability – Diagnosis and Treatment 106. Frontiers in Personality Science and Individual Differences 107. International Journal of School and Cognitive Psychology 108. OMICS Medical Journals
109. International Journal of Happiness and Development.
110. PanMinerva Med.
111. Frontiers in Psychology: Personality and Social Psychology 112. Neurology and Neurophysiology
113. Journal of Emergency Mental Health and Human Resilience 114. CNS Neurological Disorders and Drug Targets
115. International Journal of Autoimmune Disorders & Therapy 116. The Open Conference Journal
117. Journal of Police and Criminal Psychology
118. Journal Acta Medica
119. NeuroQuantology
120. Reward Deficiency Syndromes Journal
121. Archives of Depression and Anxiety
122. Autism Open Access
123. SageOpen
124. Trauma & Acute Care
125. Clinical Depression
126. International Journal of Mentoring and Coaching
127. Clinical and Experimental Psychology
128. European Journal of Oncology
129. Clinical Interventions in Aging
130. Clinical Medical Reviews & Case Reports
131. Current Psychiatry Reviews

Gamla Manus som vi ej har samt ej accepterade MS.

*Archer, T., Söderberg, U., Jonsson, G., & Ross, S.B. Systemic DSP4 administration and bilateral olfactory bulbectomy and aversive learning: A double dissociation. Manuscript, 1993.

*Archer, T., Björklund, P.E., Fowler, C.J., Jonsson, G., Mohammed, A.K., Stenström, E., Tiger, G., Wahlström, G., & Winblad, B. Behavioral and neurochemical correlates of prenatal
treatment of rats with methylazoxy-methanol.Manuscript, 1993.

*Danysz, W., Fowler, C.J., Ahlenius, S., & Archer, T. LeChatelier’s principle operates after lesioning procedures in the brain: Implications for psychopharmacological research.
Manuscript, 1993.

*226. Mohammed, A.K., Jonsson, G., Winblad, B., & Archer, T. Altered extinction and long-asting hyperactivity following prenatal treatment with methyl- azoxymethanol.Manuscript,
1993.

Borras-Valls, Archer, T. & Larsson, K.The role of serotonin in the therapy of human sexual dysfunction. (ins. till Nordic Journal of Psychiatry 940608, ej accepterad). Manuscript.

Prof.ssa Rita Businaro

Scritto da Fabio Miliucci il 15 Aprile 2024. Pubblicato in Comitato Scientifico.

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

WORK EXPERIENCE

2000-2017 Professor of Human Anatomy, Sapienza University of Rome, Italy
1982-2000 Assistant Professor of Human Anatomy, Sapienza University of Rome, Italy
1980-81 Associate Scientist Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania, USA
1978-80 Fellow, Laboratory of Cell Biology, CNR, Rome, Italy

MAIN ACTIVITIES AND RESPONSIBILITIES

Head of the Laboratory of Neuromorphology, of the Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Rome.
Responsible for the Executive Protocol Agreement between Sapienza University of Rome, Italy and Rutgers University, New Brunswick / Piscataway, USA
2014-17 Vice-President Fulbright Italian Association
2010-14 Member of the Executive board of Fulbright Italian Association
2011-2017 Director of the II level Master: “Stress, sport, nutrition: new diagnostic and therapeutic advances for wellness, fitness, prevention and rehabilitation”
2005-2014 Coordinator of II level Master: Neuroimmunology, University of Rome La Sapienza, Italy
2007-2017 Vice-President of Radiology graduate school
2001-2017 Professor of Human Anatomy, School of Medicine, Faculty of Pharmacy and Medicine, Sapienza University of Rome
2000-2017 Coordinator of integrated courses of histology, anatomy and physiology for the students of the School of Medicine and for other health I level degrees
2017 Professor of Human Anatomy in the I level degree courses: “Neuro-psychomotor therapy of developmental age”, “Radiology Techniques and Radiotherapies” ,“Physioterapists”, “Laboratory Technicians”, “Dental hygienists”
2008-2017 Member of the technical pedagogical board of the School of Medicine, Polo Pontino, Sapienza University of Rome, Italy
2011-14 member of the Doctoral School in “Innovative Technologies in Translational Medicine”
Coordinator of the Erasmus Program with Université d’Artois, France; Athens University, Greece; Gothenborg University, Sweden.
Invited Speaker at the international School of Neuroimmunopharmacology, University of Insubria, Varese

MAIN RESEARCH TOPICS

Study of comorbidity of Alzheimer’s disease and cerebrovascular disorders
Role of the cell populations and mediators of the immune response in the etiopathogenesis of atherosclerosis
Cross-talk Central Nervous System-Immune System
Development of new methods for regenerative medicine

GRANTS

2016 PRIN Prot. 2015KMMKBN Endocannabinoid Signaling in Alzheimer’s Disease: A Novel Target for Mechanistic Understanding and Potential Therapeutics. Sapienza Unit leader
2016 Sapienza University of Rome NPY and its receptors in atherosclerosis progression PI
2016 Grant from Milmed, Sweden PI
2015 MAE “Nutritional protocols for the treatment of Alzheimer’s disease” PI
2015 Italy-USA Bilateral agreement AI2615BE38 “Macrophage pro-inflammatory activity in tissue injury” PI
2015 C26A15FHES Sapienza University of Rome “Anti-inflammatory activity of polyphenolic compounds in chronic diseases “PI
2014 C26A14M7PS Sapienza University of Rome “Hierarchical role of classes of cytokines in chronic inflammatory diseases: axis IL-23-IL-17 in atherosclerosis” PI
2014 C26G142PSY “Advanced video confocal microscopy system with high resolution for the understanding of complex pathophysiological mechanisms” PI
2013 C26A13CT5H Sapienza University of Rome “Neurotransmitters and cytokines involved in inflammation associated with development and degenerative diseases” PI
2013 C26G13WLNT Sapienza University of Rome “Development of a P2 laboratory for the genetic manipulation of prokaryotic and eukaryotic cells for biomedical and translational purposes”
2012 C26I12KKHK Sapienza University of Rome FARI PI
2011 ASP (150/2008) “Social emerging diseases related to nutrition disorders with particular interest on persons with neuro-psycho-relational disabilities”
2011 C26G11SN3K Sapienza University of Rome “Quantitative analysis of the image at high resolution in modern biomedical research: a platform for numerous applications”
2009 C26F09XYBM Sapienza University of Rome “Chemiotactic and proinflammatory factors involved in the progression of atherosclerotic plaques” PI
2009 C26G09ERP2, 2008 C26G08NBBX Sapienza University of Rome “Genomic alterations in human diseases”
2008 C26A08TAB9, 2007 C26A07C23J, 2006

Referee for the following journals

Neuroscience & Biobehavioral Reviews IF 10.24 Molecular Cell Research IF 6.9 Journal of Neuroimmune Pharmacology IF 4.212 Neuroscience IF 3.6
Journal of Neural Transmission IF 2.9
Journal of Immunological Methods IF 2.087 Journal of Diabetes and its complications IF 1.5

MD cum laude, University La Sapienza, Rome,Italy
Specialization cum laude General Pathology, University La Sapienza, Rome, Italy
PhD Immunobiology of tumors, University La Sapienza, Rome, Italy
Post-doctoral course “Immunology”, Institute for Medical Research, Camden, New Jersey,USA

Cell Biology
Morphological and morphometric analyses
Immunochemical and immunohistochemical analyses
Neurotrophic and Neurotoxic factors
Stress-related disorders

73 peer-reviewed publications
h-index 18, i10-index 34, citations 961

Businaro R, Corsi, Asprino R, Di Lorenzo C, Laskin D, Corbo RM, Ricci S,Pinto A. Modulation of inflammation as a way of delaying Alzheimer’s disease progression: the diet’s role. Current Alzheimer Research. In corso di stampa IF 3.89

Capoano R, Businaro R, Tesori MC, Donello C, Lombardo F, Lo Vasco VR, Capriotti L, Corsi M, Di Raimo T, Leopizzi M, Salvati B, Ricci S. Wounds difficult to heal: an effective treatment strategy. Curr Vasc Pharmacol. 2017. doi: 10.2174/1570161115666170301122216 IF2.97

Di Raimo T, Leopizzi M, Mangino G, Rocca CD, Businaro R, Longo L, Lo Vasco VR. Different expression and subcellular localization of Phosphoinositide-specific Phospholipase C enzymes in differently polarized macrophages. J Cell Commun Signal. 2016 Dec;10(4):283-293 IF 3.123

Businaro R, Corsi M, Di Raimo T, Marasco S, Laskin DL, Salvati B, Capoano R, Ricci S, Siciliano C, Frati G, De Falco E. Multidisciplinary approaches to stimulate wound healing. Ann N Y Acad Sci. 2016 Aug;1378(1):137-142. IF 4.383

Malaviya R, Sunil VR, Venosa A, Vayas KN, Businaro R, Heck DE, Laskin JD, Laskin DL. Macrophages and inflammatory mediators in pulmonary injury induced by mustard vesicants. Ann N Y Acad Sci. 2016 Jun;1374(1):168-75 IF 4.383

Businaro R, Corsi M, Azzara G, Di Raimo T, Laviola G, Romano E, Ricci L, Maccarrone M, Aronica E, Fuso A, Ricci S. Interleukin-18 modulation in autism spectrum disorders. J Neuroinflammation. 2016 Jan 5;13:2. IF 5.366

Corsi M, Di Raimo T, Di Lorenzo C, Rapp-Ricciardi M, Archer T, Ricci S, Businaro R. Cognitive disability in Alzheimer’s disease and its management. Clin Ter. 2016 Sep-Oct;167(5):e123-e126. IF 2.925

Lo Vasco VR, Leopizzi M, Puggioni C, Della Rocca C, Businaro R. Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured humanendothelial cells. Mol Cell Biochem. 2014 Sep;394(1-2):43-52 IF 2.388

Buttari B, Profumo E, Segoni L, D’Arcangelo D, Rossi S, Facchiano F, Saso L, Businaro R, Iuliano L, Riganò R. Resveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: potential therapeutic implications in atherosclerosis. Oxid Med Cell Longev. 2014;2014:257543 IF 3.363

Buttari B, Profumo E, Domenici G, Tagliani A, Ippoliti F, Bonini S, Businaro R, Elenkov I, Riganò R. Neuropeptide Y induces potent migration of human immature dendritic cells and promotes a Th2 polarization. FASEB J. 2014 Jul;28(7):3038-49 IF 5,48

Lo Vasco VR, Leopizzi M, Puggioni C, Della Rocca C, Businaro R. Fibroblast growth factor acts upon the transcription of phospholipase C genes in human umbilical vein endothelial cells. Mol Cell Biochem. 2014;388(1-2):51-9 IF 2.33

Troili GM, Businaro R, Massoni F, Ricci L, Petrone L, Ricci P, Ricci S.Investigation on a group of autistic children: risk factors and medical social considerations. Clin Ter. 2013;164(4):e273-8. IF0.33

Buttari B, Profumo E, Businaro R, Saso L, Capoano R, Salvati B, Riganò R.Oxidized haemoglobin-driven endothelial dysfunction and immune cell activation:novel therapeutic targets for atherosclerosis. Curr Med Chem.2013;20(37):4806-14. IF 4.322

Gabriele L, Schiavoni G, Mattei F, Sanchez M, Sestili P, Butteroni C, Businaro R, Mirchandani A, Niedbala W, Liew FY, Afferni C. Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen. J Allergy Clin Immunol. 2013 Sep;132(3):686-695.e7. IF 12.047

Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, Troili GM, Pontecorvi V, Morelli M, Rapp Ricciardi M, Archer T. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res. 2013 Nov;24(4):491-501. IF 2.865

Lo Vasco VR, Leopizzi M, Chiappetta C, Puggioni C, Della Rocca C, Polonia P, Businaro R. Lypopolysaccharide downregulates the expression of selected phospholipase C genes in cultured endothelial cells. Inflammation. 2013;36(4):862-8. IF 2.457

Ippoliti F, Canitano N, Businaro R. Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective. J Neuroimmune Pharmacol. 2013;8(1):212-26. IF 3.802

Businaro R. Neuroimmunology of the atherosclerotic plaque: a morphological approach. J Neuroimmune Pharmacol. 2013; 8(1):15-27. IF 3.802

Businaro R, Tagliani A, Buttari B, Profumo E, Ippoliti F, Di Cristofano C, Capoano R, Salvati B, Riganò R. Cellular and molecular players in the atherosclerotic plaque progression. Ann N Y Acad Sci. 2012;1262:134-41. IF4.364

Businaro R, Ippoliti F, Ricci S, Canitano N, Fuso A. Alzheimer’s disease promotion by obesity: induced mechanisms-molecular links and perspectives. Curr Gerontol Geriatr Res. 2012;2012:986823. IF 0.33

Profumo E, Buttari B, Tosti ME, Tagliani A, Capoano R, D’Amati G, Businaro R, Salvati B, Riganò R. Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization. J Cardiovasc Surg 2013;54(3):349-57. IF 1.51

Lo Vasco VR, Leopizzi M, Chiappetta C, Businaro R, Polonia P, Della Rocca C, Litta P. Expression of phosphoinositide-specific phospholipase C enzymes in normal endometrium and in endometriosis. Fertil Steril. 2012;98(2):410-4. IF 3.96

Lo Vasco VR, Cosmi E, Visentin S, Di Raimo T, Salmaso R, Zanardo V, Trevisanuto D, Businaro R. IL-1β and IL-23 in amniotic fluids of ultrasound-detected aortic intima/media thickness and growth retardation. J Reprod Immunol. 2012; 93(1):64-7. IF 2.47

Ricci S, Fuso A, Ippoliti F, Businaro R. Stress-induced cytokines and neuronal dysfunction in Alzheimer’s disease. J Alzheimers Dis. 2012;28(1):11-24. IF 4.174

Lo Vasco VR, Pacini L, Di Raimo T, D’arcangelo D, Businaro R. Expression of phosphoinositide-specific phospholipase C isoforms in human umbilical vein endothelial cells. J Clin Pathol. 2011;64(10):911-5. IF 2.44

Lo Vasco VR, Salmaso R, Zanardo V, Businaro R, Visentin S, Trevisanuto D, Cosmi E. Fetal aorta wall inflammation in ultrasound-detected aortic intima/media thickness and growth retardation. J Reprod Immunol. 2011;91(1-2):103-7. IF 2.47

Buttari B, Profumo E, Di Cristofano C, Pietraforte D, Lionetti V, Capoano R, Salvati B, Businaro R, Di Giammarco G, Riganò R. Haemoglobin triggers chemotaxis of human monocyte-derived dendritic cells: possible role in atherosclerotic lesion instability. Atherosclerosis. 2011;215(2):316-22. IF 3.908

Cipollone D, Cozzi DA, Businaro R, Marino B. Congenital diaphragmatic hernia after exposure to a triple retinoic acid antagonist during pregnancy. J Cardiovasc Med (Hagerstown). 2010 Nov 23. IF 2.657

Bernardini C, Lattanzi W, Businaro R, Leone S, Corvino V, Sorci G, Lauro G, Fumagalli L, Donato FR, Michetti F. Transcritpional effects of S100B on neuroblastoma cells: perturbation of cholesterol homeostasis and interference on the cell cycle. Gene Expr. 2010;14(6):345-59. IF 1.967

Businaro R., Profumo E., Tagliani A., Buttari B., Leone S., d’Amati G., Ippoliti F., D’Arcangelo D., Capoano R., Salvati B., Fumagalli L., Fabrizi C, Businaro R, Lauro GM, Starace G, Fumagalli L. Activated alpha2macroglobulin increases beta-amyloid (25-35)-induced toxicity in LAN5 humanneuroblastoma cells. Exp Neurol. 1999;155(2):252-9. IF 4.54

Fabrizi C, Businaro R, Persichini T, Fumagalli L, Lauro GM. The expression of the LDL receptor-related protein (LRP) correlates with the differentiation of human neuroblastoma cells. Brain Res. 1997;776(1-2):154-61. IF 2.89

Businaro R, Fabrizi C, Persichini T, Starace G, Ennas MG, Fumagalli L, Lauro GM. Modulation of the alpha 2 macroglobulin receptor/low density lipoprotein receptor related protein by interferon-gamma in human astroglial cells. J Neuroimmunol. 1997;72(1):75-81. IF 3.014

Fumagalli L, Businaro R, Nori SL, Toesca A, Pompili E, Evangelisti E,Giannetti S, Ippoliti F, De Renzis G. Protease inhibitors in mouse skeletal muscle: tissue-associated components of serum inhibitors and calpastatin. Cell Mol Biol (Noisy-le-grand). 1996;42(4):535-46. IF 1.46

Businaro R, Nori SL, Toesca A, De Renzis G, Ortolani F, De Santis E, Fumagalli L. Immunohistochemical detection of three serum protease inhibitors in mouse skeletal muscle by confocal laser scanning microscopy. Ital J Anat Embryol. 1995;100 Suppl 1:123-30 IF 0.621

Fumagalli L., Businaro R., Nori S.L., Toesca A., Collier W.L., De Renzis G. (1996) Evidence for tissue-associated α2-macroglobulin in mouse skeletal muscle. Molecular and Chemical Neuropathology 27: 211-223. IF 1.163

Fabrizi C., Colasanti M., Persichini T., Businaro R., Starace G., Lauro G. M. (1994) Interferon gamma up-regulates α2macroglobulin expression in human astrocytoma cells. J. Neuroimmunol. 53: 31-37. IF 3.355

Nori S.L., Businaro R., Fabrizi C., Moestrup S.K., Starace G., Fumagalli L., Lauro G.M. (1993) Receptor-mediated endocytosis of α2macroglobulin by a glioma cell line. Neuroreport 4 (4):423-426. IF2.49

Lauro G.M., Fabrizi C., Businaro R., Fumagalli L., Torelli S., Gremo F. (1992) Human astroglial but not microglial cells synthetize α2macroglobulin in vitro. It. J. Neurol.Sci. 13:661- 665. IF 0.26

Businaro R., Fabrizi C., Fumagalli L., Lauro G.M., (1992) Synthesis and secretion of α2macroglobulin by human glioma established cell lines. Exptl. Brain Res. 88, 213-218. IF 2.05

Businaro R., Tranquilli-Leali F.M., De Renzis G., Pompili E., Pagliari G., Fumagalli L. (1992) Inter-α-trypsin inhibitor-related immunoreactivity in human tissues and body fluids. Cell. Mol. Biol. 38(4): 463-471. IF 1,449

Businaro R., De Renzis G., Fumagalli L., Fioretti E., Citro G., Ascoli F. (1989) Bovine pancreatic trypsin inhibitor and related isoinhibitors in bovine liver. A biochemical and histochemical study. Histochemistry 93:69-74. IF 2.41

Fiorucci L., De Renzis G., Businaro R., Fumagalli L., Fioretti E., Giardina B., Ascoli F. (1989) Identification and immunohistochemical localization of various bovine pancreatic trypsin inhibitor-isoforms in bovine pituitary gland. Histochem. J. 212:721-730. IF 1.56

Fioretti E., Businaro R., Fumagalli L., Angeletti M., Citro G., De Renzis G., Fiorucci L., Ascoli F. (1988) Specific antibodies as tools for cellular localization of Kunitz-type isoinhibitors in bovine organs. It. J. Biochem. 37:233-235. IF 0.379

Businaro R., Fioretti E., Fumagalli L., Citro G., De Renzis G., Ascoli F. (1988) Cellular localization of bovine pancreatic trypsin inhibitor and related molecular forms in bovine lung. Histochem. J. 20:187-193. IF 1.56

Cozza P., Businaro R., Ciano A., Nori S., De Renzis G., Fumagalli L. (1987) L`arcata zigomatico-mascellare come sistema di rinforzo orizzontale nel massiccio facciale dell`uomo. Riv. It. Odontoiatria e Protesi Dentaria 2:21-25.

Businaro R., Mannella E., Cochi S., Fioravanti D., Bettazzoni S., Ippoliti F. (1987) Inverse relationship between spontaneous interleukin-1 production and mitogen-driven proliferation in patients with pulmonary tuberculosis. Allergie et Immunologie 19:189-196.

Businaro R., Fioretti E., Fumagalli L., Citro G., De Renzis G., Ascoli F. (1987) Vascular localization of bovine pancreatic trypsin inhibitor-related molecular forms in bovine spleen. Eur. J. Biochem. 165:79-82. IF 3.27

Diamond L., Perussia B., Businaro R., Perrella F. (1985) HL-60 variant reversibly resistant to induction of differentiation by phorbol esters. Carcinogen. Compr. Surv. 10:287-302. IF 3.51

Butler R., Businaro R., Revoltella R. (1984) Interleukin-1 activity produced by various precursor monocytic cell lines. In: New Trends in Experimental Haematology. Oncogenes, Stem Cells, Bone Marrow Transplantation, Peschle C. ed. Serono Symp. Rev. 7:100-104

Revoltella R., Businaro R., Lauro G., Toesca A. (1982) Tumor-associated neural differentiation antigens detected on C1300 neuroblastoma cells by hybridoma monoclonal auto-antibodies. Cell. Immunol. 68:75-92. IF 2.14

Businaro R., Revoltella R. (1982) Different effects of hybridoma antibodies against nerve growth factor in neonatal mice. Clin. Immunol. and Immunopathol. 22:1-8. IF 2.56

Businaro R., Butler R., Rubenstein A., Revoltella R. (1981) Monoclonal antibodies against nerve growth factor produced by somatic cell hybrids. J. Neurosci. Res. 6:89-98. IF 2.84

Lauro G., Businaro R., Butler R., Revoltella R. (1980) Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells. J. Natl. Cancer Inst. 64:1169-1172. IF 10.33

Carli M., Bucolo C., Pannunzio M.T., Ongaro G.,

Prof. Pier Mario Biava M.D.

Scritto da Fabio Miliucci il 15 Aprile 2024. Pubblicato in Comitato Scientifico.

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

Prof. Pier Mario Biava

Docente per numerosi anni alla Scuola di Specializzazione di Medicina del Lavoro di Trieste, attualmente lavora presso l’Istituto di Ricerca e Cura a Carattere Scientifico Multimedica di Milano.

Primo scienziato al mondo a scoprire i fattori di crescita e differenziazione delle cellule staminali

Autore di più di 100 pubblicazioni scientifiche e di 12 libri tradotti in più lingue

Professore a contratto Universita’Nicolò Cusano

Istituto di Ricerca e Cura a Carattere Scientifico Multimedica di Milano

Prof. Marcello D’Amelio, PhD, MSc

Scritto da Fabio Miliucci il 15 Aprile 2024. Pubblicato in Comitato Scientifico.

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

Associate Professor in Neurophysiology / Team Leader

INSTITUTION AND LOCATION

Biochemistry and Molecular Biology University of Bari, Italy

Neurosciences, University of Rome “Tor Vergata”

Clinical Research, University of Rome, “La Sapienza”

Positions and Honors

1998-2000 Undergraduate student, University of Bari, (Bari, Italy) Dept. Pharmaco-Biology headed by Prof. Ferdinando Palmieri. Field of study: Identification and characterization of mitochondrial carriers. Tutor: Prof. Luigi Palmieri.
2000- 2001 Research Fellow, Medical Genetics at IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo (FG); Field of study: Molecular Genetics of Nonsyndromic Recessive Deafness and Juvenile Hereditary Hemochromatosis . Tutor: Prof. Paolo Gasparini.
2001-2003 Research Fellow, Telethon Institute of Genetics and Medicine (Napoli, Italy) headed by Prof. Andrea Ballabio. Field of study: Identification of genes involved in complex diseases. Tutor: Prof. Paolo Gasparini.
2003-2005 Research Fellow, Laboratory of Molecular Psychiatry, University of Rome, “Campus- Biomedico”, Rome, Italy. Field of study: Molecular Genetics of neuropsychiatry disorders (Autism and Schizophrenia). Tutor: Prof. Antonio Persico.
December 2003, Laboratory of Biochemistry of the Regional University Hospital of Tours (France). Field of study: Genetics of autism. Tutor: Prof. Christian Andres.
July 2004, Department of Genome Sciences, University of Washington School of Medicine, Seattle (WA, USA). Field of study: Paraoxonase enzymes involved in autism disorder. Tutor: Prof. Clement Furlong.
June 2004-June 2005, Department of Pharmacology, Vanderbilt University Medical Center, Nashville (TN, USA). Field of study: Neurodevelopmental Disorders: Genetics and Biochemistry. Tutor: Prof. Pat Levitt.
January 2007-December 2007, Department of Experimental Medicine and Pathology and Research Centre for Clinical Investigation (CRISC), La Sapienza University of Rome, Rome, Italy. Field of study: Clinical Experimentation. Tutor: Prof. R.Verna.
2005-present, Department Experimental Neurosciences, IRCCS “Santa Lucia Foundation”, (Rome, Italy). Field of study: Analysis of synaptic degeneration in mouse model of human disease (Alzheimer’s Disease and Multiple Sclerosis); Apoptosis and Autophagy applied to neuroscience field; Neurodevolopmental Disorders (Autism).
02/2010-present, Associate Professor in Human Neurophysiology and Head of Molecular Neuroscience Laboratory

Reviewer for the following International Journals

Apoptosis
Journal of Neuroscience

Editorial Board Member of

Neuromolecular Medicine
Scientific Reports section of Neuroscience (Nature group) Current Pharmaceutical Design, Special Guest Editor

Member of International PhD School in Neurosciences (University of Tor Vergata, Rome, Italy) PROFESSIONAL SOCIETY MEMBERSHIP

Since 2003 Since 2004 Since 2010 Since 2013

Member of the Italian Society of Biochemistry and Molecular Biology (SIB) Member of the Society of Neuroscience (SFN)
Member of the Italian Society of Pharmacology
Member of Italia the Society of Physiology

Scientific Prize

Bioeconomy Rome 2013, Prize for outstanding contributions of young italian scientists in the field of translational research in neurodegeneration.

Patents

Autophagy enhancing compounds, peptides and peptidomimetic compounds for use in the treatment of neuronal diseases – PCT Patent 2012/076555.

Scientific indicators of productivity

Official H index: 23
Total citations: 3959
n. of peer reviewed papers: 50
—
Nobili A, Latagliata C,Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, Krashia P, Rizzo FR, Marino R, Federici M, De Bartolo PAversa D, Dell’Acqua MC Cordella A,Sancandi M, Keller F, Petrosini L, Puglisi- Allegra S, Mercuri N, Coccurello R, Berretta N, D’Amelio M
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease Nature Communications, in press, DOI: 10.1038/ncomms14727

Gelfo F, Cutuli D, Nobili A, De Bartolo P, D’Amelio M, Petrosini L, Caltagirone C. Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration. J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160892.

Costa C, Parnetti L, D’Amelio M, Tozzi A, Tantucci M, et al. Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?. Neurobiol Aging. 2016 Dec;48:161-171. PubMed PMID: 27701029.

Krashia P, Martini A, Nobili A, Aversa D, D’Amelio M, Berretta N, Guatteo E, Mercuri NB. On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area.
Eur J Neurosci. 2017 Jan;45(1):92-105. doi: 10.1111/ejn.13364.

Guatteo E, Rizzo FR, Federici M, Cordella A, Ledonne A, Latini L, Nobili A, Viscomi MT, Biamonte F, Landrock KK, Martini A, Aversa D, Schepisi C, D’Amelio M, Berretta N, Mercuri NB. Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats. Exp Neurol. 2017 Jan;287(Pt 1):21-33

Bisicchia E, Latini L, Cavallucci V, Sasso V, Nicolin V, Molinari M, D’Amelio M, Viscomi MT. Autophagy Inhibition Favors Survival of Rubrospinal Neurons After Spinal Cord Hemisection. Mol Neurobiol. 2016 Aug 11.

Nisticò R, Florenzano F, Mango D, Ferraina C, Grilli M, Di Prisco S, Nobili A, Saccucci S, D’Amelio M, Morbin M, Marchi M, Mercuri NB, Davis RJ, Pittaluga A, Feligioni M. Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release. Sci Rep. 2015 Mar 12;5:9035. doi: 10.1038/srep09035.

Cavallucci V, Bisicchia E, Cencioni MT, Ferri A, Latini L, Nobili A, Biamonte F, Nazio F, Fanelli F, Moreno S, Molinari M, Viscomi MT, D’Amelio M. Acute focal brain damage alters mitochondrial dynamics and autophagy in axotomized neurons. Cell Death Dis. 2014 Nov 27;5:e1545. doi: 10.1038/cddis.2014.511.

Ledonne A, Nobili A, Latagliata EC, Cavallucci V, Guatteo E, Puglisi-Allegra S, D’Amelio M*, Mercuri NB*. Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. Mol Psychiatry. 2015 Aug;20(8):959-73. doi: 10.1038/mp.2014.109. *Equal senior authors

Cutuli D., De Bartolo P., Caporali P., Tartaglione A., Oddi D., D’Amato F.R., Nobili A., D’Amelio M*. and Petrosini L*. Neuroprotective effects of donepezil against cholinergic depletion. Alzheimer’s Research & Therapy 2013, 5:50, 2013. *Equal contribution

Cavallucci V, Berretta N, Nobili A, Nisticò R, Mercuri NB, D’Amelio M. Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer’s disease. Neuromolecular Med. 2013 Sep;15(3):541-8. doi: 10.1007/s12017-013-8241-2.

Middei S, Houeland G, Cavallucci V, Ammassari-Teule M, D’Amelio M and Marie H. CREB is necessary for synaptic maintenance and learning- induced changes of the AMPA receptor GluA1 subunit. Hippocampus 2013 (doi: 10.1002/hipo.22108).

Cavallucci V, Ferraina C, D’Amelio M. Key role of mitochondria in Alzheimer’s Disease synaptic dysfunction. Curr Pharm Des. 2013.

Fanelli F, Sepe S, D Amelio M, Bernardi C, Cristiano L, Cimini A, Cecconi F, Ceru’ MP, Moreno S. Age- dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer’s disease. Mol Neurodegener. 2013;8:8.

Klionsy DJ,…D’Amelio M., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 8, 445-544.

Viscomi MT, D’Amelio M. The “Janus-faced role” of autophagy in neuronal sickness: focus on neurodegeneration. Mol Neurobiol. 2012; 46:513-21.

La Rosa LR, Matrone C, Ferraina C, Panico MB, Piccirilli S, Di Certo MG, Strimpakos G, Mercuri NB, Calissano P, D’Amelio M*, Nisticò R*. Age-Related Changes of Hippocampal Synaptic Plasticity in AβPP- Null Mice are Restored by NGF through p75NTR. J Alzheimers Dis. 2012 Sep 6. *Equal Senior Authors.

D’Amelio M., Sheng M., Cecconi F., Caspase-3 in health and disease of the nervous system. Trends Neurosci. 2012 Jul 13.

D’Amelio M and Rossini PM. “Brain excitability and connectivity of neuronal assemblies in Alzheimer’s Disease” Prog Neurobiol. 2012 ; 99:42-60.

Nisticò R, Cavallucci V, Piccinin S, Macrì S, Pignatelli M, Mehdawy B, Blandini F, Laviola G, Lauro D, Mercuri NB, D’Amelio M Insulin Receptor β-Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory. Neuromolecular Med. 2012;14:262-9.

Viscomi MT*, D’Amelio M*, Cavallucci V, Latini L, Moreno S., BisicchiaE, Nazio F, Cecconi F. & Marco Molinari M Autophagy activation protects neurons from remote degeneration after acute focal damage, Autophagy. 2012 ;8, 222-235.
* Equal Contributions

D’Amelio M, Cavallucci V., Middei S., Marchetti C., Pacioni S., Ferri A., Diamantini A., De Zio D., Carrara P., Battistini L., Moreno S., Bacci A., Ammassari-Teule M., Marie H., Cecconi F. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer’s Disease. Nature Neuroscience, 2011 Jan;14:69-76

Cimini A, Moreno S, D’Amelio M, Cristiano L, D’Angelo B, Falone S, Benedetti E, Carrara P, Fanelli F, Cecconi F, Amicarelli F, Cerù MP. Early Biochemical and Morphological Modifications in the Brain of a Transgenic Mouse Model of Alzheimer’s Disease: A Role for Peroxisomes. J Alzheimers Dis. 2009

Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D’Amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni MT, Diamantini A, Butti E, Comi G, Bernardi G, Cecconi F, Battistini L, Furlan R, Martino G. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci. 2009;29:3442-52.

D’Amelio M, Cavallucci V, Diamantini A, Cecconi F. Analysis of neuronal cell death in mammals. Methods Enzymol. 2008;446:259-76.

D’Amelio M, Tino E, Cecconi F. The apoptosome: emerging insights and new potential targets for drug design. Pharm Res. 2008 Apr;25:740-51.

Research Support

Early career development grant (University Campus Biomedico, Rome) (2010-2013)
Projects for Research of National Interest, Italy (2011-2014)
Grant from the Alzheimer’s Association (NIRG-11-204588)
Grant from Italian Ministry of Health (2014-2017) Unraveling the mystery of Alzheimer’s Disease-related synaptic degeneration (Project Code: GR-2011-02351457)
Grant from International Research on Paraplegia (IRP Foundation), #P141, Switzerland (2013-2015); Role Co-PI Title: The autophagy machinery as therapeutic target to counteract remote degeneration after spinal cord injury, PI: Maria Teresa Viscomi (Santa Lucia Foundation, Rome)

Dott. Stefano Ciaurelli, Msc

DIRETTORE AREA CLINICA CENTRI VITA365 E CMNS/VITA365

EDUCATION

REFERENCES

Prof. Trevor Cornelius Stuart Archer, MD, PhD

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

Education and Appointments

Positions

Prof.ssa Rita Businaro

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

WORK EXPERIENCE

MAIN ACTIVITIES AND RESPONSIBILITIES

MAIN RESEARCH TOPICS

GRANTS

Referee for the following journals

Prof. Pier Mario Biava M.D.

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

Prof. Marcello D’Amelio, PhD, MSc

COMPONENTE COMITATO SCIENTIFICO CMNS/VITA365

Associate Professor in Neurophysiology / Team Leader

INSTITUTION AND LOCATION

Positions and Honors

Reviewer for the following International Journals

Editorial Board Member of

Member of International PhD School in Neurosciences (University of Tor Vergata, Rome, Italy) PROFESSIONAL SOCIETY MEMBERSHIP

Scientific Prize

Patents

Scientific indicators of productivity

Research Support

DIRETTORE AREA CLINICA CENTRI VITA365
E CMNS/VITA365